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Abstract
The ability to invade its surrounding tissue is one of the acknowledged hallmarks of
cancer. This complex multi-scale process is affected by many players of the tumour
microenvironment (TME), including the extracellular matrix (ECM) and various
stromal cells such as macrophages. One of these key processes is the secretion of
matrix degrading enzymes that enables the degradation of the neighbouring ECM
and cell-matrix adhesion. By varying the strength of cell-matrix and multiple cell-
cell adhesions, cancer cells can spread into the surrounding tissues which combined
with an unregulated proliferation results in an uncontrollable, indefinite growth.
This thesis considers a continuous multi-scale moving boundary model for gen-
eral solid tumours that takes into account the multi-scale interactions between the
different cell populations and a two-phase ECM as well as the proteolytic molecular
processes taking place along the leading edge of a growing solid tumour. To that
end, we investigate how one of the most abundant immune cells in the TME, the
macrophages, and their phenotype influence the overall tumour progression, by ex-
ploring their multi-scale effects. Moreover, we extend our approach and consider a
discrete cell population consisting of individual cancer cells that allows us to further
study the complex interaction between the cancer cells and a two-phase ECM as
well as the overall shape and migration type of a tumour aggregation. Finally, we
apply our general continuous model to a specific type of brain tumour, glioblas-
tomas, using patient-specific brain scans that allows us to investigate the role of




Over the last few decades, cancer has gained increased attention due to its diversity
and capability to metastasise, one of the leading causes of death. Cancer is also
known to be effective at developing drug resistance to current treatment strategies,
which further increases the need to understand this complex, deadly disease with
the hope of establishing successful treatment protocols. This has been motivating
current research interest within many different scientific fields such as biology and
mathematics. While biology collects concluding evidence for various possible treat-
ments using experiments, mathematics connects new theories and hypotheses with
these experiments, ultimately reducing the cost of novel discoveries that otherwise
would be both impractical and expensive.
1.1 Biological Background
The main difference between normal and cancer cells is that while the former one can
be controlled and regulated through different signals [77], cancer cells acquired vari-
ous hallmark capabilities that help them avoid these regulations leading to abnormal
cell functions [99, 98]. One of these identified ”hallmarks of cancer” is the cancer
cells’ ability to invade the surrounding tissues by altering their local and non-local
1
interaction to both neighbouring cells (which can either be cancerous or of different
types) and extracellular matrix (ECM). Pioneer cells that gain this ability at some
point during the tumour development may detach from the primary tumour mass
and travel to distant sites where they have a chance to form new secondary colonies.
This process is called metastasis, which can be especially lethal when cancer cells
get into the bloodstream that transports them to a new terrain where, at least at
the beginning, they have access to abundant nutrients, and space [161]. Generally
speaking, once these distant tumour sites are formed, for example, in bone, liver or
brain, the survival rate is drastically decreased and in most cases (90%) eventually
leads to death [253].
Tumours are also referred to as ”wounds that never heal” [78] because most
processes associated with wound healing are similar to the ones involved in tumour
development, and so the immune system reacts to both of them similarly. However,
while for wound healing, such an immune response is necessary and effective, for
tumour development, it has an opposite effect, and in most cases, it promotes tumour
growth rather than stops it.
1.1.1 The Tumour Micro-environment
In the following, we briefly review some components of the tumour micro-environment
(TME) which are the focus of this Thesis.
ECM. The ECM is a complex network of various macromolecules (such as fi-
brous proteins, water, minerals and proteoglycans) and plays an essential role in
any healthy tissue [77]. For instance, it regulates cell behaviour and tissue home-
ostasis, enables cell migration and communication as well as it provides structural
support. It can be split into two major phases, a fibre ECM phase, accounting for all
significant fibrous proteins (such as collagen and fibronectin) and a non-fibre ECM
phase that contains every other ECM constituent (such as non-fibrous proteins,
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enzymes, polysaccharides and extracellular Ca2+ions). To maintain its functional-
ity, the ECM is subject to continuous remodelling (via synthesis and degradation).
However, this carefully orchestrated process is disturbed by the progressing tumour,
resulting in drastic changes in the structure of the ECM (i.e., a rearrangement of the
ECM micro-fibre constituents). Moreover, in the tumour microenvironment (TME),
the excessive degradation of the ECM is related to the over-secretion of several en-
zymes capable of degrading the ECM, for instance, the matrix metalloproteinases
(MMPs). Such enzymes are not explicitly tied to cancer cells, but instead, several
other stromal cells within the TME secrete them as well [171].
Macrophages. One of these stromal cell populations is the macrophages, which
can form up to 50% of the tumour mass [132, 286]. The immune system’s response
to a tumour’s presence is to send white blood cells called monocytes (which are
produced by stem cells in the bone marrow) to the tumour sites through the blood-
stream, and once they leave the vasculature, they mature into macrophages. The,
macrophages are a heterogeneous set of differentiated immune cells that are polarised
according to the surrounding stimuli to exhibit different properties and functions.
A specific class of these cells present in the TME, is called the tumour-associated
macrophages (TAMs), and they are in general correlated with poor prognosis in var-
ious type of cancers [39, 41, 96, 151, 223, 288, 296, 306, 307, 311]. These activated
macrophages are often categorised as the pro-inflammatory M1-like macrophages
and the anti-inflammatory M2-like macrophages, and so while the former expresses
anti-tumoral functions, the latter one has pro-tumoral properties. These phenotypes
are illustrated in Figure 1.1. Due to their fundamentally different effects on the tu-
mour, the ratio between the M1 and M2 TAMs can significantly affect the prognosis
[61, 204, 303, 307, 222]. Because of the plasticity of macrophages phenotypes (i.e.,
their phenotype can be changed in response to the environment [24, 234]) (a process







  - Pro-inflammatory
  - Microbicidal
  - Anti-tumoral
M2 macrophage
Functions:
  - Anti-inflammatory
  - Wound healing
  - Pro-tumoral
Figure 1.1: Illustration of the two macrophage phenotype and their primary roles
as well as the possible switch (polarisation and re-polarisation) between the two phe-
notype.
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towards an M1 phenotype has been shown to reduce tumour progression [201, 308].
Nutrients. Nutrients (e.g. oxygen and glucose) are essential for any cells to live
and function properly, including cancer cells and macrophages, and so in healthy
tissues, a certain level of nutrients is maintained. In order to supply these vital nutri-
ents to every tissue of the body, nutrients are extravasated from the blood flow and
diffuse through the ECM. However, the progressing tumour destroys significant parts
of the vasculature, excessively influencing the blood flow and, therefore, the level
of supplied nutrients. Even though tumours are capable of promoting new blood
vessels through the secretion of vascular endothelial growth factors [34, 195, 277],
due to their rapid expansion, they outgrow the nutrient supply [250]. Consequently,
once they reach a certain size, these blood vessels can no longer fully penetrate the
tumour and reach their centre. Therefore, as the advancing tumour over-consumes
the nutrient supply, it creates areas where the level of nutrients becomes low, so
such areas first become hypoxic and then necrotic. Accordingly, cells situated in
necrotic regions are being deprived of nutrients, leading to cell death and ultimately
giving rise to a dense necrotic core. Quiescent cells that are located within the
hypoxic layer that surrounds the necrotic core change their behaviour to promote
ECM remodelling as well as they become more migratory and metastatic. In the
proliferating rim where the level of nutrients is still sufficient for typical cell func-
tions, cancer cells directly interacting with the surrounding ECM and stroma, and
so they are responsible for the invasion of the local tissue neighbourhood. These
three regions are also illustrated in Figure 1.2. Finally, since nutrients are vital for
each cell, the reduced levels affecting not only the cancer cell population but also
the macrophages in many ways, including proliferation, death and the rate at which





Figure 1.2: Illustration of a tumour with its three basic layers, namely outer pro-
liferating rim, middle hypoxic/quiescent region and inner necrotic core.
1.1.2 Local Cancer Invasion
The phenomenon of local cell invasion is a result of multiple crucial underlying
cell-scale (micro-scale) processes that are often interlinked. Together, they enable
cell migration and collective population dynamics, which result in this tissue-scale
(macro-scale) phenomenon called cell invasion. A recognised hallmark of cancer cells
[98] is that they acquire the ability to stimulate themselves with their own growth
factors (thus reducing their dependency on growth factors produced by other cells),
which leads to tumour growth. Moreover, cancer cells are also capable of secret-
ing various matrix degrading enzymes (MDEs) (such as MMPs, a property that, as
mentioned before, are not exclusive to them) which travel through the ECM (within
a cell-scale neighbourhood) and degrade several ECM components (called proteol-
ysis), resulting in changes in the local surrounding tissue structure. Ultimately, all
these processes mutually enable sustainable tumour growth and spread.
Although collective cell migration is present in a healthy environment, it also
plays a vital role in tumour development since it allows cells to travel and invade
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into the surrounding tissues as a community [25, 26, 129, 276]. This collective cell
migration is enabled by different cell-cell and cell-ECM adhesions. For instance, can-
cer cells and macrophages can establish adhesive bonds between each other through
the secretion of cell adhesion molecules; in addition, individual cells can also ini-
tiate adhesive bonds with different ECM constituents, bonds which are regulated
by integrins (a calcium-independent cell adhesion molecule that connects the cell’s
cytoskeleton to the surrounding ECM). Ultimately, cells can vary the strength of
these different adhesions, allowing them to develop different migratory patterns.
For example, a decrease in cell-cell adhesion combined with an increase in cell-ECM
adhesions enables the cancer cells to detach from the primary tumour mass and in-
vade further into the neighbouring tissues, which results in a more invasive tumour
behaviour [42].
1.1.3 Glioblastoma Multiforme
An example for a solid tumour and more specifically a brain tumour is the highly
invasive and aggressive glioblastoma multiforme which typically has poor patient
prognosis [35, 65, 139, 162, 182, 216, 252] (median survival rate is less than 1 year
[33]). These tumours arise from abnormal glial cells located in the central nervous
system, and shortly after their appearance they invade the surrounding tissues in
a heterogeneous fashion. This heterogeneous invasion pattern leads to tumours
whose outer edges are difficult or impossible to determine with current imaging
technologies, including for instance magnetic resonance imaging (MRI) and diffusion
tensor imaging (DTI), both of which measure the diffusion of water molecules and
enable the study of brain structures. For this reason, tumour recurrence is inevitable
and complete surgical resection is impossible without greatly damaging also the
healthy tissue of the brain [100].
As for other tumour cell types, the glioblastoma cell invasion into the brain
extracellular matrix (ECM) is the result of the secretion of proteolic enzymes, as well
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as cell-cell and cell-ECM interactions [100]. Glioma cells can navigate along brain
structures, such as blood vessels (but they rarely intravasate into blood vessels)
[100].
Due to the limited experimental approaches that one can use to study the brain,
researchers have started using mathematical models to provide certain biological
insights that otherwise would be difficult to obtain experimentally. Such models can
help predict how tumours grow for specific patients, aiding clinicians in decision-
making, or they can help test and provide new hypotheses about potential anti-
tumour treatments.
1.2 Mathematical Modelling of Tumour Develop-
ment
In spite of the advancements achieved over the years in theoretical and experimen-
tal biology, tumour development still poses one of the greatest challenges within
the scientific community. It is difficult to accurately predict tumour’s behaviour
as it involves modelling several interlinked processes occurring on different spatio-
temporal scales. Existing techniques are often expensive, and relax the complexity
of the problem by constraining it to a single scale,leading to significant information
loss and reduced predictive capabilities. Thus, this thesis builds on and extends a
multi-scale mathematical/computational model introduced in [279, 245], to further
propose new research hypotheses, to narrow down scientific ideas and to predict
outcomes.
1.2.1 Continuous and Hybrid Models
In the past few decades, we have seen substantial advances in mathematical and
computational modelling approaches that are used for predicting certain outcomes,
8
exploring potential treatments or just trying to capture the general underlying pro-
cesses [7, 8, 9, 11, 14, 12, 37, 44, 47, 46, 63, 67, 68, 70, 135, 141, 174, 180, 183, 217,
232, 245, 258, 272, 279, 59]. These modelling approaches can be categorised into two
main types, namely discrete and continuous models and each of these techniques
carries its own advantages and disadvantages [239]. To minimise drawbacks, people
formulated the so-called hybrid methods that combine these two models which can
also be used to study tumour development [44].
The continuous approaches
The main advantage of the continuous approaches is that they allow us to model the
dynamics on a population scale, and so we do not need to consider and store each
individual cell’s position and properties. This reduces memory storage as well as
speeds up the computation, enabling us to carry out longer computational simula-
tions within a larger space. This is especially important when we would like to study,
for example, the effects of drugs or various treatment strategies in the long term.
On the other hand, this also impedes us to give different properties to individual
cells that may be useful or required in some cases. Moreover, continuous approaches
that model cell movement also require the use of appropriate numerical schemes to
avoid, for instance, negativity and to keep the conservation of mass property of the
partial differential equation (PDE). In some cases, this may be difficult and require
additional computations.
It is now widely known that both MDEs (and so the degradation of the ECM
[164, 190]) and ECM structure [102, 301] play an important role within the cell
migration process and thus they have been incorporated into many mathematical
models. On one hand, an important aspect of these proteolytic enzymes is their
secretion and transport within a cell-scale neighbourhood, directly impacting the
level of ECM degradation in the surrounding tissue [9, 46, 67, 206, 246, 279]. On
the other hand, the structure of the underlying ECM and its effect on cell migration,
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adhesion, proliferation has also received its own spotlight [14, 17, 29, 48, 81, 203,
245, 280] as well as how the heterogeneity of the ECM affects tumour development
[48, 107, 203].
One of the first studies that proposed a continuous modelling approach for the in-
teractions between cancer cells and ECM via MDEs was [11]. There, the movement
of cancer cells was split into a diffusion term describing random cell motility, and
a haptotaxis term that biases cell movement according to the surrounding ECM. It
was concluded, using numerical simulations, that haptotaxis plays a significant role
in cancer cell invasion and that it cannot be ignored within mathematical models.
Later, a continuous approach for cell-cell adhesion was derived in [17] which describes
cell sensing and biding in a non-local fashion that ultimately guides cell movement
based on cell-cell adhesive forces. This non-local approach was extended to also
incorporate cell-matrix adhesions in [81] where a thorough numerical investigation
was carried out. Also, the same model was analytically studied in [45] with different
adhesion regimes to show how these changes affect the cancer cell population. Fur-
thermore, in recent years, a modelling approach for capturing the underlying ECM
structure was proposed in [245] where a multi-scale two-phase ECM was consid-
ered that introduces further bias for the cancer cell movement. Hence, this model
empowers the cancer cells to follow the micro-scale distribution of the fibre ECM
phase, which in the meantime is being rearranged by the cancer cell population in a
multi-scale manner. Another continuous model that focuses on tissue structure and
aims to investigate mesenchymal motion was proposed in [106] and later expanded in
[203] where it was shown that contact-guidance and ECM remodelling are adequate
for cell invasion.
The other abundant cell population within the TME is the macrophages. De-
spite the fact that they are present in significant quantities, only a modest number
of mathematical models consider their role during tumour development [63, 141,
174, 180, 200, 198, 199, 290]. Since macrophages are indeed immune cells, initial
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models [200, 199, 290] were only focusing on their anti-tumoral role and used them
within treatment strategies. However, a turning point that escalated the research
of macrophages occurred when the dual role of macrophages was discovered within
tumours [156, 214] where the positive correlation between TAMs and tumour growth
was shown. Consequently, mathematical models started to focus on the plasticity
of the macrophages, and the fact that cancer cells are able to polarise them into
the pro-tumoral M2 phenotype [141, 174]. Hence, these models began studying how
M2-like macrophages affected the overall tumour development, which ultimately led
to multiple biological research theorising the possibility of re-polarising these pro-
tumoral M2 TAMs back into the anti-tumoral M1 TAMs and whether this would
be an effective treatment strategy [49, 61, 105, 197, 204, 307]. However, due to the
novelty of this theory, the number of mathematical models focusing on it has been
limited [32, 74, 137, 142, 163, 289].
Due to their essential role, nutrients have been the focus of many mathemat-
ical models. As was mentioned before, the depleted level of nutrients emerges a
three-layer structure in tumours (necrotic core, hypoxic region of quiescent cells and
proliferating rim) which many models have successfully reproduced [13, 15, 36, 124,
126, 168, 169, 177, 244].
The hybrid approaches
Finally, the second class of mathematical models that we consider is the so-called
hybrid models. The aim of using them is to combine the advantages of both con-
tinuous and discrete models that can ultimately give further insights into some of
the underlying processes. One of the advantages of these models is that complex
intracellular changes can be modelled and follow for each individual cells (agents)
simply by using ordinary differential equations. Moreover, it is possible to trace ex-
tracellular factors via partial differential equations without the need to sacrifice the
agent-based approach. Hence, this approach is well suited for the multi-scale nature
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of cancer and can be used to model different processes on various scales [44, 231].
There are various sub-types of discrete models that one can use within a hybrid
approach such as cellular automata models [12, 136, 213, 274], cellular potts models
[10, 215, 255] and particle-force models [83, 120, 185]. Of particular importance
for us are the particle-force models, that allows us to model individual cells in an
off-lattice setup, and so the position of a cell does not depend on any predefined
grid. The model that we will use and extend was originally introduced in [135] and
later extended in several other works [27, 127, 128] to incorporate different aspects of
cancer invasion and to investigate different drug delivery strategies. Looking at these
hybrid mathematical modelling approaches over the last couple of decades in general,
we can see significant advances both in theory and application to a wide variety of
cancer related problems [43, 62, 83, 110, 149, 167, 207, 218, 233, 240, 256, 271, 280].
1.2.2 3D Continuous Glioma Models
Although the majority of the above-mentioned models do not restrict themselves
to a specific tumour type and rather focus on general tumours, there are some
models that focus on the evolution of specific tumour types such as gliomas within
the brain [5, 75, 116, 202, 241, 267, 269, 268, 270]. These models are also very
important since they help us understand how the different components of a model
can affect the overall tumour progression via fitting the model to real-word examples
of tumour growths. Recently, models also started to incorporate the structure of the
brain, by including MRI and DTI scans [53, 54, 75, 116, 121, 143, 202] which can be
thought of as one of the underlying components that can be fit to patient-specific
tumours. Even though these images are generated in 3D, most of these models
are simulating the tumour growth in 2D and only a few of them are 3D models
[53, 260, 302]. Moreover, as mentioned before, the majority of published models
focus on tumour progression only on one spatio-temporal scale and neglect the fact
that it is characterised by various biological processes occurring on different scales.
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Therefore, the literature lack of 3D multi-scale approaches that can appropriately
model complex brain tumour behaviour.
1.3 Thesis Outline
The primary aim of this thesis is to gain further insights into the complex tumour
development process by investigating the collective migration of cancer cells as well
as studying one of the most abundant stromal cells within TME, i.e., the macrophage
population. To explore the behaviour and effects of macrophages, we use a fully
continuous multi-scale moving boundary model that is expanded upon the initial
framework introduced in [279] and later expanded in [245] to account for the micro-
scale structure of the ECM. On the other hand, to further investigate both the
overall shape of tumour aggregations as well as cell migration and invasion patterns,
we develop a hybrid multi-scale model that combines a continuous multi-scale two-
phase ECM [245], and a discrete off-lattice agent-based model MultiCell-LF for
the cancer cells [27, 128, 135]. Furthermore, we apply our continuous multi-scale
framework to a specific tumour type, to study tumour growth in a 3D fibrous brain
environment.
Specifically, in Chapter 2, we will extend the multi-scale moving boundary model
introduced in [245] by including the M2 TAMs population and several of its effects
exercised on the rest of the tumour dynamics. Hence, in this model, we consider the
tumour dynamics to be given by a mix of two interacting populations, i.e., cancer
and M2 TAMs, embedded within a two-phase ECM. To this end, we will study the
movement of macrophages and how this affects the overall tumour progression by
considering both random and directed movements of these immune cells, where the
directed portion incorporates multiple non-local adhesion processes. Moreover, we
incorporate a few effects of the M2 TAMs exerted on the cancer cells within the
macro-scale dynamics, such as regulation of proliferation and bias of cell migration.
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Besides these macro-scale effects, due to their ability to secrete MDEs, M2 TAMs
also play an important role in both the proteolytic processes occurring at the leading
edge of the tumour and the fibre rearrangement process. Consequently, we capture
the effects of M2 TAMs in a multi-scale fashion and examine their extensive effects
on the overall tumour invasion process. The extension presented in this chapter
will be numerically explored, placing particular focus on the macrophage non-local
interactions.
Besides the M2-like macrophages, in Chapter 3, we also include the contribution
of M1-like macrophages to the overall tumour dynamics, by considering the impact
of these cells to both macro- and micro-scales. We pay special attention to the
dynamics of M1 and M2 cells near the tumour interface, and their interactions with
the tumour and with the ECM. We also focus on the M1→M2 tumour-induced po-
larisation (in the presence/absence of nutrients) and on the M2→M1 re-polarisation
as induced by various treatment protocols (e.g., the agonist anti-CD40 mAb [23]).
In this new extended framework, we also model the potential role of nutrients on
the proliferation/death of M1 and M2 macrophages and cancer cells. With the
help of this new extended multi-scale model, we aim to investigate the impact of
re-polarising the M2 TAMs into the anti-tumoral M1 phenotype and how such a
strategy affects the overall tumour progression. In particular, we explore numeri-
cally whether an effective macrophage M2→M1 re-polarisation strategy (within a
fibrous tissue environment which impacts macrophage dynamics) is spatial and/or
temporal dependent. Furthermore, we study how the presence of nutrients influ-
ence the overall dynamics and particularly how they affect the re-polarisation based
strategy.
Then, in Chapter 4 we derive our hybrid multi-scale modelling framework. The
main goal of this chapter is to study further the various aspects that are responsible
for the shape of the emerging tumour aggregations. To this end, here, we model
the cancer cell population as individual cells (agents) which are embedded within
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a two-phase ECM, also used in Chapters 2 and 3. Although many experimental
studies discussed the role of ECM in individual and collective cell migration, there
are still unanswered questions about the impact of non-local cell sensing of other
cells on the overall shape of tumour aggregation and its migration type. Moreover,
cell migration and tumour spread occurring at the boundary between different tis-
sues with diverse collagen fibre orientation poses further unresolved challenges. To
that end, we use numerical simulations to investigate these questions and conclude
that multiple properties of the ECM fibres heavily impact the movement of tumour
aggregations.
Finally in Chapter 5, we extend our 2D multi-scale moving boundary framework
to 3D and use it to numerically simulate the growth of a specific brain tumour type,
namely the glioblastoma multiforme. Since brain-related experiments are usually
limited by nature, mathematical models such as the one that we developed, can be
used to generate and test new biological hypotheses. Hence, in this chapter, we use
our model to capture the complex multi-scale tumour invasion patterns in 3D brains
where we pay special focus on the role of brain micro-fibres. Moreover, we utilise T1
weighted and DTI scans as initial conditions and to parametrise our model. To that
end, we use numerical simulations to investigate the role of an anisotropic diffusion
term and the effects of brain micro-fibres.
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Chapter 2
The Role and Directionality of M2
Macrophages within a Multi-Scale
Moving Boundary Tumour
Invasion Model
Aims and Novelty: In this chapter, we open up the possibility to investigate
tumour invasion in the context of a heterogeneous microenvironment, using a multi-
scale moving boundary framework, that was initially formulated in [279] and later ex-
tended in [245]. Hence, we investigate how the various types of M2 TAMs adhesions
affect the overall tumour progression and morphology within a fibrous environment,
including macrophage-macrophage, macrophage-cancer cell and macrophage-fibres
adhesions.
2.1 Introduction
During the last few decades, mathematical models have mainly focused on a few
key players of tumour invasion, namely cancer cells, ECM and MDEs. Moreover,
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most of these models do not account for the multi-scale nature of the tumour inva-
sion process, for instance, although tumours themselves can be modelled on tissue
scale, MDEs, which are secreted by several tumour constituents, interact with the
surrounding ECM on the molecular scale. To account for such interactions, a multi-
scale moving boundary model was proposed in [279] which was later expanded in
[245] also to incorporate the multi-scale nature of the ECM.
Furthermore, besides these three primary players, there are other significant con-
stituents within the TME, such as macrophages which are one of the most abundant
stromal cells, and they can form up to 50% of tumour mass [132, 286]. Although
these macrophages are usually categorised into two extreme phenotypes, namely
the classically-activated anti-tumour M1 and the alternatively-activated pro-tumour
M2 phenotype [176, 249], advanced (detectable) tumours contain mostly M2-like
macrophages [155]. Hence, we propose a (multi-scale moving boundary) model that
expands upon the one formulated in [245] and takes into consideration the M2-like
macrophages and their role in the tumour invasion process.
Therefore, in this chapter, we study the directional interactions of macrophages
with the surrounding directional/random ECM and how this affects tumour spread.
The content of Sections 2.3-2.7 has been thoroughly discussed and presented in our
recent publication [265].
2.2 Modelling Part 1: A Brief Overview of the
Existing Multiscale Moving Boundary Model
of Tumour Dynamics within a Fibrous ECM
As the work that we developed in this chapter builds on the multi-scale modelling
developed in [245, 279], in this section we focus on giving a brief overview of the key
features of the existing framework.
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2.2.1 Macro-Scale Dynamics of the Existing Model
Hence, at macro-scale, we explore the cancer invasion process occurring within a
maximal tissue cube Y ∈ RN for N = 2, 3, where the expanding tumour region
denoted by Ω(t) progresses over the time interval [0, T ] (i.e., Ω(t) ⊂ Y , ∀ t ∈
[0, T ]). We adopt the same simplified context as in [279, 206, 245, 246, 247] where
aside from the tumour cells population c(x, t) that is defied within the tumour
region Ω(t), the rest of the tumour microenvironment and surrounding tissue is
represented here simply by a generic ECM. To that end, while we acknowledge that,
besides the tumour cells, some of the tumour microenvironment components are
not ECM constituents and are rather only supported by the usual ECM, in this
framework we still regard all those constituents (such as VEGF, FGF, TGF-beta,
and ions such as Ca2+) as being part of and represented by this extended concept of
ECM. Furthermore, due to the biologically established importance played within cell
migration by the major ECM fibres, namely collagen and fibronectin, as considered
also in [246, 247, 245], we regard this ECM as two-phase matter, consisting of an
ECM fibre phase and an ECM non-fibre phase. Specifically, on one hand the ECM
fibres phase accounts exclusively for all major fibres components such as collagen
and fibronectin (notably characterised by their insolubility properties [117]), and its
amount distributed at (x, t) is denoted here by F (x, t). On the other hand, besides
the major fibres components, the ECM contains also an entire host of other soluble
constituents, such as calcium ions Ca2+ [28, 109], as well as other small proteins and
soluble peptides that beyond a certain concentration threshold lead to the formation
of insoluble amyloid fibrils [227], which notably have been found to support support
cell adhesion [84, 90, 91, 119]. Thus, here all these ECM constituents that are
not major fibres (i.e., these are neither collagen nor fibronectin) are bundled into
a second ECM phase, and to immediately distinguish these from the ECM fibres,
we simply refer to this phase as the non-fibre ECM phase. The spatio-temporal
distribution of the non-fibre ECM phase at (x, t) is denoted by l(x, t). Since ECM
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is present in the body naturally, both fibre ECM phase F (x, t) and non-fibre ECM
phase l(x, t) are defined within the maximal tissue cube Y .
Finally, for a compact notation, we denote by ũ the global three-dimensional
tumour vector given by
ũ(x, t) := (c(x, t), F (x, t), l(x, t))T , (2.1)
and ρ(ũ) represents the total space occupied at position x, i.e.,
ρ(ũ) = c(x, t) + F (x, t) + l(x, t), (2.2)
for all t ∈ [0, T ] and all x ∈ Y .
Tumour cells population dynamics of the existing model
First, the cancer cell population c(x, t) exercises not only random movement (cap-
tured here through diffusion), but their spatial transport of the cell population
is further amended and biased by a directional movement induced by the cell-
adhesion processes [115, 210, 292, 297]. Hence, assuming a logistic type growth
(see [145, 146, 275]) with constant rate µc > 0, the spatio-temporal dynamics of the





Dc∇c− cAc(x, t, ũ, θf )
]
+ µcc(1 − ρ(ũ)), (2.3)
where Dc > 0 is a constant diffusion coefficient, and Ac(x, t, ũ, θf ) describes the
cell-adhesion processes that bias the cancer cell population movement in accordance
to the spatial heterogeneous distribution of the surrounding cancer cells and ECM
components including the oriented ECM fibres. Hence, as in [245, 246, 247], here, we
explore the adhesive interactions of the cells distributed at x ∈ Ω(t) with the other
cancer cells as well as with the distribution of non-fibres ECM phase [84, 90, 91, 119]
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and the oriented ECM fibres phase [294, 295] within a sensing region B(x,R) of
radius R > 0. Ultimately, such interactions can be mathematically expressed with
the following non-local flux term:









Sccc(x+ y, t) + Scll(x+ y, t)
)
+ n̂(y, θf (x+ y, t))ScFF (x+ y, t)
][




with the involved terms being detailed as follows. First, existing biological evi-
dence [94, 109] (revealing the positive correlation between the availability of the
extracellular Ca+2 ions within the ECM and the strength of the adhesion bonds
that the cancer cells are able to establish between themselves) enables us to as-
sume that the cell-cell adhesion strength Scc depends on the non-fibre ECM density.
Hence, proceeding here as in [245, 246, 247], we take Scc to be of the form
Scc(x, t) := Smin + (Smax − Smin) exp
[
1 − 1
1 − (1 − l(x, t))2
]
,
which smoothly explores a full range of cell-cell cancer self-adhesion strengths, from
its maximum level Smax > 0 that corresponds to the Ca
+2-saturation level to its
minimum values Smin > 0 that corresponds to the minimum level of Ca
+2. Finally,
the cell-matrix adhesion manifests itself in this context both through adhesion be-
tween the cell and the ECM fibres [294, 295] and adhesion between the cells and
non-ECM fibre phase (which includes for instance densities of amyloid fibrils that
have been proved experimentally to support cell-adhesion [84, 90, 91, 119]). The
adhesion strength between cancer cells and non-fibre ECM as well as the adhesion
strength between cancer cells and fibre ECM, denoted here by Scl and ScF , respec-
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Figure 2.1: Schematics of the cell-fibre adhesion that is biassed by the orientation
of the fibres.





if y ∈ B(0, R) \ {0},
0 if y = 0,
and n̂(·, ·) is the unit vector that is biased by the fibre orientations, i.e.,
n̂(y, θf (x+ y, t)) :=

y + θf (x+ y, t)
∥ y + θf (x+ y, t) ∥
if y ∈ B(0, R) \ {0},
0 if y = 0 or y = θf (x+ y, t),
(2.5)
where θf (x, t) is the orientation of the fibres at macro-scale that was derived and
introduced for the first time in [245], being derived by exploring the structural
micro-scale mass distribution of their constituent micro-fibres and characterising the
spatial bias of the ECM fibres distributed at the macro-scale location x ∈ Y , see for
details Section2.2.2. Figure 2.1 shows one of the biased vectors y+ θf (x+y, t), with
y ∈ B(0, R), that are involved in (2.5), illustrating the way in which the orientation













Figure 2.2: Schematics of adhesion process inside the sensing region B(x,R).
In order to illustrate this process, the adhesion term Ac(·, ·, ·, ·) given in (2.4) is
appropriately given as the sum of three main constituents, namely Acc, Acl and
AcF that correspond to cell-cell, cell-non ECM fibres and cell-ECM fibres adhesions,
respectively. Here we envisaged three regions inside the sensing region B(x,R) where
one of the tumour components (i.e., either cancer cells, or ECM fibres or ECM non-
fibres) is predominant and forms a local majority in terms of their spatial distribution
versus the other two. In this context, the vector Acl is pointing from the centre
of the sensing region towards the non-fibre group because the non-local bonds are
the strongest towards that direction. We see a similar behaviour for Acc and AcF .
However, the fibre adhesion is biased by the orientation of the fibres, and so the
vector points towards a biased direction; see Figure 2.1. On the other hand, since
Scc depends on the density of non-fibre ECM, we observe that Acc is aided by the
position of the region where we have the grouping of the non-fibre component. Adding
these elements together yields Ac(x, t, ũ, θf ) that is given by (2.4) and so we expect
the mass of tumour cells distributed at position x to move towards this direction.
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To account in (2.4) also for the gradual weakening of the adhesion between cancer
cells and macrophages as well as of the adhesive bonds between the cancer cells at
x ∈ Ω(t0) and the cells and ECM fibre and non-fibre phases as we move away from
the location x within B(x,R), we use a radially symmetric K(·) that is given here
by
K(y) = ψ( y
R
), ∀y ∈ B(0, R), (2.6)
where ψ(·) is the standard mollifier defined in Appendix A.2. Here, we can notice
that due to the smoothness of the kernel K(·), the adhesion integral Ac, defined
in (2.4), is a smooth C
∞
function. Finally in (2.4), (1 − ρ(ũ))+ = max(0, 1 −
ρ(ũ)) ensures that overcrowded tumour sites do not contribute to the migration
of the cancer cells. To conclude, Figure 2.2 illustrates the way the adhesion flux
Ac(x, t, ũ, θf ) emerges, as this can be regarded as a sum of three different adhesion
contributors, namely: Acc for cell-cell cancer self-adhesion, Acl for cell-non-fibre
adhesion, and AcF for cell-fibre adhesion, which are given by:









1 − ρ(ũ(x+ y, t))
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1 − ρ(ũ(x+ y, t))
]+
,







ScFF (x+ y, t)
)[
1 − ρ(ũ(x+ y, t))
]+
.
Macro-scale dynamics of the fibres and non-fibre ECM phases of the
existing model
Based on biological evidence that the components of non-fibre ECM phase (e.g.,
the amyloid fibrils) are degraded by several classes of matrix metalloproteinases
[257, 153], here we follow [245, 246, 247] and consider the case when the non-fibre
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ECM phase is getting degraded and remodelled by the tumour cells. Hence, the
dynamics of the non-fibre component l(x, t) is described by
∂l
∂t
= −λlccl + α1(1 − ρ(ũ)), (2.7)
where λlc > 0 denotes the rate of degradation and α1 > 0 is the remodelling rate.
Finally, the macroscopic ECM fibres F (x, t) are also getting degraded by the
cancer cell population (through the secretion of MDEs), and so their macro-scale




where γFc > 0 is the ECM fibres degradation rate caused by the cancer cells.
Summary of the existing macro-dynamics
In summary, using (2.3), (2.7) and (2.8) the coupled PDEs system that describes





Dc∇c− cA(x, t, ũ, θf )
]






= −λlccl + α1(1 − ρ(ũ)), (2.9c)
with zero-flux boundary conditions. Finally in Table 2.1, we summarize the adhe-
sion effects between the different constituents that were considered throughout this
section.
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Cancer cells Non-fibre ECM Fibre ECM
Cancer cells Scc Scl ScF
Non-fibre ECM 0 0 0
Fibre ECM 0 0 0
Table 2.1: Summary of all adhesion processes that we consider in the existing
macro-scale dynamics (2.9).
2.2.2 Processes on the Micro-Scales and their Links to Macro-
Scale within the Existing Model
The macro-scale cancer invasion process is accompanied by several closely linked
micro-dynamic processes [293]. Particularly important are those micro-processes
concerning the cell-scale spatial re-distribution of the ECM fibres micro-constituents
caused by the interaction with the cancer cell population, and the cell-scale prote-
olytic processes occurring at the leading edge of the tumour. While different in
nature, both of these micro-processes are intrinsically linked to the same macro-
process, and in the following will explore the details of these micro-dynamics to-
gether with the associated double feedback links that connects them to the invasive
tumour macro-dynamics.
Fibres: their micro-scale structure and macro-scale representation
As discussed in detail in [245], it is important to observe that the macroscopic
ECM fibres are not only represented through their amount F (x, t) distributed at
(x, t) ∈ Ω(t) × [0, T ], but also through their naturally emerging spatial bias to
withstand incoming cell fluxes and forces. This spatial bias is induced by their
micro-scale distribution of micro-fibres f(z, t) on a cell-scale micro-domain δY (x) :=
x + δY of appropriate micro-scale size δ > 0. Indeed, as derived and formalised
in [245], these two important characteristics of the ECM fibres (i.e., the amount of
distributed ECM fibres, and their associated spatial bias at (x, t)) can be captured
simultaneously through a vector field representation of the ECM fibres, θf (x, t), that
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is mathematically expressed as







∥ θf,δY (x)(x, t) ∥2
. (2.10)
Here, λ is the Lebesgue measure in RN , ∥ · ∥2 denoted the Euclidean norm (i.e.
for an arbitrary vector x ∈ RN we define it as ∥ x ∥2:= (x21 + · · · + x2N)1/2 with
N = 2) and θf,δY (x)(x, t) is the revolving barycentral orientation with respect to the
measure f(z, t)λ(·) that is induced and uniquely defined by the mass distribution
of micro-fibres on the cell-scale micro-domain δY (x). This is given by the Bochner-
mean-value [304] of the barycentral vector-valued function δY (x) ∋ z 7→ z−x ∈ RN ,
namely
θf,δY (x)(x, t) :=
∫
δY (x)




Finally, the magnitude of the ECM fibres is given by the Euclidean norm of θf (x, t),
i.e.,
F (x, t) :=∥ θf (x, t) ∥2,
and represents the mean-value of micro-fibres distributed on δY (x) at time t ∈ [0, T ].
Fibre rearrangement in the presence of cancer cells
Under the incidence of the macro-scale spatial flux generated by the tumour macro-
dynamics, the rearrangement of the ECM fibres takes place on each micro-domain
δY (x) through the spatial re-distribution of its micro-fibres constituents. As con-
sidered in [245], this process is instigated by the emerging macro-scale cancer cell
flux Fc, that is defined by:
Fc(x, t) :=Dc∇c(x, t) − c(x, t)Ac(x, t, ũ, θf ), (2.12)
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Therefore, at any spatio-temporal node (x, t), the spatial flux Fc(x, t) that acts
uniformly upon the fibres distributed on the micro-domain δY (x) results in the
emergence of a micro-fibres rearrangement vector r(δY (x), t) given by
r(δY (x), t) := ωc(x, t)Fc(x, t) + (1 − ωc)(x, t)θf (x, t). (2.13)
where the weight ωc is defined by
ωc(x, t) :=
c(x, t)
c(x, t) + F (x, t)
.
Then this rearrangement vector r(·, ·) acts upon the mass distribution of the micro-
fibres f(z, t) on δY (x), causing these to be spatially redistributed both on δY (x) and
on the neighbouring micro-domains. Following [245], we use this naturally emerg-
ing macro-scale rearrangement vector r(δY (x), t), defined in (2.13), to construct the
so-called relocation vector νδY (z) (defined for each z on the micro-scale) that ac-
counts not only for the rearrangement vector r(δY (x), t), but also upon the degree
of alignment between the barycentral position vector xdir(z) := z−x and the acting
rearrangement vector r(δY (x), t) as well as both the level of fibres saturation at z
and the level of occupancy at the target position z∗. Thus, the relocation vector
νδY (z)(z, t) is mathematically formulated as:
νδY (x)(z, t) :=
[
xdir(z) + r(δY (x), t)
] f(z, t)[fmax − f(z, t)]
f ∗+ ∥ r(δY (x), t) − xdir(z) ∥2
χ{f(·,t)>0},
with fmax being the maximum level of fibres at any micro-location ζ ∈ δY (x), f ∗ =
f(z, t)/fmax being the micro-fibres level of saturation, and χ{f(·,t)>0} representing
the characteristic function of the micro-fibres support. Ultimately such relocation
vector νδY (z) allows us to compute the new position z
∗ of each micro-point z as









Figure 2.3: Sketch of the micro-fibre reallocation to the neighbouring fibres micro-
domain and the vectors required for the process.
To highlight the role of each of these vectors in the micro-scale process, we refer the
reader to Figure 2.3, where we consider a typical example of xdir(z), r(δY (x), t) and
νδY (x)(z, t).
Finally, the amount of fibres distributed at z that will be moved to the new
micro position z∗ is controlled by a movement probability pmove that explores the








and the amount of fibres moving to z∗ being given by pmove · f(z, t) and the rest of
the fibres (1 − pmove) · f(z, t) remaining at position z.
The existing boundary micro-scale dynamics
The second type of micro-dynamics that we consider here is that exercised by the
proteolytic molecular processes occurring along the invasive edge of the tumour due






Figure 2.4: Schematics of the overlapping ϵ-cubes that covers the boundary ∂Ω(t0).
which are essential for tumour progression. Secreted by the cancer cells within
the outer proliferating rim of the tumour, these molecules exercise a cross-interface
transport within a cell-scale neighbourhood of the tumour interface, leading to degra-
dation of the ECM in the peritumoural region, ultimately resulting in changes of
the tumour boundary morphology and subsequent further tumour progression.
To explore this emerging proteolytic micro-dynamics, we adopt the approach ini-
tially developed and introduced in [279]. Specifically, we denote by m(·, ·) the spatio-
temporal distribution of MDEs that are transported within a cell-scale neighbour-
hood of ∂Ω(t). This neighbourhood is represented by the union of an appropriately
constructed covering bundle of overlapping micro-domains {ϵY }ϵY ∈P(t) illustrated
in Figure 2.4, which enable us to decompose the overall boundary dynamics into a
union of proteolytic micro-dynamics taking place on each ϵY . Thus, for any macro-
scopic time t0 ∈ [0, T ] on any boundary micro-domain ϵY , at any spatio-temporal
location (y, τ) ∈ (ϵY ∩ Ω(t0)) × [t0, t0 + ∆t], a source h(·, ·) of MDEs arise as a
collective contribution of the cancer cells distributed within the tumour’s outer pro-





c(x, t0 + τ)dx
λ(B(y, γ) ∩ Ω(t0))
, y ∈ ϵY ∩ Ω(t0),
h(y, τ) =0, y /∈ ϵY \ (Ω(t0) + {z ∈ Y | ∥z∥2 < ρ}),
(2.14)
where B(y, τ) := {z ∈ Y | ∥y− z∥∞ ≤ γ} denotes the ∥ · ∥∞ ball with appropriately
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chosen radius γ > 0 where the source of MDEs is accumulated, and 0 < ρ < γ
is a small mollification range that smooths out the source h(·, ·) along the tumour
interface. Also, the infinity norm is defined for an arbitrary vector x ∈ RN as
∥ x ∥∞:= max(|x1|, |x2).




= Dm∆m+ h(y, τ),







which ultimately enables us to determine the movement of this interface. Hence,
using the solution of (2.15), we adopt the technique developed in [279] to determine
the relocation of the boundary. To that end, as described in [279], we select an
appropriate dyadic decomposition {Dk}k∈J of the boundary micro-domain ϵY (x) ∈
P(t). Furthermore, we denote by yk the barycentre of each Dk and we further select
a subfamily of dyadic cubes {Dk}J ∗ that are furthest away from x and are outside
of Ω(t0) with the property that they still support a level of MDEs that exceeds the
mean of MDEs distributed on ϵY (x). Then, the transitional measure of movement
that was introduced in [279] (assessing the likelihood of the boundary to migrate




m(y, τf ) dy∫
ϵY (x)
m(y, τf ) dy
. (2.16)
and is used to evaluate whether the boundary point x will be moved to a new loca-
tion or will stay at the same position. This assessment is carried out by comparing
the likelihood for invasion given by the transitional measure of movement with re-
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spect to the significant level of peritumoural ECM degradation that is explored by
a tissue parameter β ∈ (0, 1), as defined in [279]. This tissue parameter β explores
the necessary level of significant (but not complete) ECM degradation for the tu-
mour to progress, and captures the tissue conditions for invasion through the tissue
thresholds ω : (0, 1) × ϵY (xB) → [0, 1] given by
















if α(x) > β,
(2.17)
where α(x) is defined by
α(x) :=




l(ξ, t+ ∆t) + F (ξ, t+ ∆t)
] .
Provided that sufficient degradation but not total destruction of the ECM has taken
place over the time interval [t0, t0 + ∆t], situation that is explored by the condition
q(x) > ω(β, ϵY (xB)),
Then the predicted tumour boundary movement is exercised in the direction ηϵY (x)
and magnitude ξϵY (x) obtained from the boundary micro-dynamics (as described
in [279]), given by



















m(y, τf ) dy
∥ −→xyl ∥2 .
(2.18)
















macro dynamics of cancer and ECM 




















Figure 2.5: Links between the scales, and how the scales affect each other, in
particular, the link between boundary-micro and macro scales as well as fibre-micro
and macro scales.
ω(β, ϵY (xB)) and so the ECM is either degraded too much or not enough, the bound-
ary point xB stays at the same position (or equivalently its movement magnitude
is zero: ξϵY (x) = 0). This way, over the time interval [t0, t0 + ∆t], the macroscopic
tumour Ω(t0) will be progressed into a newly expanded invasive tumour domain
Ω(t0 + ∆t).
2.2.3 Summary of the Links Between the Scales
In summary, both micro-scales have their unique link to the macro-scale and vice
versa. First, we recall that the spatial flux defined in (2.12) result in a vector
field induced by the movement of the cancer cells. This spatial flux interacts in a
weighted manner with the oriented fibres (represented here again as a vector field),
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ultimately enabling the rearrangement of distribution of the micro-scale constituents
of the fibres (referred to as micro-fibres), resulting in a changed spatial orientation
of the ECM fibres. This establishes a fibres top-down link and it is illustrated in
Figure 2.5. On the other hand, the freshly rearranged micro-fibre density translate
into a change of density as well as the orientation of the ECM fibres observed at the
macro-scale, as detailed in Section 2.2.2, which in turn have a major impact upon
the macro-scale dynamics (2.9). This establishes now a fibres bottom-up link, that
connects the fibre-micro-scale to the macro-dynamics.
Shifting our focus to the relation between the boundary micro-dynamics and the
macro-dynamics, the source of the MDEs (2.14) on the micro-scale is induced by
the macro-scale population of cancer cells. Under the presence of this source, the
micro-dynamics (2.15) takes place within a cell-scale neighbourhood enabled by a
covering bundle of overlapping boundary micro-domains {ϵY }ϵY ∈P(t), and their so-
lution on each of ϵY ultimately enables us to determine a direction and magnitude
for the movement of the tumour boundary captured by ϵY . The local expansion
of the tumour domain in the direction and by the magnitude determined from the
proteolytic boundary micro-dynamics is finally exercised provided that a significant
but not complete level of ECM degradation within the peritumoural tissue negh-
bourhood is realised. A quantification of this significant but not complete level of
peritumoural degradation (which translates in the most favourable tissue conditions
for invasion) is explored through a tissue parameter β ∈ (0, 1) that has been in-
troduced and formalised in [279], and also described in Section 2.2.2, but for full
details, we refer the reader to this initial reference. Thus, this connection between
the boundary micro-dynamics and macro-dynamics are again connected through a
top-down – bottom-up double feedback loop that is illustrated in the bottom half of
Figure 2.5.
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2.3 Modelling Part 2: Novel Multiscale Modelling
of Tumour and Macrophages Interacting Dy-
namics within Fibrous ECM
Building on the multiscale moving boundary modelling approaches proposed for
cancer invasion in [245, 279] and described in Section 2.2, in this work we extend
and advance this modelling platform by exploring further the macro- and micro-scale
dynamics of the tumour invasion process. Specifically, in contrast to the situation
addressed in [245, 279] and Section 2.2, we expand now the biological context by
exploring the multiscale process of cancer cells invasion in the presence of M2 TAMs.
This will extend the modelling presented in [245] and Section 2.2 by incorporating
here the dynamics of M2 TAMs population and the impact of its directional motility
on the overall tumour progression.
2.3.1 Macro-Scale Tumour-Macrophages Interacting Dynam-
ics
Along with the macro-scale constituents considered in 2.2, i.e., cancer cells c(x, t),
fibre F (x, t) and non-fibre ECM l(x, t) phases, here, we also consider the presence
of a population of M2-like TAMs, denoted by M2(x, t) within the tumour domain
Ω(t). Furthermore, M2 TAMs infiltrate the tumour as an immune response though
the outer boundary that we denote by ∂Ωo(t) ⊂ ∂Ω(t), which is mathematically
defined in Appendix A.1 and is illustrated schematically in Figure 2.6. Hence, here,
we denote by ∂Ω(t) the boundary of the tumour in the usual sense and we denote by
∂Ωo(t) a subset of the whole tumour boundary that for instance do not include the
boundary of the ”islands” located within the tumour, as illustrated in Figure 2.6.
Finally, for a compact notation, we denote by u the global four-dimensional tumour
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Figure 2.6: Illustration of the outer boundary ∂Ωo(t) that is highlighted with the
dashed red line.
vector given by
u(x, t) := (c(x, t), F (x, t), l(x, t),M2(x, t))
T , (2.19)
and ρ(u) represents the total space occupied at position x, i.e.,
ρ(u) = c(x, t) + F (x, t) + l(x, t) +M2(x, t), (2.20)
for all t ∈ [0, T ] and all x ∈ Y .
Tumour cells population dynamics in the presence of M2 TAMs
Recent biological evidence shows that M2 TAMs macrophages enhance the cancer
cell proliferation process [89]. Hence, assuming logistic type growth for the cancer
cell population as in Section 2.2, this enhancement brought in by the macrophages
leads to an augmented proliferation for the cancer cells, which can be captured
mathematically as:
Pc(u) := µcc(1 + µcMM2)(1 − ρ(u))+, (2.21)
where µc > 0 is the baseline proliferation rate and µcM > 0 is the cancer proliferation
enhancement rate due to the presence of M2 TAMs. Furthermore, as in Section 2.2,
we model the movement of the cancer cell population by both random and direc-
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tional movement induced by the cell-adhesion processes [115, 210, 292, 297]. In this
context, the spatio-temporal dynamics of the cancer cell population can therefore





Dc∇c− cAc(x, t,u, θf )
]
+ Pc(u), (2.22)
where Dc > 0 is the constant diffusion coefficient, and Ac(x, t,u, θf ) describes the
various cell-adhesion processes. Specifically, in addition to the situation considered
in Section 2.2, here the flux term Ac(x, t,u, θf ) explores the key biological evidence
underlining the contribution of the macrophages to the directional movement of
the tumour cells. Indeed, this explores not only the fact that cancer cells bind
themselves to TAMs [49], but also accounts for the experimental evidence detailed
in [55, 92, 291, 300] that underscores the existence of a cross-talk between tumour
cells and macrophages which is mediated through various chemokines. Further, while
we do not model here explicitly the involved chemokine activities, mathematically
we account for this cross-talk through the following non-local flux term:










+ ScMM2(x+ y, t) + Scll(x+ y, t)
)
+ n̂(y, θf (x+ y, t))ScFF (x+ y, t)
][




where Scc, Scl and ScF are the adhesion strengths of the cancer-cancer, cancer-
non-fibre ECM and cancer-fibre ECM adhesions, R is the radius of the sensing
region B(x, t), n(·) is the unit radial vector, n̂(·, ·) denotes the unit radial vector
biased by the fibre orientations, K(y) accounts for the gradual weakening of the
various adhesion bonds and (1 − ρ(u))+ ensures that overcrowded tumour sites do














Figure 2.7: Schematics of adhesion process inside the sensing region B(x,R).
In order to illustrate this process, the adhesion term Ac(·, ·, ·, ·) given in (2.23) is
appropriately given as the sum of four main constituents, namely Acc, Acl, AcF and
AcM that correspond to cell-cell, cell-non ECM fibres, cell-ECM fibres adhesions
and cell-macrophage adhesion contributions, respectively. Here we envisaged four
regions inside the sensing region B(x,R) where one of the tumour components (i.e.,
either cancer cells, or ECM fibres or ECM non-fibres or M2 TAMs) is predominant
and forms a local majority in terms of their spatial distribution versus the other
three. In this context, the vector Acl is pointing from the centre of the sensing region
towards the non-fibre group because the non-local bonds are the strongest towards
that direction. We see a similar behaviour for Acc, AcF and AcM . However, the
fibre adhesion is biased by the orientation of the fibres, and so the vector points
towards a biased direction; see Figure 2.1. On the other hand, since Scc depends on
the density of non-fibre ECM, we observe that Acc is aided by the position of the
region where we have the grouping of the non-fibre component. Finally, AcM points
from the centre point x towards the groupings of M2 TAMs due to adhesion. Adding
these elements together yields Ac(x, t,u, θf ) that is given by (2.23) and so we expect
the mass of tumour cells distributed at position x to move towards this direction.
already been introduced and defined in Section 2.2.1 except that here we plug in
the tumour vector that contains also the macrophages u instead of ũ (which did
not include the macrophages). However, with (2.23), we also account for a cancer-
macrophage adhesion with strength ScM > 0.
In Figure 2.7, we illustrate the way the adhesion flux Ac(x, t,u, θf ) emerges. As
before, we note that this can be considered as the sum of all the different adhesion
contributors, namely: Acc for cell-cell cancer self-adhesion, AcM for cell-macrophage
adhesion, Acl for cell-non-fibre adhesion, and AcF for cell-fibre adhesion, that are
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defined as:









1 − ρ(u(x+ y, t))
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1 − ρ(u(x+ y, t))
]+
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ScFF (x+ y, t)
)[
1 − ρ(u(x+ y, t))
]+
.
Macro-scale dynamics of the fibres and non-fibre ECM phases in the
presence of M2 TAMs
Here, we extend the context considered in [245, 246, 247] and Section 2.2, where the
non-fibre ECM degradation was considered to be caused only by the MMPs secreted
by the cancer cells. So now we consider not only the contribution of cancer cells
but also that of the macrophages to the secretion of the various classes of matrix
metalloproteinases [16, 114]. Hence, the degradation of the non-fibre ECM phase
is caused indirectly (through the secretion of MMPs) not only by the tumour cells,
at rate λlc > 0, but also by the M2 TAMs, at rate λlM > 0. Furthermore, while
depending on the free space available, the remodelling of the ECM is also enhanced
by the presence of the macrophages [3, 89, 254]. Hence, the dynamics of the non-fibre
component l(x, t) is described by
∂l
∂t
= −l(λlcc+ λlMM2) + (α1 + α2M2)(1 − ρ(u)), (2.24)
where α1 is the remodelling rate in the absence of M2, and α2 represents the remod-
elling enhancement rate enabled by the presence of M2.
38
Moreover, at macro-scale the ECM fibres F (x, t) are also degraded both by the
cancer cells and by the macrophages (with collagen-endocytosing TAMs being one
of the main contributors towards the degradation of collagen in tumours, according
to [173]). Thus, their dynamics can be mathematically formalised as
∂F
∂t
= −F (γFcc+ γFMM2), (2.25)
where γFc and γFM are the ECM fibres degradation rates associated with cancer
cells and macrophages, respectively.
M2 macrophage
The last macro-scale tumour constituent that we consider in this work is the fam-
ily of M2 TAMs macrophages M2(x, t). To describe the macrophages dynamics we
note that the experimental study in [229] showed that: (i) the number of peritumoral
macrophages increased during oncogeny, (ii) the macrophages entering the circula-
tion from the bone marrow (to reach the tumour site) already had a M2-phenotype,
likely due to tumour-derived biochemical signals [229]. Moreover, the experimental
study in [92] showed that TAMs localise at the invasive area of the tumour, where
they secrete cytokines and proteases that contribute to tumour invasion. Therefore,
in this study we assume that the M2-like macrophages enter the tumour through
blood vessels at the tumour boundary, at a constant influx density M0. Denoting
the tumour boundary by Ωo(t), we define the M2 influx term as follows:
MI(x, t) := M0(χ∂Ωo(t) ∗ ψρ)(x). (2.26)
Here, χ
∂Ωo(t)
represents the characteristic function of the outer boundary ∂Ωo(t)
(defined in Appendix A.1), ψρ(·) denotes the standard mollifier given by ψρ(x) :=
1
ρN
ψ(x) with a small cell-scale mollification range ρ > 0 and “ ∗ ” is the convolution
operator [64].
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Regarding macrophages proliferation, on one hand biological evidence [40, 52,
122] shows that cancer cells trigger this proliferative process through the production
of survival and proliferation factors. On the other hand, the ECM stiffness was
also shown to enhance macrophages proliferation [2]. Furthermore, based on the
biological evidence presented in [220], where it was demonstrated experimentally
that increased collagen matrix density increases matrix stiffness (a fact that was
further confirmed in [184, 298]), there exists a direct correlation between the ECM
stiffness and the ECM fibre phase density. Hence, this direct correlation enables us
to assume here not only that the ECM stiffness is directly proportional to the ECM
fibre phase density, but in fact that the ECM stiffness is actually given directly by
F (x, t) (i.e., the proportionality constant is considered here to be 1). Thus, the
proliferation law of the macrophages can therefore be mathematically formulated as
PM(u) := µMM2c(1 + µMFF )(1 − ρ(u))+,
where µM > 0 is the baseline proliferation rate, µMF > 0 is the enhancement rate
of the fibres and (1 − ρ(u))+ ensures that there is no overcrowding.
Similar to the cancer cells, macrophages exercises not only random movement
but also directed migration. Hence, we account for the random movement part via
diffusion with a coefficient DM > 0 (which for the time being is considered con-
stant), while their directed movement is captured through an adhesion term that
is similar to the one that we used for the cancer cell population in (2.23). Specif-
ically, we consider here a cell-cell M2 TAMs self-adhesion with constant strength
SMM > 0 and a macrophage-cancer cell adhesion with strength SMc > 0 (we have
already mentioned in Section 2.3.1 that cancer cells can bind themselves to TAMs,
in addition to attracting TAMs, as shown in [55, 72, 299]). Finally, since we aim to
explore the various factors that may affect macrophage movement, we also consider
macrophage-fibre ECM adhesion with strength SMF > 0. Hence, the macrophage
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adhesion term AM(x, t,u, ·) is given by









SMMM2(x+ y, t) + SMcc(x+ y, t)
)
+ n̂(y, θf (x+ y, t))SMFF (x+ y, t)
][




We note here that the rest of the terms have already been introduced and defined
in Section 2.2.1. Due to the similarities between the structure of the two adhesion
fluxes, i.e., Ac(x, t,u, θf ) given in (2.23) and AM(x, t,u, θf ) given in (2.27), we refer
the reader to Figure 2.1 and Figure 2.7 for illustration of the macrophage adhesion
term (2.27).
Therefore, the dynamics of the M2-like macrophages M2(x, t) is given by
∂M2
∂t
= ∇ · [DM∇M2 −M2AM(x, t,u, θf )] − dMM2 +MI + PM(u), (2.28)
where dM > 0 represents the macrophages natural macrophages death rate.
Remark. Since various experimental studies discuss the distribution of M2 TAMs
macrophages inside tumour tissue and its prognostic value [158, 261], here we focus
exclusively on the tumour-macrophage interactions on the tumour domain, rather
than considering these mixed within the ECM further afield outside the tumour.
This is another reason for which our modelling assumptions assume a macrophage
influx through tumour boundary (see equation (2.26)).
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Summary of the macro-dynamics
In summary, using (2.22), (2.24), (2.25) and (2.28) the coupled system of PDEs that










= −F (γFcc+ γFMM2), (2.29b)
∂l
∂t
= −l(λlcc+ λlMM2) + (α1 + α2M2)(1 − ρ(u)), (2.29c)
∂M2
∂t
= ∇ · [DM∇M2 −M2AM(x, t,u, θf )] − dMM2 +MI + PM(u), (2.29d)
with zero-flux boundary conditions. Finally, in Table 2.2 we also summarise all the
different adhesion effects/strengths that occurs between the various components of
this extended model.
Cancer cells M2 TAMs Non-fibre ECM Fibre ECM
Cancer cells Scc ScM Scl ScF
M2 TAMs SMc SMM 0 SMF
Non-fibre ECM 0 0 0 0
Fibre ECM 0 0 0 0
Table 2.2: Summary of all adhesion processes that we consider in our macro-scale
dynamics (2.29).
2.3.2 Processes on the Micro-Scales and their Links to Macro-
Scale in the presence of M2 TAMs
In this section, we detail the how the presence of M2 TAMs extends both micro-
scale processes. However, we first note that the representation of fibres on the
macro-scale does not change, and so to avoid repetition, we omit the details of the
fibres bottom-up link.
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Fibre rearrangement in the presence of both cancer cells and macrophages
populations
As in Section 2.2, the rearrangement of the ECM fibres takes place on each micro-
domain δY (x) due to the cell movements occurring at macro-scale. However, since
M2 TAMs also secrete MDEs, this process is induced not only by the emerging
macro-scale cancer cell flux Fc (as considered in Section 2.2), but also by the spatial
flux of migrating M2 TAMs macrophages FM , these being defined by:
Fc(x, t) :=Dc∇c(x, t) − c(x, t)Ac(x, t,u, θf ),
FM(x, t) :=DM∇M2(x, t) −M2(x, t)AM(x, t,u, θf ).
(2.30)
Hence, now the emergence of the micro-fibres rearrangement vector r(δY (x), t) is
due to the combined spatial flux Fc(x, t) + FM(x, t), and so is given by
r(δY (x), t) := ωc(x, t)Fc(x, t) + ωM(x, t)FM(x, t) + ωF (x, t)θf (x, t). (2.31)
where the weights are appropriately given by the associated mass fractions of cancer












Then using this new extended rearrangement vector r(δY (x), t) (2.31), we can follow
the same process as in Section 2.2 to construct the relocation vector νδY (z) and
ultimately determine both the new positions z∗ of each micro-points z and the
appropriate amount of fibres that will be moved to these new positions.
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Boundary micro-scale in the presence of M2 TAMs
To account for the second micro-dynamics, i.e., the proteolytic processes occurring
along the tumour interface, we follow the same procedure as in Section 2.2. However,
biological evidence suggest that besides cancer cells, TAMs also produce matrix-
degrading enzymes (MDEs), such as matrix-metalloproteinases (MMP) of both type
2 (MMP-2) and of type 9 (MMP-9) molecules [89], which are essential for tumour
progression. Thus, at any spatio-temporal location (y, τ) ∈ (ϵY ∩Ω(t0))×[t0, t0+∆t],
the source h(·, ·) of MDEs now arise as a collective contribution of both the cancer
cells and the macrophages distributed within a small neighbourhood of the tumour’s
invasive edge. Thus, we extend the source term by also considering the contribution




αcc(x, t0 + τ) + αMM2(x, t0 + τ)dx
λ(B(y, γ) ∩ Ω(t0))
, y ∈ ϵY ∩ Ω(t0),
h(y, τ) =0, y /∈ ϵY \ (Ω(t0) + {z ∈ Y | ∥z∥2 < ρ}),
(2.32)
where αc and αM are the MDE secreting rate of the cancer and the M2 TAMs,
respectively (and the rest of the terms remain the same as before in Section 2.2).
Furthermore, since we do not have to modify the micro-dynamics of the MDEs
defined in (2.15), the MDE bottom-up remains the same and to avoid repetition we
omit the details of it and for further details we refer the reader to Section 2.2.
2.4 Numerical Approach
To describe our numerical approach, let us introduce some basic notation that will be
used throughout the whole section. Let L be the length of Y and hL = ∆x = ∆y to
be the spatial step size, that is uniform in both direction. The uniform discretisation
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of the maximal tissue cube Y is represented through the set of discretised macro-
spatial locations {(xi, yj)}i,j=1...N , with N = L/hL + 1.
To numerically solve the macro-dynamics (2.29) we adopt the non-local predictor-
corrector scheme introduced in [245] (involving the Euler method as predictor, and
a non-local Trapezoidal rule as corrector with uniform step size ∆t) as well as we
follow [70, 81, 82] to construct a flux limiter method for the spatial derivatives.
Also, to evaluate the adhesion terms Ac and AM defined in (2.23) and (2.27), re-
spectively, we aim to use a fast convolution-driven approach. Finally, we detail the
MDE-micro-scale calculations.
2.4.1 Macro-Scale Dynamics
In this section we focus on deriving the numerical scheme for model (2.29). Hence,
in (2.29), we have two distinct spatial operators, namely a diffusion and an adhesion
term. Since the form of both of these terms are similar for cancer cells and M2
TAMs, in the following we will focus only on describing the scheme that we derive
for the cancer cell population.
Focusing now on the discretisation of the spatial operator in (2.29), which can
be expressed as
∇ · Fc := ∇ · [(Dc∇c) − cAc],
let us start by addressing first the diffusion part, ∇ · (Dc∇c), and only afterwards
will formulate the computational approach for the adhesion part ∇ · cAc.
Discretisation of the diffusion operator ∇ · (Dc∇c)
Since in this model we consider the diffusion coefficient Dc to be described by a




this diffusion part of the spatial operator ∇ · Fc,D can therefore be rewritten as
∇ · (Dc∇c) = ∇ · Fc,D, and to discretise this we simply use a second order central
difference scheme with the usual 5 point stencil.
During the computations, we detect our expanding tumour domain Ω(t0) via an
indicator function denoted by I(·, ·) : X × Y → {0, 1}, with X = Y = {1, ..., N},
and defined by
I(i, j) :=
1 if (xi, yj) ∈ Ω(t0),0 otherwise. (2.33)
which enables us to determine whether a spatial node is inside or outside the tumour
domain. Further, we construct a similar indicator function for the boundary nodes.
Hence, let us denote this by IB(·, ·) : X × Y → {0, 1} and define it as
IB(i, j) :=
1 if (xi, yj) ∈ ∂Ω(t0),0 if (xi, yj) /∈ ∂Ω(t0), (2.34)
where ∂Ω(t0) denotes the boundary of the domain Ω(t0). These two functions al-
low us to split the macro-scale dynamics computation into two parts, i.e., strictly
inside the tumour and on the tumour boundary. The motivation behind this is
that, given the complexity of our multiscale algorithm (where ”on-the-fly” rear-
rangements of micro-fibres are required), to reduce the computational time, we aim
to apply some appropriately constructed universal discrete macro-scale numerical
operators that would enable us to deal with the approximation of the right-hand
side spatial operators at as many macro-nodes as possible at once, ultimately result-
ing in a macro-scale computational techniques that is faster than the one proposed
in [245]. However, due to the continuously changing tumour domain Ω(t) (resulting
in an irregular tumour shape) and the presence of zero-flux boundary conditions
for the tumour macro-dynamics, we cannot derive one global numerical approach
for the dynamics at all the tumour macro-points, and rather we need to split the
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computation in these two parts (i.e., inside the tumour and tumour boundary) and
deal with them separately.
For convenience, we also define the indicator function for the interior of Ω(t0) by
II(·, ·) = I(·, ·) − IB(·, ·) as
IIn(i, j) :=
1 if (xi, yj) ∈ Ω(t0) and (xi, yj) /∈ ∂Ω(t0),0 else, (2.35)
Then using these two indicator functions (2.34) and (2.35) we also define two
sets of points ΛB and ΛIn, containing the boundary and interior nodes, respectively,
ΛB := {(i, j) ∈ X × Y | IB(i, j) = 1},
ΛIn := {(i, j) ∈ X × Y | IIn(i, j) = 1}.
(2.36)
Since, aiming to reduce computational cost, our goal is to partition the problem
into two main computational components, it is therefore indispensable to split ap-
propriately the numerical approximation of the diffusion part of the spatial operator,
namely of ∇·Fc,D. For this, let us notice that at any spatial node (xi, xj) ∈ Ω(t0) ⊂
Y , the discretisation of ∇ · Fc,D can actually be represented as follows
∇ · Fc,D(i, j) =

∇ · F Inc,D(i, j) if (i, j) ∈ ΛI ,
∇ · FBc,D(i, j) if (i, j) ∈ ΛB,
0 else.
(2.37)
Further, considering now the three-row matrices {Ti}i=2,N−1
Ti := [0 . . .0︸ ︷︷ ︸
i−2
, I3,0 . . .0︸ ︷︷ ︸
N−i−1
] (2.38)
where 0 represents an 3−dimensional zero column vector and I3 is the 3×3 identity
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matrix, for any (i, j) ∈ {2, . . . , N − 1}, we extract the 3× 3 sub-matrices centred at
(i, j) that contain the values at (i, j) and its corresponding 8 neighbouring locations
for the various constituents of the coupled dynamics. Thus, these sub-matrices are
given by
[cni,j] = Ti c
n T ⊺j , (2.39)
where cn is the corresponding discretised values for the cell population at the mesh
points {(xi, yj)}i,j=1...N , at time step n. With this notation (detailed in (2.39)), we
will be able to represent finite difference approach for ∇ · Fc,D in terms of matrix
operations.
In this context, our scheme for spatial flux ∇ · Fc,D(·, ·) can be written down
explicitly using central differences and midpoint approximations. Thus, for ∇ ·
F Inc,D(·, ·), using the Hadamard product “◦” (defined for completion in Appendix
A.3 while for further details we refer the reader to [111]), ∀(i, j) ∈ ΛIn and for any
time-step n, we have that
(


















denotes the Frobenius inner product [87], which, for completion, is also
defined in the Appendix A.3. Furthermore, in (2.40) KkF and KkB denote the 3 ×
3 matrices induced by the forward and backward differences at each (i, j) ∈ ΛI ,























Finally, we can observe that at the interior nodes of Ω(t0), equation (2.40) can be
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equivalently expressed via discrete convolutions, and so we can write this as
(















where ∗ is the discrete convolution operator [64] for the discretised tumour dynamic
constituents. Furthermore, due to the definition of discrete convolution, the K̃s used
in (2.42) are appropriately derived from Ks (defined in (2.41)) and are given as
K̃ := J3KJ3,







However, for the boundary nodes, the discretisation formulated in (2.42) could not
be applicable directly, and so for this we revisit (2.40) by taking into account now
the zero-flux boundary conditions. These boundary conditions are accounted for
through a new family of 3 × 3 sub-matrices that are defined as follows:
[cni,j]





where 1 is a 3×3 matrix of ones, J3 is the anti-diagonal identity matrix defined
in (2.43), while the 3×3 matrices [Ini,j] are given at each (i, j) by
[Ini,j] := Ti In T
⊺
j .
Therefore, using (2.44) we separate these boundary-sub-matrices into two parts,
i.e., a part that is inside the tumour and to another part that is outside the tumour
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(determined by the indicator function I). Hence, in these 3 × 3 boundary-sub-
matrices the distribution at the nodes that are inside the tumour are the same as
the one defined in (2.39), but we appropriately provide values on the neighbouring
nodes, captured by [Ini,j], outside the tumour so that we could implement the zero-
flux boundary condition. Hence, at any time tn, our scheme at any boundary node




















where the “K” matrices involved here are the non-convolutional ones that we already
defined in (2.41).
Discretisation of the adhesion operator ∇ · cAc
Now we shift our attention to the cancer cell adhesion term ∇ · cAc. Postponing
for the moment, the spatial discretisation of the adhesion vector field Ac at time
tn, which we denote by Anc , whose details will be discussed in Section 2.4.2, in
the following we will focus on addressing the overall discretisation of the adhesion
operator ∇ · cAc, for which we will propose a flux limiter approach.
Although also here we will split the discretised spatial tumour domain into two
regions, these will be slightly different from the interior and boundary parts men-
tioned in the previous section. Further, since we aim here is to use a flux limiter,
such approach requires the usage of “ghost” outside nodes that are further away
from the boundary nodes than their immediate neighbours (for instance the ghost
point (i + 2, j) if (i, j) ∈ ΛB). Thus, we appropriately split Ω(t0) into two regions
that we refer to as the “layer” and “inside” parts.
Focusing first on the inside part, this is determined by the requirements of
the flux limiter (detailed below), which, for calculations at position (i, j), demands
availabilities for the values of the quantities involved on a region that includes the
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four neighbours (in both i and j direction) of the four neighbouring locations with
respect to (i, j). Therefore, the inside part contains the discretised spatial region
given by the macro-nodes of the domain Ω(t0) that are at least two macro-nodes
”distance” away from the boundary, hence this consists of all the points that are
neither boundary points nor immediate neighbours of any boundary point. Thus, we
can determine the inside part mathematically by considering the following indicator
function denoted by II(·, ·) : X × Y → {0, 1} and define by
II(i, j) :=
1 if (I ∗ Kin)i,j = 1,0 if (I ∗ Kin)i,j = 0, (2.46)






0 0 1 0 0
0 1 1 1 0
1 1 1 1 1
0 1 1 1 0
0 0 1 0 0

,
which is based on the stencil induced by the flux limiter scheme.
Turning now our attention to the layer part, the macro-nodes that are considered
to be in this region of the discretised tumour domain Ω(t0) are the ones that are
either classified as boundary nodes or their immediate neighbours. The motivation
behind this is again to treat nodes that use values at ghost/outside points differently
than the ones that do not require such values during the approximation and would
this way enable a reduction in the computational cost. Thus, the points in the layer
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region are simply given by the difference indicator function IL := I − II , i.e.,
IL(i, j) :=
1 if I(i, j) − II(i, j) = 1,0 if I(i, j) − II(i, j) = 0. (2.47)
Therefore, using (2.46) and (2.47), we obtain that the discretised inside and layer
parts of Ω(t0), denoted here by ΛI and ΛL, are given by the preimages ΛI := I−1I ({1})
and ΛL := I−1L ({1}), respectively, i.e.,
ΛI := {(i, j) ∈ X × Y | II(i, j) = 1},
ΛL := {(i, j) ∈ X × Y | IL(i, j) = 1}.
Focusing now on computations on the inside region of Ω(t0), at any time tn and any
inside node (i, j) ∈ ΛI , the cancer cell adhesion discretisation is defined by













where Hxi,j and H
y
i,j are defined as




i,j]}(L+x )ni,j + min{0, sgn[(Fxc,A)ni,j]}(L−x )ni,j,














i,j denote the cancer cell adhesion
fluxes and they are given by
















T (defined in (2.19)) with the matrices cn, F n, ln, Mn2
and (θf )
n represent the discrete values at the grid points of the cancer cells, fibres
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ECM, non-fibres ECM, M2 TAMs, and oriented ECM fibres, respectively. Also, in
(2.50) Axc and Ayc denote the x and y components of the adhesion vector field Ac,
respectively.















are usually referred to as state interpolants, and to construct these we involve the
so-called limiter function ϕ(r), which ultimately enables us to use second order
approximation when the solution is smooth and a first order approximation near
sharp gradients. Hence, these state interpolants at time tn and any inside node
(i, j) ∈ ΛI are defined by
(L+x )
n













































where rxi,j and r
y
i,j are the smoothness monitor functions in x and y directions,
respectively, i.e., they are given by
rxi,j :=

(Fxc )ni+1,j − (Fxc )ni,j
(Fxc )ni,j − (Fxc )ni−1,j
if (Fxc )ni,j ̸= (Fxc )ni−1,j





(Fyc )ni,j+1 − (Fyc )ni,j
(Fyc )ni,j − (F
y
c )ni,j−1
if (Fyc )ni,j ̸= (Fyc )ni,j−1
and (Fyc )ni,j+1 ̸= (Fyc )ni,j,
0 otherwise.
(2.52b)
In all of our numerical simulations (presented Section 2.6) we use the so-called
53
“UMIST limiter function” [154] (although there are more limiter functions available
[144]) that is given by
ϕ(r) := max[0,min(2r, 0.25 + 0.75r, 0.75 + 0.25r, 2)],
which completes the flux limiter part of the scheme for any inside node (i, j) ∈ ΛI
at time tn.
Finally, we turn our attention to the computations on the layer part ΛL of the
discretised tumour domain Ω(t0). To approximate the cancer cell adhesion term
∇ · cAc in this region, we use a first order upwind scheme, which we obtain by
choosing ϕ ≡ 0 in (2.51). Hence, with ϕ ≡ 0, we can now use directly the method
derived in (2.48)-(2.52) for any node that are a layer point, but not a boundary point,
i.e., at all spatial nodes (i, j) ∈ ΛL \ ΛB. This leaves us with only the boundary
nodes where we still need to address the computation. Since at these points we also
aim to use the unwinding scheme, we need to appropriately approximate the value
of any ghost point. To that end, we involve a first order approximation of the cancer
cell zero-flux boundary condition which then enables us to appropriately estimate
the values at the required ghost/outside point. Finally, this allows us to use the
method derived in (2.48)-(2.52), for any boundary node (i, j) ∈ ΛB at any time-step
n, with ϕ ≡ 0. Therefore, we have fully defined our numerical scheme for the spatial
transport of the cancer cell population i.e. for ∇ · Fc. To avoid repetition, we did
not include here also the details of the derivation of the numerical scheme for the M2
TAM macrophages, as, due to the similarity in the structures of the spatial operators
(involved in the transport of M2 TAMs), the numerical treatment is identical to the
one outlined for the cancer cell equation. Hence, the scheme derived in this Section
is straightforward to implement for the M2 TAMs as well, or in fact for any other
population with the same spatial operators and so we do not pay special attention
for this procedure.
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Figure 2.8: The sensing region B(0, R). a) Decomposition of the region using
annulus sectors Sν with barycentres bSν , highlighted with red dots. b) Illustration
of the vector valued Ac(x, y), influenced by the surrounding components and the
strength of these bonds. c) Highlight of an annulus sector Sν with its barycentre bSν
as well as the four neighbouring on-grid points {yibSν }i=1,4.
2.4.2 Adhesion Terms
Focusing now our attention to the sensing region x+B(0, R), where the cell-adhesion
processes cell-fibres ECM adhesion and cell-non-fibres ECM adhesion, as well as
cell-cell self-adhesion and cell-cell adhesion for both cancer cells and M2 TAMs
macrophages populations (modelled in (2.23) and (2.27)) are exercised, we adopt
the partitioning of this region from [245] as illustrated in Figure 2.8. Furthermore,
as the computational procedure is identical for both adhesion operators Ac (that is
associated with cancer cell) and AM (that is associated M2 TAMs macrophages), let
us detail this approach simultaneously, i.e., for the adhesion operator A ∈ {Ac,AM}.
Thus, let us denote the number of annulus sectors in this partitioning by Ns, and
since this determined by the intersection of each of the s annuli centred at x with
a number of uniformly distributed sectors 2m+(k−1) (which is dyadic-ally increasing
as k progresses from the first and inner most annulus to that last and biggest one),






Then, denoting these annulus sectors by Sν , with ν = 1, . . . , Ns, this enables us to
approximate the adhesion integral (2.23) the integral of the step function associated
with these sectors, whose value on each Sν is appropriately constructed as a linear
combination of the mean-values on Sν of the cancer cell-populations, M2 TAMs
macrophages, and ECM components involved in the adhesion processes described
by (2.23) and (2.27).
Hence, to calculate these mean-values, on each Sν , we first need to integrate the
cancer and M2 TAM macrophages populations, the non-fibres ECM, the fibres ECM
as well as the fibres orientation on Sν . For this, we denote the off-grid barycentres
of each annulus sector by bSν and observe first that each bSν belongs to the rectangle
defined by its four immediately surrounding on-grid macro-mesh neighbouring nodes
{yibSν }i=1,4, as illustrated in Figure 2.8 c), namely
bSν ∈ [y1bSν , y
3
bSν




Then, we use bi-linear shape functions to obtain the values of cancer population,
M2 TAMs macrophages, the non-fibres ECM, the fibres ECM as well as the fibres
orientation on Sν at bSν as a convex combination with uniquely determined weights
βkν , k = 1, . . . , 4 of the values these quantities carry at the neighbouring on-grid
points {yibSν }i=1,4.
Finally, since we seek to use again convolutions for our calculation, Ns different
matrices are constructed (one for each barycentre) that we denote here by KSνA . For
this, considering an arbitrary annulus k and a sector j that defines Sν , the associated
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KSνA is given by
KSνA =

0 . . . . . . . . . . . . 0
...
. . .
0 . . . β1ν β
3
ν . . . 0
0 . . . β2ν β
4
ν . . . 0
...
. . .
0 . . . . . . . . . . . . 0

,
which is a P × P− matrix (with P := (⌈2R/∆x⌉ + 1)) that corresponds to the
on-grid minimal squared regions of macro-mesh points {yix}i=1,P 2 that cover the
sensing region B(x,R), and that is nonzero only on the four positions corresponding
to the barycentre bSν neighbouring locations where this is given by the weights β
k
ν ,
k = 1, . . . , 4.
Therefore, at each instance of time tn, the approximation of the adhesion integral





where the expression of AnSν for each of the two adhesion operators in {Ac,AM} are
as follows:






















n) ◦ (1 − ρ(un))+
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.

























with K̃SνA being the flipped matrix associated with K
Sν
A obtained with the help of




2.4.3 Boundary Micro-Scale Dynamics
To calculate the source term h(·, ·) defined in (2.32) which is used in the MDE micro-
scale equation (2.15), we need to integrate the cancer and M2 TAMs densities. For
any such integral we can use discrete convolutions with an appropriately chosen
matrix KI that will be detailed below. As before, we split the source into two parts
h(i, j) =
hI(i, j) if (i, j) ∈ ΛIn ∪ ΛB,0 else.
Hence, at time tn the source inside the tumour domain is given by
hnI = 4γ












where, I was defined in (2.33), 1 is a matrix of ones with size being the same as
KI that is a [2γ/∆x + 1] × [2γ/∆x + 1] matrix with γ defined in (2.32). Equation
(2.53) is simply the measure of the boundary domain ϵY multiplied by the ratio of
the nodes that lie inside the tumour times the integral. For our calculations, we
construct KI via the trapezoidal method, and so this is given by
KI =

1 2 . . . 2 1






2 4 . . . 4 2




At this point, we need to note that besides the usual error that the trapezoidal
method gives due to the discontinuity we have in B(y, γ) ∩ Ω(t) using a universal
matrix for the integration has its drawbacks. This is because when we use the same
matrix KI for each B(y, γ) ∩ Ω(t), then essentially we ignore that the function is
discontinuous, resulting in an increase in the coefficients of the boundary nodes. On
the other hand, by constructing unique kernels, we also run into difficulties in some
cases; therefore, a universal matrix KI was chosen to calculate the integral.
Since both cancer and macrophage densities are on the macro-scale, and we need
to solve the MDE equation defined in (2.15) on the micro-scale, the source needs
to be approximated on each micro point y. To do this, we adopt the technique
described in [279], i.e., involving bilinear shape functions on a square micro-mesh.
Finally, due to the simplicity of the equation, we involve the Method of Lines, where
the time-marching is carried out via the backward Euler method, while the space
discretisation is based on central differences.
2.5 Parameter Values
In Table 2.3 we present the baseline set of parameters that we will use in the up-
coming section.
Table 2.3: Parameter set used for the numerical simulations in this chapter. If we
could not find any references for some of our parameters then we “Estimated” them
(i.e., we chose an arbitrary value for the simulations).
Variable Value Description Reference
Dc 10
−4 Diffusion coeff. for the cancer [70]
cell population c
DM 5 × 10−5 Diffusion coeff. for the M2 Est. using [101]
Continued on next page
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Table 2.3 – continued from previous page
Variable Value Description Reference
TAM population M2
Dm 2.5 × 10−3 Diffusion coeff. for MDEs [206]
Smax 0.5 Cell-cell adhesion coeff. [245]
Smin 0.01 Minimum level of cell-cell adhesion Estimated
Scl 0.01 Cell-non-fibre adhesion coeff. [245]
ScM 0.125 Cell-macrophage adhesion coeff. Estimated
ScF 0.3 Cell-fibre adhesion coeff. [70]
SMM 0.175 Macrophage self adhesion coeff. Estimated
SMc 0.125 Macrophage-cancer adhesion coeff. Estimated
SMF 0.3 Macrophage-fibre adhesion coeff. Estimated
µc 0.25 Proliferation coeff. for cancer cell [70]
population c
µcM 1.4 Coeff. for the M2 TAMs Est. using [113]
dependence in the cancer cell
proliferation
M0 0.05 Influx of the M2 TAMs Estimated
µM 0.1 Inside tissue proliferation rate of Estimated
M2 TAMs
µMF 2.4 Coeff. for the ECM stiffness Est. using [101]
dependence in the M2 TAMs
proliferation
Continued on next page
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Table 2.3 – continued from previous page
Variable Value Description Reference
dM 0.03 Decay rate of M2 Est. using [259]
λlc 1.0 Degradation coeff. for non-fibre Estimated
ECM due to the tumour
λlM 1.0 Degradation coeff. for non-fibre Estimated
ECM due to the M2 TAMs
γFc 0.75 Degradation coeff. for fibre ECM Estimated
due to the tumour
γFM 0.75 Degradation coeff. for fibre ECM Estimated
due to the M2 TAMs
α1 0 Baseline remodelling Estimated
α2 0 Remodelling of the non-fibre ECM Estimated
due to the M2 TAMs
αc 1 MDE secreting rate by the Estimated
cancer cells
αM 1 MDE secreting rate by the Estimated
M2 TAMs
R 0.15 Sensing radius [245]
r 0.0016 Width of micro-fibres [245]
fmax 0.6360 Maximum of micro-fibre density [245]
at any point
p 0.2 Percentage of non-fibre ECM [245]
Continued on next page
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Table 2.3 – continued from previous page
Variable Value Description Reference
hL 0.03125 Macro-scale spatial step-size [279]
ϵ 0.0625 Size of the boundary [279]
micro-domain ϵY (x)
δ 0.03125 Size of the fibre micro-domain [245]
δY (x)
∆t 10−3 Macro-scale temporal step size Estimated
∆τ 10−4 MDE micro-scale temporal step size Estimated
2.6 Computational Simulations
For the numerical simulations we consider a spatial domain Y = [0, 4] × [0, 4]. We
start with the following initial conditions
c(x, 0) = 0.2 · χ
B((2,2),0.25)
(x),






















where, for consistency, we take the form of the non-fibre phase from previous works
[245, 246, 247].
These macro-scale initial conditions can be seen in Figure 2.9 a). Here, the white
curves indicate the boundary of the tumour. In Figure 2.9 b) we show the initial
condition for one micro-scale fibre domain δY (x), which is repeated for all macro-
scale points. Note that the pattern of the fibres on the micro-scale is not visible on
the macro-scale because in order to get the density of the fibres at any macro-point
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Figure 2.9: a) Initial conditions for the macro scale densities i.e. for cancer,
non-fibre ECM and fibres ECM defined in (2.54). b) The initial condition of one
micro-fibre domain which is repeated for every point on the macro scale.
x we integrate the corresponding fibre-micro domain δY (x) seen in Figure 2.9 b).
We note here that the ratio between the fibres and non-fibres components of ECM is
assumed to be 20% : 80%, a choice which is based on previous works [245, 246, 247].
In this section, we present all of our simulations at time 50∆t, using the param-
eter values from the set S described in Table 2.3 which we regard as baseline, and
any departure from these values will be stated accordingly.
We note here that any small differences in the model outcomes will be exclusively
the result of changes in the parameter values, and not of any model stochasticity,
as all equations and initial conditions are deterministic.
2.6.1 Simulation Results
In this section we investigate numerically the dynamics of the macro-scale model
(2.29), where both cancer and macrophage diffusions are constants.
Baseline dynamics. In Figure 2.10 we show the distribution of macroscopic vari-
ables at time 50∆t, when we assume that all macrophage adhesion terms are zero:
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Figure 2.10: Baseline simulation at time 50∆t where none of the newly introduced
adhesions are present i.e., we set ScM = 0, SMM = 0, SMc = 0 and SMF = 0.
ScM = 0, SMM = 0, SMc = 0 and SMF = 0 (while all other parameters are as in Ta-
ble 2.3). We observe that in this case the M2 TAMs are located near the outer bound-
ary of the tumour. This is the result of the assumptions that macrophages infiltrate
the tumour though the outer boundary (see Eq. (2.26)), and that macrophages dif-
fuse with constant coefficient. Further, we observe that the initial homogeneous
cancer cell density becomes heterogeneous due to the many cancer cell adhesion
precesses, highly influenced by the rearranged and degraded ECM (caused by both
cancer cells and TAMs). On the other hand, in peritumoral regions, the ECM degra-
dation creates free space for the tumour to expand and spread to the neighbouring
tissues resulting in some tumour fingering, which gives an irregular tumour domain
(that mainly follows the ECM pattern). This effect is complemented by the rear-
rangement of the micro-fibres that ultimately induces new a fibre structure. For
illustrative purposes, in Figure 2.10 we coarsen four-fold the ECM fibre field.
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The impact of macrophage interactions on tumour dynamics. In Fig-
ure 2.11 we investigate the effect of each individual adhesion interaction that we
introduced in this paper i.e., cancer-M2, M2-M2, M2-cancer and M2-fibres interac-
tions. For comparison purposes, Figure 2.11a) shows again the baseline cancer and
TAM dynamics (as copied from Figure 2.10).
In Figure 2.11b) we show the effect of cancer-M2 adhesion interaction (i.e.,
ScM = 0.125, while SMM = SMc = SMF = 0). Interestingly, we do not see much
difference compared to Figure 2.11a) (baseline simulation). This may indicate that
this particular interaction is overwhelmed by the many other cancer cell-cell and cell-
ECM adhesive interactions, and thus the cancer-M2 adhesion alone is not powerful
enough to lead to a distinct tumour invasion pattern.
In Figure 2.11c) we show the effect of M2 TAMs self-adhesion (i.e., SMM = 0.175
and ScM = SMc = SMF = 0). Compared to the baseline simulations, here the density
of M2 TAMs becomes higher in the peripheral tumour region. As expected, when
macrophages infiltrate the tumour, they prefer not to migrate but to stay together
(due to SMM > 0).
In Figure 2.11d) we consider the M2-cancer adhesion process (i.e., SMc = 0.125,
and ScM = SMM = SMF = 0). We notice here a more aggressive tumour fingering
morphology compared to the baseline result. Moreover, the minimum of the M2
TAMs density inside the tumour domain is also decreased. To understand the reason
behind this we refer to the M2-cancer adhesion part of (2.27), where we note that
this process does not only depend on the cancer cell density but also on the free
space available (accounted for via (1 − ρ(u))+). Therefore, M2 TAMs prefer areas
of the tumour domain where the density of the cancer cells is high yet not too high,
so that there is some free space available. Hence, this process could be one of the
mechanisms responsible for accumulating and keeping M2 TAMs in the peripheral
region.
In Figure 2.11e) we consider the effect of M2-fibre adhesion (to explore the
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Figure 2.11: Simulations illustrating the effects of each freshly introduced adhesion
separately. Hence, a) corresponds to the baseline solution (also seen in Figure 2.10),
and b)-e) represent the effect of each strength ScM , SMM , SMc and SMF , respectively.
Finally, f) corresponds to their combined effects ( i.e., we take ScM , SMM , SMc and
SMF from the parameter set S in Table 2.3). Each simulation presented in this
figure uses the initial conditions from (2.54) and Figure 2.9 as well as corresponds
to 50∆t.
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possibility that M2 TAMs movement depends also on the oriented ECM fibres). To
this end we set SMF = 0.3 (and ScM = SMM = SMc = 0). Comparing this simulation
result with the baseline result shown in Figure 2.11a), we can see that the M2 TAMs
follow the fibre orientations. Since we assumed aligned ECM fibres (i.e., induced
by the oriented ECM fibre density shown in Figure 2.9b)), the M2 TAM density in
the peripheral region is higher in the direction of the oriented ECM fibres (as the
initial ECM fibres have all the same top-left orientations on the macro-scale), and
so at the top-left region of the tumour the M2 TAMs macrophages density is higher.
This indicates that M2 TAMs accumulations may also depend on the oriented ECM
fibre distribution.
Finally, in Figure 2.11f), we combine all these adhesion processes (i.e., we use
the values from the parameter set S in Table 2.3 for ScM , SMM , SMc and SMF ).
Until this point, we have not emphasised the fact that by considering each of these
processes separately, we observed a slightly smaller tumour spread compared to the
baseline simulation. However, as shown in Figure 2.11f), by combining all these
adhesion processes, we see an increase in tumour spread. This suggests that it may
not be enough to focus only on one aspect of macrophages and rather we need to
focus on these processes as a whole in order to stop the pro-tumoural behaviour
of the M2 TAMs. Hence, these different adhesion processes may work with and
magnify each other in an underlying fashion that creates a favourable environment
for tumour development.
The impact of ECM fibre structure and fibre-adhesion strengths on tu-
mour dynamics. Next, we explore how the fibrous composition of ECM and
the corresponding fibre-adhesion strengths affect the evolution of the solid tumour.
In Figure 2.12, we investigate the effect of changing (i) the ECM fibre percentage
(compared to the non-fibre ECM), and (ii) the M2-fibre and cancer-fibre adhe-
sion strengths, for the particular case where we have only M2-fibre adhesion (i.e.,
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ScM = 0, SMM = 0, SMc = 0). For comparison purposes, in Figure 2.12a) we
present again the M2-fibre adhesion case (i.e., the one shown in Figure 2.11e), where
SMF = 0.3, and ScF = 0.3.
In Figure 2.12b) we decrease the fibre magnitude and take the ratio between the
fibre and non-fibre ECM to be 10% : 90%. In this case we see both more tumour
fingers, as well as an increase in the tumour spread. This is expected since by
decreasing the fibre percentage, we also decrease the fibre adhesions. Moreover, the
accumulation of fibres at tumour boundary becomes less dense, allowing the tumour
to spread further, more efficiently.
In Figure 2.12c), we consider again the baseline ECM fibre percentage (20%) but
we decrease the M2-fibre adhesion strength to SMF = 0.1 (while keeping the cancer-
fibre adhesion strength SMF = 0.3). We observe here that due to the changes within
the oriented ECM fibres distribution (caused by the fibres rearrangement at the
micro-scale induced by the macro-scale spatial flux of cancer cells and M2 TAMs),
the macrophages cannot move efficiently within the tumour microenvironment, and
within the assumed conditions of low macrophages-fibre adhesion strength, the ef-
fect of the macrophages diffusion increases. Comparing these simulation results
with those in Figure 2.12a), we see a considerable increase in tumour spread. This
suggests that the decrease in the M2-fibres adhesion leads to a diffusion-dominated
macrophage movement, which likely helps tumour spread indirectly via the degra-
dation of ECM.
In Figure 2.12d), we present the simulation results when we decrease the fibre
percentage to 10% and keep a low small M2-fibre adhesion strength (SMF = 0.1; as in
Figure 2.12c). Compared to the situation addressed in Figure 2.12b), where we had
larger macrophage-fibre adhesion strength, we note here an increase in the tumour
spread. However comparing now the results in row four to the ones in Figure 2.12c)
(where we had identical adhesion strength, but with increased level of ECM fibres
to 20% was considered) we observe a decrease in the tumour spread. Hence, the de-
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Figure 2.12: Simulations when only M2-fibre adhesion is present ( i.e., we set
ScM = 0, SMM = 0, SMc = 0) at time 50∆t: a) baseline for this figure and so it
is identical to Figure 2.11e) with 20% fibres (80% non-fibre ECM) and ScF = 0.3,
SMF = 0.3; b) same fibre-adhesion strengths but with only 10% fibres (90% non-fibre
ECM); c) 20% fibres with decreased M2-fibre adhesion SMF = 0.1; d) 10% fibres with
decreased M2-fibre adhesion SMF = 0.1; e) 20% fibres and both cancer and M2-fibre
adhesion strengths are reduced ScF = 0.1 and SMF = 0.1; f) 10% fibres with the
reduced fibre adhesion strengths ScF = 0.1 and SMF = 0.1.
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creased level of macrophages-fibres adhesion strength (considered in simulations on
rows three and four) reverse the observation concerning tumour spread that emerged
by comparing Figures 2.12a) and b) (with a higher level of macrophages-fibres ad-
hesion strength, SMF = 0.3). Hence, macrophages-fibres mediated movement exert
a level of control on the tumour spread and the evolution of its morphology, by
monotonically reducing tumour diffusive spread and at the same time stimulating
lobular cancer invasion patterns.
In Figures 2.12e) and f), we investigate the effects of weak M2-fibre adhesion
combined with weak cancer-fibre adhesion (i.e., ScF = 0.1, SMF = 0.1). Comparing
the simulation results in Figure 2.12e) with those in Figure 2.12c), we conclude
that by reducing the cancer-fibre adhesion strength we decrease significantly the
tumour spread. However, if we reduce also the amount of fibres to 10% (see rows
five and six), we see an increase in tumour spread (likely due to larger cell-non-fibre
adhesions).
Next, in contrast to Figure 2.12, where no macrophage-macrophage self-adhesion
nor cancer-macrophage or macrophage-cancer adhesion relations were considered, we
address the case in which these processes are present, namely ScM > 0, SMM > 0
and SMc > 0 (with the baseline values given in Table 2.3, used also in Figure 2.11f)).
Furthermore, as before, we vary the values of cell-fibres and macrophages-fibre ad-
hesion, ScF and SMF . In these conditions, in Figure 2.13, we explore the importance
of the M2-fibre adhesion compared to the the rest of the adhesion terms. Again, for
comparison purposes, in Figure 2.13a) we show the baseline dynamics of this case,
as copied from Figure 2.11f).
In these new conditions, Figures 2.13a)-d) show that changes in macrophage-
fibre adhesion at ECM fibres regimes of both 20% and 10% do not have a significant
impact on the tumour spread (although a smaller cancer spread is noticed when
lower SMF is considered).
However, as shown in the ECM regime with 20% fibres levels, the comparison of
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Figure 2.13: Simulations at time 50∆t when all new M2 TAM adhesions are
present: i.e., using the values from the parameter set S (see Table 2.3, for ScM , SMM ,
SMc) while altering ScF and SMF : a) the baseline for this figure that is identical to
Figure 2.11f); b) decreased M2-fibre adhesion SMF = 0.1 with 20% fibres; c) 10%
fibres with SMF = 0.3; d) 10% fibres with decreased M2-fibre adhesion SMF = 0.1;
e) 20% fibres and both cancer and M2-fibre adhesion strengths are reduced ScF = 0.1
and SMF = 0.1; f) 10% fibres with the reduced fibre adhesion strengths ScF = 0.1
and SMF = 0.1.
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the results from row five (where low cancer-fibre adhesion ScF = 0.1 is considered)
with those in row two highlight the importance of cancer-fibres adhesion within
the invasion, as we record higher tumour spread for higher values of ScF . The
same behaviour is observed through the comparison of row four and row six, where
the same variation of ScF when we consider a lower level of ECM fibres and of
macrophage-fibre adhesion, SMF = 0.1.
Finally, by comparing Figures 2.13a), b) and e) we observe that it is the cell-
fibres rather than the macrophages-fibre adhesion that plays the dominant role at
higher level fibres (20%) within the ECM. However, the comparison between rows
three, four and six of Figure 2.13 shows that in regimes with lower levels of fibres
(10%) within the ECM, the influence of the macrophages-fibres adhesion on the
overall cancer invasion is still important.
The effect of random micro-fibre distribution. In all our previous numerical
simulations we used the micro-fibre structure described in Figure 2.9b) that we
repeated for each micro-fibre domain δY (x), thus inducing the same fibre orientation
at each macro-scale node (top-left orientation seen in Figure 2.10). Now we consider
random mass distributions of micro-fibres for each micro-domain δY (xi, yj), (i.e., we
draw five random straight lines in each δY rather than use the five-line configuration
presented in Figure 2.9b)).
In Figure 2.14, we present three simulations with randomised mass distributions
of micro-fibres on each δY (xi, yj), i, j ∈ {1, . . . , n} (where the same random distri-
bution is used for all three simulations as an initial condition). Here we focus on
the case when all of the adhesion terms are present (i.e., ScM , SMM , SMc, SMF ,
ScF > 0, as given in Table 2.3).
In Figure 2.14a) we use 20% fibres, and we observe that due to the random fibres,
the tumour spread is reduced (by ≈ 25%) compared to Figure 2.11f). This is not
surprising as we moved from aligned fibres to a random oriented fibres, where the
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Figure 2.14: Simulations with random fibre structures for each micro-fibre domain
δY combined with every adhesion terms ( i.e., using ScM , SMM , SMc, SMF and ScF
from the parameter set S Table 2.3) at time 50∆t: a) (first two rows) represent
the result of random micro-fibre structure, but their macro-scale magnitude is still
considered to be a constant 20%; b) (third and fourth rows) presents the result of 10%
fibres with random structures; c) (last two rows) also uses random structure but also
uses random macro-scale magnitude for each micro-domain δY between 10% and
20%.
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movement is expected to be slower.
In Figure 2.14b) we reduce the fibres to 10%, and we observe an even greater
tumour reduction compared to the aligned fibre case in Figure 2.12b) (approximately
43% reduction in tumour area). Also, as before, we see an increase in the tumour
spread when we decrease the fibres from 20% to 10%.
In Figure 2.14c) we consider not only random micro-fibre structures but also use
random macro-fibre magnitudes (i.e., at each macro-node, we now have a random
level of fibres between 10% and 20%). For this case we see that tumour spread is
slightly greater than for the 20% fibre case, but slightly smaller than for the 10%
case. We can conclude from here that using random fibres may considerably reduce
tumour spread, but it does not introduce new tumour morphology.
2.6.2 Different Tissue Conditions
Based on biological knowledge [99, 293], given the complex and naturally multi-
scale cancer invasion process, a solid cancer progresses further within the surround-
ing tissue provided that significant but not complete tumour peritumoural ECM
degradation will have been achieved, i.e., favourable tissue conditions for invasion
are met. In all the simulation that we carried out so far in this work, these tissue
conditions for tumour progression have been explored within the framework defined
in [279], where these were captured through a tissue parameter β ∈ (0, 1), which
characterises the relative level of significant degradation of the peritumoural ECM.
For all the results presented in Figures 2.10-12, this parameter was set to the level
of β := 0.65, which corresponds to relatively mild conditions for invasion. However,
as we wish to explore our modelling also for more demanding tissue conditions for
tumour invasion, that requires more elevated levels of significant peritumoural ECM
degradation, we now vary the parameter β by increasing its value.
To illustrate our results in new tissue conditions favourable for tumour progres-
sion induced by elevated values of β, in Figure 2.15a) we show the result for our
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model without the new adhesion processes and tissue conditions induced by β = 0.8.
Here we observe a pronounced lobular formation and increased fingering within the
tumour morphology where the number and size of the islands inside tumour are also
increased. Then, the results in Figure 2.15b) show that, by increasing further the
tissue parameter β = 0.825 (while keeping the same diffusion and adhesion regime),
we obtain an even more aggressive tumour fingering and lobular formation, and a
rather decreased tumour area compared to Figure 2.15a). Finally, in Figure 2.15c)
we show the results that we obtain when we re-introduce the adhesion processes
(i.e., we take ScM , SMM , SMc and SMF from the Parameter set S in Table 2.3)
which results in further decrease in the tumour area while maintaining a significant
tumour fingering and lobular behaviour.
2.7 Discussion
In this study, we further developed the multi-scale moving boundary framework
for tumour invasion introduced in [245, 279], by including also a tumour-associated
macrophage cell population, with the goal of investigating the interactions between
macrophages directional movement and the directionality of ECM fibres on the
overall tumour spread. We focused on the M2-like macrophages since various exper-
imental and clinical studies have shown that these cells are not only one of the most
abundant immune cell populations that infiltrate the tumour mass [132, 286], but
they are also involved in the degradation of ECM [69, 172, 194, 228] thus helping
tumour invasion. We considered this modelling and computational approach since
in the experimental literature there is still little knowledge about the directional in-
teractions of macrophages with the directional/random ECM architecture, and how
this affects tumour spread.
To address this lack of knowledge and to propose new hypotheses on these in-
teractions, we started with the modelling framework in [245] that focused on the
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Figure 2.15: Simulations, at time 50∆t, with the extended model (2.29) for dif-
ferent tissue conditions (β), while we consider 20% fibres. a) simulation with zero-
macrophage adhesion coefficients ( i.e., ScM = 0, SMM = 0, SMc = 0 and SMF = 0)
and an increased β = 0.8; b) the tissue parameter is further increased to β = 0.825
without considering any macrophage adhesion processes ( i.e., ScM = 0, SMM = 0,
SMc = 0 and SMF = 0); c) simulation with β = 0.825 where we take the values for
ScM , SMM , SMc and SMF from the Parameter set S in Table 2.3.
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dynamics of tumour cells and extracellular matrix at both micro- and macro-scales,
and introduced a new macro-scale equation for the pro-tumour M2 cells. In this new
equation, we considered the M2 TAMs movement to be both random and directed,
with the directed movement being the result of self-adhesion and fibre-adhesions,
as well as M2-cancer adhesion. The rest of the M2 TAMs dynamics included a
linear death term, a proliferation term and an influx term where we assumed a
constant influx of M2 TAMs on the outer tumour boundary. Since the M2 TAMs
secrete MDEs, the degradation of both ECM components is not only influenced by
the density of the cancer cells but also by the density of M2 TAMs. Therefore,
the macrophages have a direct contribution to the source for the proteolytic micro-
dynamics of MDEs occuring at the invasive edge of the tumour, which ultimately
determines the way the tumour boundary is relocated during invasion. Furthermore,
as macrophages are moving, they influence the re-arrangement of the micro-fibres
through the flux that they induce. Thus, the M2 macrophages are involved in both
the top-down and bottom-up links of the two interconnected multiscale subsystems
that take place both at leading edge and on the bulk of an invading tumour (which
are schematically summarised in Figure 2.5).
While the genuine heterogeneous and multiphase structure of the ECM has been
acknowledged by the entire experimental and biological community [99, 117], the
two-phase ECM modelling perspective proposed in this current work (as well as in
[245, 246, 247]) not only that was naturally motivated, but the insights that this
brings (through the possibility of exploring in detail the multiscale and complex
adhesive interaction between the cells and macrophages on one hand and both the
non-fibres ECM phase [84, 90, 91, 119] and the oriented ECM fibre phase [294, 295])
open the way for a deeper understanding of both directed and undirected tumour
cell population movement in the presence of M2 TAMs macrophages. This will have
direct implication in the planned future works on drug and chemotherapy delivery
which naturally follows the non-fibres ECM phase, rather than the ECM fibres
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phase.
We used this new extended multi-scale moving boundary mathematical model
to explore some biological hypotheses regarding the role of M2 cells on tumour
spread. First we investigated the individual effects of the cancer-M2 and M2-cancer
adhesions, as well as the M2-self and M2-fibre adhesions, and we concluded that in-
dividually these interactions do not lead to a significant increase in tumour spread.
However, they do change the tumour morphology, by leading to various accumula-
tion sites for the M2 TAMs (see Figure 2.11). We also showed that combining all
these different adhesion terms leads to an increase in tumour spread. Then we ex-
plored how the fibrous component of the ECM and the corresponding fibre adhesion
strengths could affect tumour development (see Figures 2.12 and 2.13). The simu-
lations showed that decreasing the fibre density could be helpful to reduce tumour
spread; but this depended also on the M2 TAMs directed movement via fibre ad-
hesion. We also investigated the importance of M2-fibre adhesion compared to the
rest of the adhesions. In our model, this suggested that the M2-fibre adhesion play
a minor role and do not significantly affect tumour development. Moreover, we con-
sidered an unstructured, random micro-fibre structure that revealed that although
it does not introduce new properties, it can reduce the spread quite dramatically.
We note here that all these numerical results were obtained with a low β value
(to be consistent with the studies in [245, 246, 247]), which means that even if
the ECM was not significantly degraded the tumour was still able to invade the
surrounding tissue. Therefore, changes in the various parameter values considered
in Figures 2.11-2.14 did not lead to huge differences in tumour invasion patterns.
However, in Figure 2.15 we presented some simulations for the tumour dynamics ,
as we varied the tissue environment parameter β. We have seen that for higher β,
changes in cell-cell and cell-matrix adhesion strengths lead to completely different
tumour invasion patterns, with more tumour fingering, and clear uni-directional
movement towards the direction of ECM fibres.
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All these numerical results indicate that the combined effects of macrophage-
tumour-ECM interactions (via different cell-cell and cell-fibre adhesions) are impor-
tant for tumour development. Moreover, these results allow us to conclude that
it is difficult to ascertain at a macroscopic level the specific molecular (i.e., adhe-
sion) mechanisms that could be responsible for the observed macroscopic patterns
of tumour spread and/or accumulation.
The complexity of the interaction between tumour cell and macrophages exceeds
the context captured in this work through the mutual adhesion terms involved in the
macroscopic model equations. For example, this approach does not capture explic-
itly the complex cross-talk between tumour cells and macrophages via chemokines.
Such aspects will be investigated in future studies. Further, due to the complexity of
the multi-scale moving-boundary framework and the numerical simulations of these
equations, in this work we focused only on the dynamics of the tumour and the im-
mune cells infiltrating it. For this reason, we assumed that macrophages enter the
tumour though tumour boundary. In the future, we will extend this modelling ap-
proach to account also for the dynamics of macrophages outside the tumour (which
are attracted to the tumour site via chemokines secreted by the tumour cells [92]).
Finally, another aspect that will be addressed in future work is the analysis
of the complex multi-scale numerical framework proposed in this study. As this





within a Multi-Scale Moving
Boundary Tumour Invasion Model
Aims and Novelty: In this chapter, we aim to expand further upon the multi-
scale moving boundary framework introduced in Chapter 2 by incorporating not
only the M1-like macrophages but the nutrients as well. Ultimately, this allows us
to explore how different scenarios could affect a potential re-polarisation (M2→M1)
based treatment strategy.
3.1 Introduction
The last few decades have seen a shift in the focus of cancer research: from re-
search that was focused on individual tumour cells to research that is now focused
on the TME and the interactions between different types of cells inside the TME
[104]. In Chapter 2 we have acknowledged the fact that macrophages are one of
the most abundant stromal cell populations within the TME [132, 286]. However,
we focused on the pro-tumoral M2 TAMs alone and did not consider the presence
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of the anti-tumoral M1 TAMs since the majority of macrophages are polarised into
the M2 phenotype in advanced (detectable) tumours [155]. Due to their plastic-
ity, macrophages can switch their phenotype (M1↔M2), and over the last decades,
experimental and clinical studies have shown that re-educating TAMs to exhibit
anti-tumour responses by switching their cell phenotype from M2-like to M1-like
cells can lead to successful anti-cancer treatment protocols [155]. An example of
such a treatment protocol involving macrophage re-polarisation, which was shown
to be successful in human pancreatic cancer, involved the use of agonist anti-CD40
mAb [23].
Besides cancer cells, macrophages and the ECM, the tumour’s vasculature also
plays a crucially important role within the TME since it is responsible for the supply
of nutrients (e.g. oxygen and glucose) that are vital for any cells to live and func-
tion properly, including cancer cells and macrophages. In avascular solid tumours,
nutrients are extravasated from the blood flow and diffuse through the ECM into
the tumour through the tumour boundary, and therefore tumour progression leads
to the formation of regions inside the tumours with very low nutrient levels. These
regions first become hypoxic and then necrotic, and cells in these regions undergo
cell death due to deprivation of nutrients. Moreover, these hypoxic conditions can
also modify the polarisation of macrophages and influence the malignant behaviour
of some cancer cells [130].
Therefore, in this chapter, we explore how the re-polarisation of TAMs (M2→M1)
affects the overall tumour progression (mass and spread) and whether a re-polarisation
based treatment strategy is space-time dependent. On the other hand, we also
study how the introduction of nutrients within this multi-scale moving boundary
approach influence tumour behaviour and whether it has a meaningful effect on a
re-polarisation based treatment. The content of this chapter has also been explored
and discussed in full detail in our recent publication [264].
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3.2 Multi-Scale Modelling of the Tumour Dynam-
ics
Using the multi-scale moving boundary framework described in Chapter 2 where
we only considered the presence of the M2 phenotype (besides the cancer cell pop-
ulation and a two-phase ECM), here, we further extend this modelling platform
by introducing the M1-like macrophages. Hence, we assess the impact of this anti-
tumoral phenotype within the interlinked tissue-scale (macro-scale) and cell-scale
(micro-scale) tumour dynamics. Moreover, the biological context of the tumour
macro-dynamics is further broadened by considering the presence of the nutrients,
which include components such as glucose and oxygen that are crucial constituents
of the tumour microenvironment and play an essential role within overall tumour
progression.
3.2.1 Macro-Scale Dynamics
Since the model described in this chapter extends the one outlined in Chapter 2, we
have the same underlying multi-scale features that for clarity, we briefly discuss here
again. Hence, on the macro-scale we focus on the expanding tumour region Ω(t)
that progresses within a maximal tissue cube Y ⊂ RN , for N = 2 and over the time
interval [0, T ] (i.e., Ω(t) ⊂ Y, ∀t ∈ [0, T ]). In this context, at at any macro-scale
spatio-temporal point (x, t) ∈ Ω(t)× [0, T ], we consider a mixed cell population con-
sisting of distributions of: (a) cancer cells c(x, t); (b) M1-like macrophages, M1(x, t),
briefly addressed here as M1 TAM; and (c) M2-like macrophages, M2(x, t), which
are briefly referred to as M2 TAM. This mixture of cancer cells and macrophages
exercise their naturally multi-scale dynamics within a two-phase ECM, which as in
Chapter 2 and in [245, 246, 247], is regarded as consisting of two major phases,
namely a fibrous and a non-fibrous one. Thus, as before, the fibre ECM phase
accounts for all major fibrous proteins (such as collagen and fibronectin), whose
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spatio-temporal distribution at the macro-scale point (x, t) is described by a vector
field θf (x, t), where θf (·, t) : RN → RN , with its Euclidean norm F (x, t) :=∥θf (x, t)∥2
representing the amount of fibres at (x, t) and for further details we refer the reader
to Section 2.2.2. On the other hand, as in Chapter 2 we bundle together the rest of
the ECM constituents (such as non-fibrous proteins, enzymes, polysaccharides and
extracellular Ca2+ ions) and refer to it as the non-fibre ECM phase, whose distribu-
tion at each (x, t) is denoted by l(x, t). Similarly to Chapter 2, here we also define
all cell populations (c(x, t), M1(x, t) and M2(x, t)) within the tumour domain Ω(t)
and the two ECM phases (F (x, t) and l(x, t)) within the tissue cube Y . Therefore,
to also include the density of M1 TAMs, in this chapter we define the global tumour
vector u as
u := (c(x, t),M1(x, t),M2(x, t), l(x, t), F (x, t))
⊺, (3.1)
as well as we define the total space occupied at (x, t) as
ρ(u) := c(x, t) + F (x, t) + l(x, t) +M1(x, t) +M2(x, t), (3.2)
for all (x, t) ∈ Y ×[0, T ]. Furthermore, the last component of the macro-scale dynam-
ics is the nutrients density σ(x, t), whose level within the tumour microenvironment
is depleted by the invading cancer.
Finally, we consider the macrophages to infiltrate the tumour through the same
outer boundary ∂Ωo(t) ⊂ ∂Ω(t) that we used previously in Chapter 2 and which is
defined in Appendix A.1 (see Figure 2.6 for illustration).
Nutrient
In this chapter we focus on an avascular tumour mass, whose growth is supported
by an influx of nutrients that diffuse through the outer boundary of the tumour.
To incorporate this aspect into our mathematical model, we consider the overall
influx of a generic nutrient through the outer tumour boundary ∂Ωo(t) by using
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Dirichlet boundary conditions. Hence, here, we consider a nutrient field that is only
affected within the tumour, and so outside of the tumour its level is assumed to
be unaffected/normal. Although different cell types uptake the supplied nutrients
at different rates, for simplicity here we assume that all present cell populations
(cancer cells, M1 and M2 TAMs) uptake nutrients at the same constant rate dσ > 0.
The spatial transport of the nutrients is modelled by a diffusion term with constant
coefficient Dσ > 0. Since this diffusion occurs more rapidly than cell diffusion (i.e.,
cell random walk), we use a quasi steady state reaction-diffusion equation (similar
to the one for instance in [169]) for the generic nutrients σ(x, t):
0 =Dσ∆σ − dσ(c+M1 +M2)σ, (3.3a)
σ(x, t) =σnor, ∀x ∈ ∂Ωo(t),∀t ∈ [0, T ]. (3.3b)
Here, σnor is the normal level of nutrients along the tumour interface, which is
considered to be a constant.
Since cells require nutrients to function properly, here we introduce four smooth
bounded effect-functions that we use to model the effects of the nutrients on the
different cell functions that considers the following critical nutrients levels:
 the necrotic minimal threshold σn > 0 (i.e., if σ ≤ σn this leads to necrotic
tumour cell death in that area [148];
 the intrinsic nutrient level sufficient for cells to function properly: σp > 0;
 the normal level of nutrients: σnor (threshold value that is used also as the
Dirichlet boundary condition in (3.3)).
Hence, we have the following relationship between these three values, namely: σnor >
σp > σn.
Starting with the effect of nutrients on cell proliferation, we first assume that
this effect is relatively similar for cancer cells and both macrophage populations, in
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the sense that very low nutrient level impedes cell proliferation and extremely high
nutrient level cannot increase cell proliferation rate above a certain maximum. We
consider a maximal proliferation enhancement rate Ψp,max > 0 which corresponds
to nutrient levels σ ≥ σp. Also, we assume no proliferation in the necrotic regions.
Thus, we define the proliferation effect-function:
Ψp(σ) :=

0 if σ ≤ σn,
Ψp,max if σ ≥ σp,
Φ(σ,Ψp,max, 0, σp − σn) otherwise,
(3.4)
where Φ(σ, ·, ·, ·) is a generic cosine function that describes a smooth transition














where Φmin is the minimum, Φmax is the maximum and ΦL controls the phase shift
of the cosine function. We illustrate the proliferation effect-function, defined in (3.4)
in Figure 3.1.
As opposed to cell proliferation, we distinguish between the death of cancer cells
and death of macrophages, since cancer cells resist death [98, 99] while macrophages
do not. Moreover, experimental studies have shown that macrophages can die in
the absence of nutrients [238]. Also, it is known that following hypoxia-induced
chemo-attractant signals, macrophages position themselves into pre-necrotic regions
to clear out dead cells in the necrotic regions [181]. Therefore, we consider a maximal
enhancement death rate Ψd,max > 0 in necrotic regions for both populations, and
while we assume no death for cancer cells, we consider a minimal level of macrophage
enhancement death rate ΨdM,min > 0 in regions where the nutrient level is σ ≥ σp.
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Hence, cancer cell death and macrophage death effect-functions are defined as (using
the transition function (3.5)):
Ψdc(σ) :=

Ψd,max if σ ≤ σn,
0 if σ ≥ σp,




Ψd,max if σ ≤ σn,
ΨdM,min if σ ≥ σp,
Φ(σ,ΨdM,max,ΨdM,min, 0) otherwise.
(3.6b)
These death effect-functions are illustrated in Figure 3.1.
Finally, it was shown experimentally [273] that the nutrient level affects the
macrophages polarisation rate, and so here we consider also a polarisation effect-
function. Thus, we consider a maximal enhancement rate ΨM,max > 0 in necrotic
regions and a minimal enhancement rate ΨM,min > 0 in regions with normal nutrient




ΨM,max if σ ≤ σn,
ΨM,min if σ ≥ σnor,
Φ(σ,ΨM,max,ΨM,min, 0) otherwise.
(3.7)
This function is illustrated in Figure 3.1.
Dynamics of both M1 and M2 TAMs
Focusing now on the macrophage population, specifically to the two extreme phe-
notypes, M1 and M2 TAMs, in this chapter, we focus on the dynamics of the two
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Figure 3.1: Schematic plots of the four nutrients effect-functions a) Ψp(σ), b)
Ψdc(σ), c) ΨdM(σ) and d) ΨM(σ) defined in (3.4), (3.6), and (3.7), respectively.
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TAMs populations exclusively inside the tumour domain Ω(t), the evolution of the
macrophages distribution in the surrounding tumour stroma being beyond the scope
of this current work. Hence, since macrophages are recruited to tumour sites as an
immune response through the peritumoral vasculature, here this influx is represented
by a source of M1 TAMs that is localised along the outer tumour boundary ∂Ωo(t),
which is enabled by the immediate activation of macrophages into M1 TAMs as
they enter the tumour [265]. As in Chapter 2, for simplicity, we assume that both
profile and maximal magnitude M0 > 0 of this source are identical along the tumour
interface, and so this influx term is given by
MI := M0(χ∂Ωo(t) ∗ ψρ)(x). (3.8)
Here, ψρ is the standard mollifier with appropriately chosen range ρ > 0, “ ∗ ” is
the convolution operator [64] and χ∂Ωo(t) is the characteristic function of the outer
boundary ∂Ωo(t).
Experimental studies have shown that resident macrophages can proliferate in
situ, which can lead to the accumulation of tumour-associated macrophages inside
various tumours [281]. Moreover, as in Chapter 2 and [265], we recognise that
the stiffness of the ECM plays a role in the proliferation of the macrophages [101]
and that according to several biological studies [40, 52, 122], cancer cells trigger the
proliferation of macrophages by producing survival and proliferation factors. Hence,
we denote by µMF > 0 the macrophages proliferation enhancement rate due to the
fibres while the proliferation effect-function Ψp(σ) defined in (3.4) accounts for the
effect of nutrients on the macrophage proliferation. For simplicity, both the fibre
enhancement rate and the effect-function are assumed to remain unchanged for both
phenotypes. Thus, we formulate the proliferation laws for the M1 and M2 TAMs as
88
PM1(u) :=µMΨp(σ)(1 + µMFF )M1c(1 − ρ(u))+, (3.9a)
PM2(u) :=µMΨp(σ)(1 + µMFF )M2c(1 − ρ(u))+, (3.9b)
respectively. In (3.9), µM is the positive baseline proliferation rate while the term
(1 − ρ(u))+ := max(0, 1 − ρ(u)) ensures that there is no overcrowding.
Experimental studies have shown that macrophages’ death can be induced by
nutritional starvation [238]. Thus, for both M1 and M2 TAMs, we consider a natural
death rate dM > 0 that is regulated by the available nutrients through the death
effect-function ΨdM(σ) introduced in (3.6b), and so the death terms are defined by
QM1(u) := dMΨdM(σ)M1, (3.10a)
QM2(u) := dMΨdM(σ)M2, (3.10b)
for the M1 and M2 TAMs populations, respectively.
Due to the versatility of the macrophages, their phenotype can be switched from
one to another [24, 234]. In the present work, we focus on two factors that drive
the polarisation of M1 TAMs into M2 TAMs, which are detailed as follows. On the
one hand, cytokines secreted by the cancer cells were shown [205, 248] to trigger the
polarisation process. On the other hand, the nutrient level was also shown [273] to
affect this process. As a consequence, we describe the polarisation of M1 TAMs to
M2 TAMs by
T12(u) := p12ΨM(σ)cM1, (3.11)
where p12 > 0 is a constant proliferation rate, and ΨM is the polarisation effect-
function defined in (3.7). Furthermore, in vitro, it has been demonstrated [66] that
the M2-like macrophages can be re-polarised back into the M1 phenotype which
may be a viable strategy against tumour development. To that end, we explore
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Figure 3.2: Schematic of the re-polarisation domain Ωp(t, Rp) that is highlighted
with red.
here mathematically the possibilities of the re-polarisation strategy through a re-
polarisation term of the form
T21(u) :=
 0 if t < tp,p21M2(χΩp(t,Rp) ∗ ψρ)(x) if t ≥ tp. (3.12)
Here, p21 > 0 is the constant re-polarisation rate, tp > 0 is the activation time and
χ
Ωp(t,Rp)
is the characteristic function of the re-polarisation domain Ωp(t, Rp) that
is defined in Appendix A.4 and illustrated in Figure 3.2. This re-polarisation term
(3.12) allows us to examine whether or not we would need to account for spatio-
temporal dependencies through the domain Ωp(t, Rp) and activation times tp > 0 in
order to obtain an effective re-polarisation strategy.
The motility of both macrophages phenotypes is driven both by random and
directed movement. Based on recent biological evidence [101], increased stiffness of
the substrate leads to an increase in macrophages’ speed, aspect explored in our
modelling through a diffusion enhancement that corresponds to with the level of
ECM fibres. To that end, we consider a stiffness-dependent macrophage diffusion
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coefficient DM(u) of the form
DM(u) := DM(1 +DMFF ), (3.13)
where DM > 0 is the baseline macrophage diffusion rate, and DMF > 0 is the dif-
fusion enhancement rate due to the presence of fibres. On the other hand, besides
random movement, macrophages also exercise directed migration due to a both ad-
hesive interactions with the surrounding cells and the ECM as well as an underlying
cross-talk between themselves and the cancer cells. A similar “non-local flux term”
to the one introduced in Chapter 2 and in [265] is used here to explore the complex
interactions of the cells distributed at x ∈ Ω(t0) with other cells within a sensing
region B(0, R), and this accounts for: (1) cell-cell TAMs self-adhesion [60]; (2) nu-
trients level mediated movement[188]; and (3) the contribution of the cancer cells
to the directional movement of the macrophages [49, 55, 72, 299]. Specifically, the
contribution of the cancer cells to the directional movement of the macrophages
account not only for the biological evidence that cancer cells can bind themselves
to TAMs [49] but also for the fact that cancer cells can attract TAMs [55, 72, 299]
by secreting various chemokines. Although we neither model explicitly the involved
chemokine activities within this cross-talk nor the chemo-attractant activities in-
volved with the nutrients, here we appropriately account for both of them through














M1(x+ y, t) +M2(x+ y, t)
)
+ SMcc(x+ y, t)
][




where R represents the radius of the sensing region B(0, R). Further, SMc > 0 is
the combined strength of the macrophage-cancer adhesion, and SMσ > 0 denotes
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strength of the macrophage-nutrient relationship, with both SMc and SMσ being
assumed to maintain their individual values unchanged when considering the cases
of M1 and M2 TAMs populations. Furthermore, SMM denotes the self-adhesion
strength that differs for M1 and M2 TAMs [60], i.e.,
 for M1 TAMs SMM = SM1M > 0, and
 for M2 TAMs SMM = SM2M > 0,
with SM1M ̸= SM2M . As in Chapter 2, to account in (3.14) for the gradual weakening
of these different adhesions as we move away from the centre x within B(x,R), we





, ∀y ∈ B(0, R),
where ψ(·) is the standard mollifier. Moreover, in (3.14), [1 − ρ(u)
]+
ensures that
overcrowded tumour regions do not contribute to macrophage migration and n(·) is





if y ∈ B(0, R) \ {0},
0 if y = 0.
(3.15)
Thus, aggregating now all these different aspects of macrophages explored in (3.8) -




=∇ · [DM(u)∇M1 −M1AM(x, t,u,SM1M)] + PM1(u) −QM1(u)
− T12(u) + T21(u) +MI , (3.16a)
∂M2
∂t
=∇ · [DM(u)∇M2 −M2AM(x, t,u,SM2M)] + PM2(u) −QM2(u),
+ T12(u) − T21(u), (3.16b)
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where SM1M > 0 and SM2M > 0 are the self-adhesion strengths of M1 and M2 TAMs,
respectively.
Dynamics of the cancer cell population
The third cell population that we consider at the macro-scale is the cancer cell pop-
ulation. Crucially important for cancer development and invasion, cancer cell prolif-
eration is a complex process regulated by several processes involving nutrients and
macrophages. From the modelling perspective, while we consider the proliferation
process as being of logistic type [145, 146, 275] analogously to Chapter 2, we explore
the influence of nutrients and macrophages as follows. On the one hand, similar to
both TAMs populations, we consider the proliferation effect-function Ψp(σ) defined
in (3.4) to explore the influence of the available nutrients on the rate of cancer cell
proliferation. On the other hand, biological evidence shows that while M2 TAMs
promote cancer cell proliferation [113], M1 TAMs inhibits this [157]. Thus, here we
expand the proliferation law introduced in Chapter 2 and [265] by accounting for
the negative effect of M1 TAMs, leading to the following proliferation law:
Pc(u) := µcΨp(σ)(1 − µcM1M1 + µcM2M2)c(1 − ρ(u))+, (3.17)
where µc > 0 is a baseline proliferation rate that is being regulated by the available
nutrients, being enhanced by the M2 TAMs at a rate µcM2 > 0 and at the same
time weakened by the presence of the M1 TAMs at a rate µcM1 > 0. Again, here
the term (1 − ρ(u))+ ensures that there is no overcrowding.
Besides proliferation, it is well known that cancer cells resist death [98, 99].
However, due to the peritumoral vasculature as well as the excessive degradation
of the ECM, the efficiency of the nutrients delivery significantly reduces inside the
tumour, leading to necrosis [309]. In addition, numerous studies have shown [30, 147,
170, 179, 192] that classically activated M1-like macrophages can produce significant
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amounts of pro-inflammatory cytokines and thereby have the ability to kill cancer
cells. To that end, we assume here a baseline death rate dc > 0 that is regulated not
only by the cancer cell death effect-function Ψdc(σ) introduced in (3.6a), but also
by the M1 TAMs at a rate dcM1 > 0. This results in the following mathematical
representation of the cancer cell death process, namely
Qc(u) := dc(Ψdc(σ) + dcM1M1)c. (3.18)
Similar to the macrophages, for the cancer cell population, we also account
for the diffusion enhancement that the spatial distribution of ECM fibres enables
[6, 50, 73, 118, 160, 224, 230, 237, 278]. Furthermore, the random movement of
the cell population is also affected by the presence of both macrophage populations.
While in general, the M2 TAMs were shown to promote cancer cell motility, [3]
recent biological evidence [150, 157] indicates that the M1 phenotype has a negative
effect on the cancer cell motility. Therefore, the diffusion coefficient for the random
movement of the cancer cells can be formulated mathematically as
Dc(u) := Dc(1 +DcM2M2 +DcFF −DcM1M1). (3.19)
where Dc > 0 is a baseline diffusion rate, DcF > 0 is the ECM fibres enhancement
coefficient, DcM1 > 0 represents the weakening effect due to the presence of M1
TAM, and DcM2 > 0 accounts for the positive motility effect due to the presence of
M2 TAM.
Besides random motility, the directed movement of the cancer cells induced by
various adhesion mediated processes [49, 55, 115, 210, 292, 297] is a central player
in cancer invasion within the oriented fibrous environment. To that end, extending
here on the modelling approach proposed in Chapter 2 and [265] to include the
interactions of cancer cells with both families of macrophages, i.e., M1 and M2
TAM, we have that the non-local spatial flux that drives the directed movement is
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given in this case as:









Sccc(x+ y, t) + Scll(x+ y, t)
+ ScM(M1(x+ y, t) +M2(x+ y, t))
)
+ n̂(y, θf (x+ y, t))ScFF (x+ y, t)
][




where R, n(·) and K(·) are the same as in (3.14). Further, in (3.20) n̂(·, ·) is the
unit radial vector biased by the orientation of the fibres, i.e.,
n̂(y, θf (x+ y)) :=

y + θf (x+ y, t)
∥ y + θf (x+ y, t) ∥2
if y ∈ B(0, R) \ {0},
0 if y = 0 or y = θf (x+ y, t).
(3.21)
Since (3.20) is built on the same concept as the non-local adhesion term in Chapter 2,
for illustration we refer the reader to Figures 2.1 and 2.7. Moreover, in (3.20)
ScM > 0 represents the strength of the adhesion relationship between the cancer cells
and M1 and M2 TAMs, ScF > 0 is the strength of the cell-fibre ECM adhesion [295]
and Scl > 0 corresponds to strength of adhesion between the cancer cells and the
non-fibre ECM phase (that includes for instance amyloid fibrils, which can support
cell-adhesion processes [90, 91]). Furthermore, as high level of extracellular Ca+2
ions (which form one of the constituents of the non-fibre ECM phase) are necessary
for cell-cell adhesion [94, 109], proceeding as in Chapter 2 and in [245, 246, 247, 265]
the cancer cells self-adhesion coefficient Scc is taken here as
Scc(x, t) := Smin + (Smax − Smin) exp
(
1 − 1
1 − (1 − l(x, t))2
)
,
where Smax > 0 and Smin > 0 correspond to maximum and minimum levels of Ca
+2
ions. Therefore, Scc smoothly increases from a minimal to a maximum value in order
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to fully explore the varying strengths of cell-cell adhesion.
Thus, using (3.17) to (3.20) the spatio-temporal dynamics of the cancer popula-
tion c(x, t) is expressed as
∂c
∂t
=∇ · [Dc(u)∇c− cAc(x, t,u, θf )] + Pc(u) −Qc(u). (3.22)
Two-phase ECM macro-scale dynamics
Besides the cancer cells, both macrophage phenotypes contribute to the degradation
of the ECM by secreting proteolytic enzymes [69, 89, 173, 194, 228] (e.g., various
classes of matrix metalloproteinases). To that end, we extend the dynamics of the
fibre, and non-fibre ECM components used in Chapter 2 and [265] by incorporating
the effects of the M1 phenotype. Thus, the dynamics of the non-fibre l(x, t) as well
as the fibre ECM F (x, t) are formalized as
∂l
∂t
= − l(βlcc+ βlM1M1 + βlM2M2) + (γ0 + γM2M2)(1 − ρ(u))+, (3.23a)
∂F
∂t
= − F (βFcc+ βFM1M1 + βFM2M2), (3.23b)
where βlc, βlM1 , βlM2 are the positive degradation rates of the non-fibre ECM phase
due to the cancer cells, M1 and M2 TAMs, respectively. Similarly, βFc, βFM1 , βFM2
are all positive and describe the degradation rates of the fibre component of the
ECM due to the cancer cells, M1 and M2 TAMs, respectively. Finally, in (3.23)
γ0 > 0 represents the constant rate of remodelling and γM2 > 0 is the remodelling
enhancement rate induced by the M2 TAM population [3, 89, 254].
96
The full macro-scale dynamics
In summary, using (3.3), (3.16), (3.22) and (3.23) the non-dimensional macro-scale
dynamics is given by the following coupled PDEs
∂c
∂t
=∇ · [Dc(u)∇c− cAc(x, t,u, θf )] + Pc(u) −Qc(u), (3.24a)
∂M1
∂t
=∇ · [DM(u)∇M1 −M1AM(x, t,u,SM1M)] + PM1(u) −QM1(u)
− T12(u) + T21(u) +MI , (3.24b)
∂M2
∂t
=∇ · [DM(u)∇M2 −M2AM(x, t,u,SM2M)] + PM2(u) −QM2(u)
+ T12(u) − T21(u), (3.24c)
∂l
∂t
= − l(βlcc+ βlM1M1 + βlM2M2) + (γ0 + γM2M2)(1 − ρ(u)), (3.24d)
∂F
∂t
= − F (βFcc+ βFM1M1 + βFM2M2), (3.24e)
0 =Dσ∆σ − dσ(c+M1 +M2), (3.24f)
in the presence of appropriate initial conditions (such as those specified in (3.51))
with zero-flux boundary conditions for c, M1, M2, l and F , as well as Dirichlet
boundary condition (3.3) for the nutrients σ.
3.2.2 Processes on the Micro-Scales and Links Between the
Scales
As the process of cancer invasion is truly a multi-scale phenomenon [293], the macro-
scale dynamics are tightly linked together with several micro-scale processes. Anal-
ogously to Chapter 2, among these micro-scale processes, of primary interest for us
are the micro-scale rearrangement of ECM fibre micro-constituents as well as the
cell-scale proteolytic processes that take place at the leading edge of the tumour. In
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the following, we outline how these micro-scale processes, detailed in Section 2.2.2,
change for this new extended model.
Fibres on the micro-scale and their bottom-up and top-down links to
macro-dynamics
First, since we do not modify the naturally emerging fibres bottom-up link from the
one described in Section 2.2.2, we utilise the micro-fibres distribution f(x, t) the
same exact way to represent the ECM fibres through their amount F (x, t) and their
spatial bias θf (x, t).
On the other hand, within the micro-fibres rearrangement process, i.e., in the
fibre top-bottom link, we need to account for the fact that M1 TAMs are also capable
of secreting MDEs. Indeed, the collective migration of the cancer cells, M1 TAMS,
and M2 TAMs lead naturally to the emergence of the associated spatial fluxes Fc,
FM1 , and FM2 given by
Fc(x, t) :=Dc(M1,M2, F )∇c− cAc(x, t,u, θf ),
FM1(x, t) :=DM(F )∇M1 −M1AM(x, t,u,SM1M),
FM2(x, t) :=DM(F )∇M2 −M2AM(x, t,u,SM2M),
respectively. The combined action of these fluxes upon the ECM fibres distributed at
(x, t) ∈ Ωt× [0, T ] is felt uniformly by its constituent micro-fibres f(z, t) distributed
on the associated micro-domain δY (x), consequently inducing a micro-fibres rear-
rangement vector similar to the ones proposed in Section 2.3.2 and in [245, 265] of
the form
r(δY (x), t) :=ωc(x, t)Fc(x, t) + ωM1(x, t)FM1(x, t)
+ ωM2(x, t)FM2(x, t) + ωF (x, t)θf (x, t),
(3.25)
which triggers a spatial redistribution of the micro-fibres in δY (x). In (3.25), the
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non-linear weights ωc, ωM1 , ωM2 and ωF are the associated mass factions of cancer
cells, M1 TAMs, M2 TAMs, and ECM fibres at (x, t), and so these are given by
ωc(x, t) :=
c(x, t)








c(x, t) +M1(x, t) +M2(x, t) + F (x, t)
,
ωF (x, t) :=
F (x, t)
c(x, t) +M1(x, t) +M2(x, t) + F (x, t)
,
respectively. Ultimately, as in Section 2.2.2, the rearrangement vector (3.25) induces
a relocation vector νδY (x)(z, t), and as a result we can appropriately calculate the
new positions z∗ of any micro-scale node z ∈ δY (x).
Finally, since the rest of the dynamics based is on the exact same approach as
in Section 2.2.2, for further details on the process as well as for illustrations on
the rearrangement process and the two links between the macro-scale and the fibre
micro-scale, we refer the reader to Section 2.2.2 and Figures 2.3 and 2.5.
MDE boundary micro-dynamics and its connections to macro-dynamics
Analogously to Chapter 2, the second micro-process that we consider is the pro-
teolytic molecular processes which are driven by the secretion of matrix-degrading
enzymes (MDEs) (such as matrix-metalloproteinases) and takes place along the
leading edge of the tumour. Indeed, all three cell populations (cancer cells, M1
TAMs and M2 TAMs) secrete MDEs [69, 89, 173, 194, 228] within the proliferating
outer rim of the tumour, and so this way, the tissue-scale dynamics induces a source
for cell-scale proteolytic activity. Thus, following here the approach introduced in
Section 2.2.2 and [279], we explore the emerging spatio-temporal molecular MDEs
micro-dynamics m(y, τ) on an appropriate cell-scale neighbourhood of the tumour
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interface ∂Ω(t) enabled by the union of a covering bundle of cubic micro-domains
{ϵY }ϵY ∈P(t), with each ϵY being of micro-scale size ϵ > 0.
Therefore, at any spatio-temporal point (y, τ) ∈ (ϵY ∩Ω(t0))× [0,∆t], a source of
MDEs arises as a collective contribution of the cancer cell and now both macrophage
populations from the outer proliferating rim of the tumour that are situated within
a distance γh > 0 from y ∈ ϵY . Hence, in this case, the M1-like macrophages also






λ(B(y, γh) ∩ Ω(t0))
y ∈ ϵY ∩ Ω(t0),
0 y /∈ ϵY \ (Ω(t0) + {z ∈ Y | ∥z∥2 < ρ}),
(3.26)
where λ(·) is the Lebesgue measure in RN , B(y, γh) denotes the ∥ · ∥∞ ball with
appropriately chosen radius γh > 0 and 0 < ρ < γh is a small mollification range
which smooths out the source function h(·, ·). Further, in (3.26) hΣ is given by
hΣ(x, τ) := αcc(x, t0 + τ) + αM1M1(x, t0 + τ) + αM2M2(x, t0 + τ),
where αc > 0, αM1 > 0 and αM2 > 0 are constant secretion rates of the MDEs by
the cancer cells, M1 and M2 TAMs respectively. As before, since this source term
h(y, τ) is naturally induced by the macro-scale, this establishes a MDE top-down
link between the tumour macro-dynamics and MDE-micro-dynamics occurring at
the tumour interface.





= Dm∆m+ h(y, τ),







where Dm > 0 is the constant diffusion coefficient and n is the outward normal
vector. Similarly to Section 2.2.2, this enables us to capture the changes in tumour
morphology by determining the direction of movement ηϵY (x) and magnitude of the
displacement ξϵY (x) of invading cancer in the surrounding tissue [279]. To further
details on this micro-process as well as illustration of the overlapping ϵ-cubes and
the two-links that connects the macro-scale to the MDE micro-scale, we refer the
reader to Section 2.2.2 and Figures 2.4 and 2.5.
3.3 Numerical Approaches
In this section, we describe the numerical approach developed to solve the tumour
macro-scale dynamics (3.24). First, to solve the quasi-steady nutrients σ equation
(3.24f), we use the usual successive over-relaxation method with relaxation param-
eter ω = 0.5 and tolerance of 10−5. For the rest of the dynamics (3.24a)-(3.24e), we
use the method of lines approach to discretise the system (3.24) first in space and
then for the resulting ODEs we use a non-local predictor-corrector scheme [245]. In
this context, we carry out an accurate approximation of the two distinct spatial oper-
ators, namely the diffusion and adhesion operators, by using fast convolution-driven
approaches. Specifically, while for the diffusion, we construct a convolution-based
second-order central difference scheme [265], for the adhesion operators, we formu-
late a convolution-driven fifth-order weighted essentially non-oscillatory (WENO5)
finite difference scheme.
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Furthermore, to approximate the adhesion integrals (3.14) and (3.20), we adopt
the numerical approach used in Section 2.4.1 and [265]. Here, we omit the technical
details of this method since it follows identical steps, the sole difference being that
within the formulas, we use the total macrophage population, i.e., M1 + M2 TAMs
instead of only the M2 TAMs population. For the same rationale, we also skip
the details of the numerical method used in the MDE micro-scale, and for further
details, we refer the reader to Section 2.4.1 and [265].
To facilitate the description of the numerical approaches, let us first introduce
some basic notations. As in Chapter 2, we discretise the maximal tissue cube Y ∈ R2
uniformly in each direction with spatial step size ∆x = ∆y. Therefore, the discreti-
sation of Y can be represented through the macro-spatial locations {(xi, yj)}i,j=1..N ,
with N = L/hL +1. Then the discretised global tumour vector at any time-step n is
denoted by un = [cn,Mn1 ,M
n
2 , l
n, F n]⊺, while the discretised nutrient field is denoted
by σn. Further, we denote the diffusion coefficient functions and adhesion integrals
for cancer cell and TAMs by (Dc)n, (DM)n, (Ac)n and (AM)n, respectively. Finally,




=∇ · [D(u)∇u] −∇ · F(u) + S(u),
























PM1(u) −QM1(u) − T12(u) + T21(u) +MI
PM2(u) −QM2(u) + T12(u) − T21(u)
−l(βlcc+ βlM1M1 + βlM2M2) + (γ0 + γM2M2)(1 − ρ(u))
−F (βFcc+ βFM1M1 + βFM2M2)

.
3.3.1 Diffusion Operators: ∇ · [D(u)∇u]
Starting with the discretisation of the diffusion operators ∇ · [D(u)∇u] in (3.28),
during the computations, we first detect, as in Section 2.4.1, whether a spatial
node (i, j) is inside or outside the expanding tumour domain Ω(t0) via an indicator
function I(·, ·) : X ×X → {0, 1}, with X = {1, ...,M} that is defined by
I(i, j) :=
1 if (xi, xj) ∈ Ω(t0),0 otherwise. (3.29)
Similarly, we detect any boundary nodes using a boundary indicator function defined
by
IB(i, j) :=
1 if (xi, xj) ∈ ∂Ω(t0),0 otherwise, (3.30)
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where ∂Ω(t0) is boundary of Ω(t0), and for convenience we also define the interior
indicator function by
IIn(i, j) :=
1 if (xi, xj) ∈ Ω(t0) \ ∂Ω(t0).0 otherwise. (3.31)
These two functions, given in (3.30) and (3.31), enable us to split the domain into
two parts, namely to boundary and strictly inside parts. The motivation behind this
is the same as before, namely to use two different computational techniques on these
parts which eventually reduces the computational cost. Hence, while for any interior
node we can use the same discrete universal numerical operator (convolution), for
a boundary point we need to apply unique operators due to the zero-flux boundary
condition and the continuously changing tumour domain (that may result in an
irregular tumour shape). Therefore, to achieve the reduction in computational cost,
we accordingly split the spatial operators ∇ · [D(u)∇u] into two components as
well, and so at any spatial node (xi, yj) ∈ Ω(t0) ⊂ Y , the diffusion operators can be
represented as
∇ · [D(u)∇u](i, j) :=

∇ · [D(u)∇u]In(i, j) if IIn(i, j) = 1,




In this context, the usual two dimensional second-order central difference scheme











































⊺. Further, we observe that (3.33) can be
equivalently expressed by sum of discrete convolutions and so for all interior nodes



























where ∗ is the discrete convolution and ◦ is the Hadamard product, that is defined
in A.3 (and for further details we refer the reader to [87]). Also, in (3.34) each
K̃kA, with k = 1 . . . 4 describe the average between the point (i, j) and one of its
immediate neighbour and so they are defined by









Moreover, in (3.34) K̃kF and K̃kB with k = 1, 2 are induced by the forward and
backward differences, respectively. Hence, they are defined in both direction i (if
k = 1) as well as in direction j (if k = 2) by










However, for boundary nodes, we cannot use the form (3.34) due to the imposed
zero-flux boundary condition and the continuously changing tumour domain. This is
because the calculation of the diffusion operators at the boundary nodes involves the
approximation of the values at any node that does not belong to the tumour domain,
i.e., for any node (xi, yj) /∈ Ω(t0). In some cases, due to the irregular domain, such
values may not be uniquely defined because multiple nodes can require the value
of the same ghost/outside node, however, with different values. Consequently, for
any boundary node, instead of the convolutional form (3.34), we instead use the
usual form (3.33) and symmetrically reflect the values of the interior nodes to the
ghost/outside nodes in a node by node fashion.
3.3.2 Adhesion Operators: ∇ · F(u)
The other spatial operators that contribute to the motility are the adhesion operators
∇·F(u) in (3.28). The procedure to approximate these differential operators is based
on the standard WENO5 scheme proposed in [123, 159]. However, it was shown [310]
that these standard WENO5 schemes suffer from slight post-shock oscillations. As a
consequence, we adopt here the modified WENO5 scheme proposed in [310], which
uses modified smoothness indicators and is referred to as the ZSWENO scheme.
Similarly to the diffusion operator case, here we split the domain into two parts
as well. However, ZSWENO schemes induce larger stencils compared to the second-
order central difference scheme and so, we need to split the domain Ω(t0) into two
parts differently. We refer these two parts as the inside and layer parts. First, the
former one is detected by using an inside indicator function II(i, j) that we define
by
II(i, j) :=
1 if (I ∗ KI)i,j = 1,0 otherwise, (3.37)
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,
which is induced by the fifth-order ZSWENO stencils. Then the layer part of the
domain is detected by a layer indicator function formulated as
IL(i, j) :=
1 if I(i, j) − II(i, j) = 1,0 otherwise. (3.38)
Similarly to the diffusion, using these indicator functions (3.37) and (3.38), we split
the adhesion operator into two parts and so at any spatial node (xi, yj) ∈ Ω(t0) this
operator is represented as
∇ · F(u)(i, j) :=

∇ · F(u)I(i, j) if II(i, j) = 1,
∇ · F(u)L(i, j) if IL(i, j) = 1,
0 otherwise.
(3.39)
Therefore, for the inside operator ∇ · F(u)I , we use the usual conservative form





,j − F̂i− 1
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are the numerical fluxes at (xi+ 1
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) and (xi, yj− 1
2
), respectively. Also in (3.40), for compact notation, F̂ and
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Ĝ denotes the x and y components of the vector field F(·), respectively.
For brevity, we will only focus on defining F̂i+ 1
2
,j and F̂i− 1
2
,j, and note that




follows identical steps. In this
context, we split the x component of F(·) into two parts
F̂ (u) = F̂+(u) + F̂−(u),
where dF̂+(u)/du > 0 and dF̂−(u)/du ≤ 0. Then, we define these parts by using





F̂ (u) ± αu
)
, (3.41)
where we approximate α := max |dF̂ (u)/du|, i.e., the spectral radius of the Jacobian
generated by F̂ (·) in a Jacobian-free manner, detailed in Section 3.3.3. To this end,








the numerical fluxes obtained by splitting F̂ (·)
into the positive and negative parts, respectively. Then these numerical fluxes used






















the weighted combination of the three third-order essentially non-oscillatory (ENO)



























































































































































Finally, in (3.43) and (3.44) F̂±(u) are given by the Rusanov-type flux splitting
method defined in (3.41).
Since our aim is to reduce the computational cost and so for this we seek to
use convolution, we observe that indeed these ENO fluxes (3.43) and (3.44) can be









where K̃±k,+ and K̃
±
k,− are the induced vectors from (3.43) and (3.44), and for com-
pleteness they are defined in Appendix A.5.





to construct the ZSWENO approximation in (3.42). Following again the usual
























































where we take the usual p = 2, ϵ
W
= 10−6 values [123], and define the optimal
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are the ZSWENO smoothness

























































































































Once again, in (3.47) and (3.48) the positive F̂+(u) and negative F̂−(u) parts are
defined by using the Rusanov flux splitting (3.41). Furthermore, we can observe
that these smoothness indicators (3.47) and (3.48) can be equivalently expressed in


















where the appropriately induced vectors K±k,+ and K
±
k,− are defined in A.5. This
completes the description of the convolution-driven ZSWENO scheme for the inside
differential operators ∇ · F(u)I , i.e., the approximation of ∇ · F(u) for all inside
nodes.
However, since the adhesion operators ∇·F(u) were split into two parts in (3.39),
it remains to describe the ZSWENO scheme for the layer operator ∇ · F(u)L, ac-
counting for all nodes that are considered to be in the layer part of the domain. As
in Section 3.3.1 for the boundary diffusion operators, here we also need to appro-
priately approximate the value of any point that is located outside of the tumour
domain Ω(t0). To this end, we symmetrically reflect the values of the interior nodes
to the ghost nodes in a node by node fashion due to the irregular tumour domain.
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This ultimately enables us to use the standard non-convolutional ZSWENO scheme
(3.43), (3.44), (3.47) and (3.48) instead of the convolutional forms (3.45) and (3.49)
to approximate the layer operators ∇ · F(u)L.
3.3.3 Approximation of the Propagation Speed α
Due to the complexity of F(·), calculating its Jacobian dF̂ (u)/du is extremely time
consuming. Hence, to find the largest eigenvalue α, we rather skip the exact evalua-
tion of the Jacobian and choose to approximate the propagation speed in a Jacobian-
free manner. For this, let us first define the eigenvalue problem by
Jv = λv, (3.50)
where J = dF(u)/du is the Jacobian, v is an eigenvector, and λ is an eigenvalue
of J . Then in order to find the largest eigenvalue α, we solve (3.50) iteratively
with convergence tolerance of 10−14 and with a random initial guess for v. Hence,
similarly to, for instance, a Jacobian-free Newton-Krylov method [131, 140], to find
λv in (3.50) we evaluate the Jacobian-vector product Jv instead of J , which is proved
to be a significantly less time-consuming task. To that end, the approximation of
Jv is carried out via the first-order Taylor series expansion, and so it is given by
Jv ≈ F(u + ϵpv) −F(u)
ϵp
,
where ϵp is a small perturbation parameter. Since the precision is limited in the




(1+ ∥ u ∥)ϵmach
∥ v ∥
,
where ϵmach > 0 is the machine precision.
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3.4 Parameter Values
In Table 3.1, we summarise the parameter values that we will use in the upcoming
result section.
Table 3.1: Parameter set used for the numerical simulations in this chapter. If we
could not find any references for some of our parameters then we “Estimated” them
(i.e., we chose an arbitrary value for the simulations).
Variable Value Description Reference
Dc 10
−4 Diffusion coeff. for the cancer cell
population c [31, 70]
DcM1 4.5 Coeff. of the M2 TAMs dependence
in the cancer diffusion Est. using [150, 157]
DcM2 1.8 Coeff. of the M2 TAMs dependence
in the cancer diffusion [112]
DcF 8 Coeff. of the fibres dependence
in the cancer diffusion Estimated
DM1 5× 10−5 Diffusion coeff. for the M1 TAM
population [101]
DM1F 16 Coeff. of the ECM stiffness
dependence in the M1 TAMs diffusion [101]
DM2 5× 10−5 Diffusion coeff. for the M2 TAM
population M [101]
DM2F 16 Coeff. of the ECM stiffness
dependence in the M2 TAMs diffusion [101]
Dσ 1 Diffusion coeff. for the nutrients [169]
Dm 2.5× 10−3 Diffusion coeff. for MDEs [206]
Smax 0.5 Cell-cell adhesion coeff. [245]
Smin 0.01 Minimum level of cell-cell adhesion [265]
Continued on next page
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Table 3.1 – continued from previous page
Variable Value Description Reference
Scl 0.01 Cell-non-fibre adhesion coeff. [245]
ScF 0.3 Cell-fibre adhesion coeff. [70]
ScM 0.125 Cell-macrophage adhesion
coeff. [265]
SM1M 0.175 M1 TAMs self adhesion coeff. [60]
SM2M 0.05 M2 TAMs self adhesion coeff. [60]
SMc 0.125 Macrophage-cancer adhesion
coeff. [265]
SMσ 0.1 Strength of the Macrophage-nutrients
relationship Estimated
µc 0.25 Proliferation coeff. for cancer cell
population c [70]
µcM1 4.0 Coeff. for the M1 TAMs dependence
in the cancer cell proliferation Estimated
µcM2 1.4 Coeff. for the M2 TAMs dependence
in the cancer cell proliferation [113]
M0 0.05 Influx of the M1 TAMs Estimated
µM 0.2 Inside tissue proliferation rate of M1
and M2 TAMs Estimated
µMF 1.8 Coeff. for the ECM stiffness dependence
in the M1 and M2 TAMs prolifs. [101]
dc 0.1 Decay rate of the cancer cells Estimated
dcM1 50.0 M1 TAMs killing rate of the cancer cells Estimated
dM 0.03 Decay rate of M1 and M2 TAMs [259]
dσ 80.0 Nutrients uptake rate Estimated
Continued on next page
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Table 3.1 – continued from previous page
Variable Value Description Reference
βlc 3.0 Degradation coeff. for non-fibre ECM
due to the tumour Estimated
βlM1 3.84 Degradation coeff. for non-fibre ECM
due to the M1 TAMs Estimated
βlM2 0.96 Degradation coeff. for non-fibre ECM
due to the M2 TAMs Estimated
βFc 1.5 Degradation coeff. for fibre ECM
due to the tumour [245]
βFM1 1.92 Degradation coeff. for fibre ECM
due to the M1 TAMs Estimated
βFM2 0.48 Degradation coeff. for fibre ECM
due to the M2 TAMs Estimated
γ0 0 Baseline remodelling [265]
γM2 0 Remodelling of the non-fibre ECM
due to the M2 TAMs [265]
p12 14.0 Baseline polarisation rate Estimated
p21 6.0 Baseline re-polarisation rate Estimated
tp 0 Re-polarisation staring time Estimated
Rp 0 Radius of the re-polarisation domain Estimated
σnor 0.4 Normal level of nutrients [169]
σp 0.35 Maximal level of nutrients that
is still sufficient Est. using [169]
σn 0.2 Necrotic threshold for the
nutrients level Est. using [169]
Ψp,max 1.0 Maximal proliferation enhancement
rate Estimated
Continued on next page
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Table 3.1 – continued from previous page
Variable Value Description Reference
Ψd,max 5.0 Maximal death enhancement rate Estimated
ΨdM,min 1.0 Minimal death enhancement rate Estimated
ΨM,max 2.0 Maximal polarisation enhancement
rate Estimated
ΨM,min 1.0 Minimal polarisation enhancement
rate Estimated
αc 0.625 MDE secreting rate by the cancer cells Est. using [103]
αM1 0.8 MDE secreting rate by the M1 TAMs Est. using [103]
αM2 0.2 MDE secreting rate by the M2 TAMs Est. using [103]
β 0.75 Optimal level/tissue environment
controller of the ECM density [279]
R 0.15 Sensing radius [245]
r 0.0016 Width of micro-fibres [245]
fmax 0.636 Maximum of micro-fibre density
at any point [245]
hL 0.03125 Macro-scale spatial step-size [279]
ϵ 0.0625 Size of the boundary
micro-domain ϵY (x) [279]
δ 0.03125 Size of the fibre micro-domain δY (x) [245]
∆t 10−3 Macro-scale temporal step size Estimated
∆τ 10−4 MDE micro-scale temporal step size Estimated
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3.5 Numerical Results
In this section, we present the numerical results for our multi-scale model. Hence, for








































which are illustrated in Figure 3.3a). Here the white curves indicate the boundary
of the tumour domain ∂Ω(0). Besides these macro-scale initial conditions, we also
illustrate the initial state of one micro-scale fibre domain δY (x) in Figure 3.3b),
which is repeated for all macro-scale points. Also, the ratio between the fibre and
non-fibre ECM phases are assumed to be 20% : 80% for all simulations.
Finally, all presented simulations correspond to time 50∆t. The baseline param-
eters values are provided in Appendix 3.4, and any alteration from these values will
be stated accordingly.
3.5.1 Spatial Dependency of the Re-polarisation
First, we investigate numerically the effects of changing the re-polarisation domain
Ωp(t, Rp) used in (3.12), defined in Appendix A.4 and illustrated in Figure 3.2.
Hence, here we study whether the success of a M2→M1 re-polarisation strategy
against the tumour is dependent on the spatial domain Ωp(t, Rp), specifically on
Rp=the distance from the outer boundary ∂Ωo(t). For this let us use the radii
Rp ∈ {0,∆x, 2∆x, 3∆x, 4∆x} for the re-polarisation domain Ωp(t, Rp), as well as let
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Figure 3.3: a) Initial conditions of the cancer cells, both M1 and M2 TAMs, non-
fibre ECM and the nutrients, respectively. b) Initial condition of the micro-fibres on
δY (x), which is repeated for all x.
us start the process at time 0, i.e., we take tp = 0 in (3.12). To further study these
spatial effects, we also consider multiple tissue conditions by changing the tissue
environment controller β ∈ {0.75, 0.7875, 0.825} (see [279]).
To compare the resulting tumours, we measure the overall tumour mass and
spread at final time 50∆t, using the total density of the cancer cells as well as the area
of the tumour. Ultimately, this enables us to quantify the changes resulting from
the modification of the re-polarisation domain Ωp(t, Rp). Specifically, the overall
tumour mass is measured by integrating the cancer cell density c(x, 50∆t) and the
overall tumour spread as given by the area of the tumour domain Ω(50∆t).
Baseline cases: In Figure 3.4 we present the numerical results for the baseline
case characterised by the absence of M2→M1 re-polarisation. Specifically, in Fig-
ure 3.4 a)-c) we investigate the no-repolarisation case in the context of different
tissue environment controllers: a) β = 0.75, b) β = 0.7875, and c) β = 0.825. As
we can see, at time 50∆t, the tumour is enlarged and has invaded some of its sur-
roundings, and within the tumour domain Ω(50∆t) we observed heterogeneity in all
three cell populations (cancer cell, M1 and M2 TAMs). We also notice that near M2
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Figure 3.4: Baseline simulation with no macrophage re-polarisation ( i.e., we set
Rp = 0) at final time 50∆t. a) β = 0.75, b) β = 0.7875, c) β = 0.825.
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TAMs accumulations sites, the density of cancer cells also seems to be higher. In
contrast, higher M1 TAMs density usually corresponds to both low M2 TAMs as well
as low cancer cell populations. Moreover, the movement and spatial distribution of
tumour and immune cells are influenced directly and indirectly by the ECM fibres.
For illustrative purposes, the rearranged fibre structure is portrayed by a four-fold
coarsened oriented ECM fibres field in Figure 3.4. Furthermore, the peritumoral
degradation of the two-phase ECM (caused by the cancer cells and both TAMs)
allows the tumour to expand and spread to the neighbouring tissues, resulting in
some tumour fingering patterns that vary with the controller β: higher β leads to
more tumour fingering. This induces an irregular tumour domain, as well as the
formation of ”islands” inside the tumour, which corresponds to areas of initially low
ECM density, i.e., the ECM level was too low in such areas to support tumour move-
ment. Finally, in Figure 3.4, we also present the level of available nutrients. Hence,
we can see that since the nutrients are only supplied through the outer boundary
Ωo(t), the initial normal level of nutrients is significantly depleted (by the three cell
populations) inside the tumour. This can lead to hypoxia and then eventually create
a necrotic core (not modelled explicitly in this study).
The impact of M2→M1 re-polarisation: In Figure 3.5 a)-c), we introduce
the re-polarisation of the M2 TAMs to M1 TAMs within the domain Ωp(t,∆x)
(i.e., Rp = ∆x), and again we investigate the role of three controller values: a)
β = 0.75, b) β = 0.7875, c) β = 0.825. While in Figure 3.4 the M1 TAMs mainly
accumulated near the tumour boundary, in Figure 3.5 we see that the re-polarisation
of M2 TAMs leads to an increase in the M1 TAMs population inside the tumour,
leading to several accumulation sites located further away from the leading edge. In
contrast, the presence of M2 TAMs inside of the tumour is decreased compared to
Figure 3.4, and these immune cells now accumulate only in a small neighbourhood
of the boundary (because we do not re-polarise M2 TAMs into M1 TAMs in a
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Figure 3.5: Simulation with re-polarisation domain Ωp(t,∆x) and with starting
time tp = 0 at the final time 50∆t. a) β = 0.75, b) β = 0.7875, c) β = 0.825.
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Rp = ∆x neighbourhood of the boundary; see Fig 3.2). Since both macrophage
populations interact with the cancer cells, we also see some differences in the cancer
cell population, and these differences depend on the degradation level of ECM as
controlled by the value of β. Using two measures (spread and mass), we first focus
on the β = 0.75 case and compare Figures 3.4 a) and 3.5 a): re-polarisation leads to
an ≈ 11% increase in tumour spread as well as an ≈ 20% decrease in tumour mass.
Then for β = 0.7875 (Figures 3.4 b) and 3.5 b)) we observe an ≈ 5% reduction
in spread and an ≈ 34% decrease in mass. Finally, for β = 0.825 (Figures 3.4
c) and 3.5 c)), the tumour spread is increased by ≈ 15% and the tumour mass is
reduced by ≈ 31%. Hence, although re-polarising M2 TAMs into M1 TAMs does
not show an overall improvement in terms of tumour spread, it significantly impeded
the migration of the cancer cell mass from hypoxic regions to the proliferating rim
as well as helped to reduce the mass by killing the cancer cells. However, since
Rp = ∆x, the M2 TAMs are able to accumulate in a ∆x neighbourhood of the
interface, and so we can still observe a moderate density of cancer cells near the
boundary.
Tumour spread/mass changes with respect to Rp: In Figure 3.6 we vary
Rp and present the changes in the dimensionless tumour area (spread) and mass
resulted by changing the radius Rp. Specifically, in Figure 3.6 a)-c) we again consider
the three previously used environment controllers β = 0.75, β = 0.7875, β = 0.825.
Moreover, since various types of cancers secrete MMPs at different rates [86], here we
also consider high, medium and low MDE secretion rates. Finally, we vary the radii
for the re-polarisation domain, Rp ∈ {0,∆x, 2∆x, 3∆x, 4∆x}, while we assume that
the re-polarisation process starts at time 0, i.e., we take tp = 0. The left panels of
Figure 3.6 show the changes in the dimensionless variable for tumour areas/spreads
with respect to Rp, while the right panels show the changes in the dimensionless
variables for tumour mass with respect to Rp. Here, the blue circles correspond to
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Figure 3.6: Results of varying the radius of the re-polarisation domain Rp ∈
{0,∆x, 2∆x, 3∆x, 4∆x} with starting time tp = 0. Left panel shows the change
in the tumour spread and the right panel shows the change in tumour mass with
respect to Rp. Here the blue circles correspond to a high ECM degradation rate by
cancer cells (βlc = 3.0, βFc = 1.5, αc = 0.625), the orange diamonds to a medium
ECM degradation rate (βlc = 2.0, βFc = 1.0, αc = 0.42) and the red crosses to a low
degradation rate (βlc = 1.0, βFc = 0.5, αc = 0.21). The environment controller β is
set to a) β = 0.75, b) β = 0.7875, c) β = 0.825.
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high ECM degradation rates (βlc = 3.0, βFc = 1.5, αc = 0.625), the orange diamonds
correspond to medium degradation rates (βlc = 2.0, βFc = 1.0, αc = 0.42), and the
red crosses correspond to low degradation rates (βlc = 1.0, βFc = 0.5, αc = 0.21).
Comparing first the changes due to varying the tissue controller β, we can see a clear
overall decrease in both tumour spread and mass as we increase β. This was seen also
in Figures3.4 and 3.5, where a more prominent tumour fingering pattern was present
as we increased β which resulted in a decrease in tumour spread. Furthermore,
in Figure 3.6 a)-c) the overall behaviour of the tumour spread does not change
significantly as we vary the radius of the re-polarisation domain Rp. Hence, even
though the proteolytic molecular processes at the leading tumour edge change (via
the MDE source (3.26)) following the M2→M1 re-polarisation, we cannot see a clear
trend in tumour spread. This might be because of the complex interactions between
tumour and infiltrating immune cell populations: although we see an increase in the
M1 TAMs populations near the boundary (that also secrete more MDEs than the
M2 cells [103]), the overall proteolytic molecular processes at the leading edge of
the tumour might not change too much, which would mean similar tumour spread.
Second, the rearrangement of the micro-fibre distribution also affects tumour spread
since the amount of fibres being re-located near the leading edge depends on the
fluxes generated by the different cell populations. Therefore, our model suggests
that merely re-polarising the M2 TAMs into the anti-tumoral M1 phenotype might
not be enough to stop tumour spread.
On the other hand, in Figure 3.6 a)-c) we see that the tumour mass is greatly
reduced in all of the presented cases. These results also show that for the largest
reduction we need to re-polarise the M2 TAMs inside the whole tumour domain (i.e.,
Rp = 0, which means that the re-polarisation domain is Ωp(t, 0) = Ω(t)). Hence,
the presence of M2 TAMs in the proliferating rim may be enough to maintain the
tumour mass and induce tumour spread by leading to a moderate presence of cancer
cells in the proliferating rim. In conclusion, the results in Figure 3.6 suggest that
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re-polarising M2-like macrophages to the M1 phenotype have the ability to reduce
tumour mass, but we may need a supplementary strategy primarily focusing on
tumour spread or tumour stroma in order to restrain tumour development.
3.5.2 Temporal Dependency of the Re-polarisation
Let us now concentrate on the temporal aspects of a possible re-polarisation strat-
egy. Since in the previous section, we have shown that the M2→M1 re-polarisation
impacts predominantly tumour mass, and since this effect was the strongest when
Rp = 0, here we investigate the effect of changing tp on tumour mass when we
re-polarise the M2 TAMs within the whole tumour domain. Thus, by varying tp
used in (3.12) we aim to investigate the effectiveness of such strategy when we intro-
duce the re-polarisation of M2 TAMs at time tp > 0. This is crucial since tumours
are only detectable above a certain size, and so a potential treatment that uses re-
polarisation cannot be started at time tp = 0. To this end, in Figure 3.7 we present
the change in the dimensionless tumour mass with respect to the re-polarisation
start time tp. As before, Figure 3.7 a) corresponds to β = 0.75, Figure 3.7 b) to
β = 0.8785 and Figure 3.7 c) to β = 0.825. The blue circle corresponds to high ECM
degradation rates by cancer cells, the orange diamond to medium degradation rates,
and the red cross to low degradation rates for each of these sub-cases. The results
in Figure 3.7 suggest that the lowest tumour mass can be achieved by starting the
re-polarisation as soon as possible, as one would expect. However, even at moderate
times, for instance, at 25∆t, the tumour mass can be controlled at relatively low
values. All these tumour values obtained following re-polarisation at different times
tp are smaller than the tumour value obtained for no re-polarisation (see the last
point on the horizontal axis in Figure 3.7). This indicates that a re-polarisation
based strategy is not only viable when it is introduced at a very early stage, but it
could also be effective even against a more advanced and larger tumour.
125














































































Figure 3.7: Results of varying the re-polarisation start time tp ∈
{0, 5∆t, . . . , 45∆t, 50∆t}. The blue circles correspond to a high ECM degradation
rates by cancer cells (βlc = 3.0, βFc = 1.5, αc = 0.625), the orange diamonds to
medium ECM degradation rates (βlc = 2.0, βFc = 1.0, αc = 0.42) and the red
crosses to low ECM degradation rates (βlc = 1.0, βFc = 0.5, αc = 0.21). The envi-
ronment controller β is set to a) β = 0.75, b) β = 0.7875, c) β = 0.825.
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3.5.3 In the Absence of Nutrients
So far, we have considered the presence of nutrients and the related effect-functions
within the macro-scale dynamics (3.24). However, here, we also investigate how
the absence of these components influence the overall tumour dynamics. Hence, for
the rest of this section, we take σ(x, t) ≡ 0, ∀(x, t) ∈ Y × [0, T ] and Ψp(σ) ≡ 1,
Ψdc(σ) ≡ 1, ΨdM(σ) ≡ 1 and ΨM(σ) ≡ 1, ∀σ and SMσ = 0. For reasons of compara-
bility, we use the same scenarios as before, and so first, in Figure 3.8, we present the
case of no re-polarisation and no nutrients. Although comparing Figures 3.4 and 3.8
we can observe some expected tumour morphology changes, the main difference that
we would like to emphasise is that in the absence of nutrients, all three cell pop-
ulations form a more homogeneous distribution. For example, while in Figure 3.8
there is only one cancer cell accumulation region (about (2, 2) where we centred our
initial condition), in Figure 3.4 this is not the case, and rather cancer cells are more
heterogeneously distributed throughout the tumour domain Ω(50∆t) creating var-
ious accumulation regions. Furthermore, we can also see an M2 TAMs population
that penetrate the tumour deeper in the presence of nutrients. This is because in
this case in Figure 3.8 there are no nutrients mediated movement (since SMσ = 0),
and so the combination of macrophage-macrophage and macrophage-cancer adhe-
sions is not adequate to guide the M2-like macrophages away from the boundaries in
most cases. Hence, these results suggest that the nutrient mediated movement play
an important, non-negligible role in guiding macrophages towards necrotic regions,
which is consistent with biological experiments [188]. Moreover, in Figure 3.9, we
introduce M2→M1 re-polarisation (with Ωp(t,∆x) and tp = 0), and so we can com-
pare it to the results of Figure 3.5 where we presented the same scenario but in the
presence of nutrients. By comparing these results, we can observe more homoge-
neous cell populations (cancer, M1 and M2 TAMs) as well as the same phenomena
as before but with the M1 TAMs population (due to the re-polarisation), i.e., in the
absence of macrophage-nutrient relationship (since SMσ = 0) M1-like macrophages
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Figure 3.8: Baseline simulation with no macrophage re-polarisation and no nutri-
ents ( i.e., σ(x, t) ≡ 0, ∀(x, t) ∈ Y × [0, T ] and Ψp(σ) ≡ 1, Ψdc(σ) ≡ 1, ΨdM(σ) ≡ 1
and ΨM(σ) ≡ 1, ∀σ and SMσ = 0) at final time 50∆t. a) β = 0.75, b) β = 0.7875,
c) β = 0.825.
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Figure 3.9: Simulation with re-polarisation domain Ωp(t,∆x), starting time tp =
0 and with no nutrients ( i.e., σ(x, t) ≡ 0, ∀(x, t) ∈ Y × [0, T ] and Ψp(σ) ≡ 1,
Ψdc(σ) ≡ 1, ΨdM(σ) ≡ 1 and ΨM(σ) ≡ 1, ∀σ and SMσ = 0) at the final time 50∆t.
a) β = 0.75, b) β = 0.7875, c) β = 0.825.
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are accumulated closer to the boundary and are less efficient in penetrating the tu-
mour. This may be of particular interest for future mathematical models due to
recent advances regarding macrophage-mediated drug delivery [152], an approach
that can be used not only for tumours but for other diseases as well.
To investigate the effects of nutrients on the tumour spread and mass behaviour
that we have seen in Figure 3.6, here for comparability, we also present the same
scenarios but in the absence of nutrients in Figure 3.10. Hence, we consider the
three previously used environment controllers β = 0.75, β = 0.7875, β = 0.825 with
the three ECM degradation rates (high, medium and low) and present both the
tumour spread and mass for each case. Although with some expected changes in
the values, in Figure 3.10 we detect a similar behaviour as in Figure 3.6 that the
proteolytic molecular processes at the leading edge of the tumour do not change
drastically, i.e., varying the radius of the re-polarisation domain Rp does not affect
tumour spread substantially. Furthermore, we find consistent results for tumour
mass as well, since we achieve the greatest reduction in the case of Rp = 0 and then
as we increase the radius Rp, tumour mass also increases. Therefore, our results
suggest that although nutrients play an important role in the movement of both
macrophage phenotype, it does not affect the features and properties of the spatial
dependency of the re-polarisation, i.e., both in the presence and in the absence of
nutrients the tumour spread and mass react to changes in the re-polarisation radius
Rp in a similar fashion.
3.6 Discussion
In this chapter, we have further developed and extended a multi-scale moving bound-
ary framework for cancer invasion, introduced in Chapter 2 and [245, 265, 279] by
also considering the dynamics of the anti-tumoral M1 TAMs as well as the nutrients.
On the one hand, we took into account the nutrients since every cell requires them
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Figure 3.10: Results of varying the radius of the re-polarisation domain Rp ∈
{0,∆x, 2∆x, 3∆x, 4∆x} with starting time tp = 0 in the absence of nutrients ( i.e.,
σ(x, t) ≡ 0, ∀(x, t) ∈ Y × [0, T ] and Ψp(σ) ≡ 1, Ψdc(σ) ≡ 1, ΨdM(σ) ≡ 1 and
ΨM(σ) ≡ 1, ∀σ and SMσ = 0). Left panel shows the change in the tumour spread
and the right panel shows the change in tumour mass with respect to Rp. Here
the blue circles correspond to high ECM degradation rates by cancer cells (βlc = 3.0,
βFc = 1.5, αc = 0.625), the orange diamonds to medium degradation rates (βlc = 2.0,
βFc = 1.0, αc = 0.42) and the red crosses to low degradation rates (βlc = 1.0,
βFc = 0.5, αc = 0.21). The environment controller β is set to a) β = 0.75, b)
β = 0.7875, c) β = 0.825.
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to live and function properly, so their presence is indispensable. On the other hand,
we focused on the classically activated M1-like macrophages since they are known to
be capable of killing cancer cells. Moreover, since macrophages are one of the most
abundant immune cells in the tumour microenvironment and their plasticity enables
them to switch phenotypes, they are prime candidates to assist in the fight against
cancer. To this end, we investigated how the re-polarisation of the M2 TAMs into
M1 TAMs can affect cancer development by focusing especially on the macrophage
populations near the leading edge of the tumour. Specifically, we studied the spatial
aspect of the M2→M1 re-polarisation through the definition of a re-polarisation do-
main Ωp(t, Rp), and the temporal aspect via the starting re-polarisation time tp used
in (3.12). Finally, while in this work we considered the death of macrophages induced
through nutritional starvation, this is only one aspect in the wider picture concern-
ing the death and survival of macrophages within the necrotic region, which so far
has not been fully explored experimentally. Future mathematical modelling studies
will explore other death and survival aspects involved concerning macrophages in
necrotic regions.
To propose new hypotheses, we first introduced a macro-scale quasi-steady reaction-
diffusion equation for the nutrients where we considered the spatial transport to
be described by diffusion with constant-coefficient as well as a linear uptake rate.
Then, to account for the effect of nutrients on the different cell functions, we defined
four effect-functions that we used for the rest of tumour dynamics. Furthermore,
we introduced another macro-scale equation, describing the behaviour of the M1
TAMs where the motility of the M1 phenotype is represented both by random and
directed movements. The rest of the equation involves an influx term, nutrient-
dependent proliferation and death laws, as well as nutrient-dependent polarisation
and re-polarisation terms that describe the switch between the two phenotypes.
Similarly to the M2 TAMs, the M1 phenotype also secrete MDEs that can degrade
the ECM. Therefore, this M1 phenotype directly contributes to the re-arrangement
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of the micro-fibres constituents and serves as a source of MDEs for the proteolytic
processes that occur on the invasive edge of the tumour.
We used this extended model to explore the possibilities of macrophage re-
polarisation to depend on the spatial domain as well as on time. First, in Fig-
ures 3.4, 3.5 and 3.6 we presented the result of the spatial dependency by varying
the re-polarisation domain Ωp(t, Rp). We concluded that even though the tumour
spread does not seem to be affected much by the M2→M1 re-polarisation (which
may be expected as biological studies [103, 165, 197] have shown that M1 TAMs
located in the stoma can promote cancer progression), the tumour mass can be
reduced significantly. Therefore, even though we may need additional strategies di-
rectly targeting tumour spread, the tumour mass can potentially be reduced by the
re-polarisation of M2 TAMs to M1 TAMs.
Finally, since tumours are only detectable above a certain size and therefore the
M2→M1 re-polarisation is usually applied at later stages in tumour development,
in Figure 3.7 we investigated the temporal dependency of M2→M1 re-polarisation.
There, we showed that while the smallest tumour mass can be obtained when the
re-polarisation starts as soon as possible, in some cases, it is possible to keep the
tumour under control even when we re-polarise at later times. For example, in
Figure 3.7a), for high ECM degradation levels, tumour mass did not change when
tp ≤ 25∆t. However, tumour mass slowly increased as we delayed the re-polarisation
time for medium and low ECM degradation. All these theoretical results suggest
that macrophages re-polarisation protocols (through various immunotherapies, such
as the use of agonist anti-CD40 mAb [23]) might have to be adapted to the tumour
environment and the degradation levels of the ECM.
We emphasise that due to the complexity of this modelling framework, which
forced us to work with a nondimensionalised model, the results in this chapter are
only qualitative. Nevertheless, they provide new theoretical hypotheses regarding
the possible roles of macrophage re-polarisation (within specific regions of the solid
133
tumours and within specific time scales) in the context of immunotherapies for
cancer.
To conclude, we suggest that in addition to the re-polarisation of M2 TAMs, we
also need additional strategies targeting tumour spread or tumour stroma in order
to stop the tumour from advancing entirely.
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Chapter 4
Collective Cell Migration in a
Fibrous Environment: a Hybrid
Multi-Scale Modelling Approach
Aims and Novelty: In this chapter, we further extend our multi-scale framework
to construct a hybrid tumour model where we use our continuous model to capture
the two-phase ECM (introduced in Chapter 2) and we use a discrete, agent-based
model for the cancer cells. Therefore, this enables us to further study the interaction
between the individual cancer cell and ECM fibres and investigate how varying the
different adhesion strengths and fibre structure affect the overall tumour shape and
invasiveness.
4.1 Introduction
As we have mentioned before, one of the key underlying micro-scale processes in-
volves the micro-scale degradation and redistribution of the ECM fibres. The result-
ing change in the structure of the ECM is of great importance since the structural
component (such as collagen) enables and regularises the movement of cancer cells.
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A mathematical model that accounts for such multi-scale nature of the ECM was
introduced in [245], which we also used in both Chapter 2 and 3. However, here
the cancer cells were modelled as densities in a continuous setting which may not
be ideal [239]. On the other hand, fully discrete mathematical models also have
their drawbacks and in some cases they are not fitted for a certain task [239]. This
motivates the formulation of hybrid models which aim to bring out the best from
both modelling frameworks.
Hence, we formulate a hybrid mathematical model that uses a continuous two-
phase ECM (that we used in Chapter 2 and 3) and a discrete agent-based cancer
cell population [27, 128, 135]. Similarly to Chapter 2, here we concentrate on in-
vestigating cell migration patters. However, while in Chapter 2 we focused on the
movement of the M2-like macrophages, in this chapter we will exclusively focus on
the collective cell migration of the discrete cancer cell population in the absence of
any macrophages. The content of this chapter has been discussed in full details in
our recent publication [263].
4.2 The Multi-scale Hybrid Model
There are two main types of models that are often used to capture the dynamics of
tumour development, namely discrete and continuous models (such as the ones given
in Chapter 2 and 3). Both have advantages and drawbacks over the other [239] and
to minimise these disadvantages, recent extensive efforts have been made to combine
these models into hybrid ones [44].
In this chapter, we employ a hybrid modelling framework [44] that combines the
off-lattice agent based model MultiCell-LF [27, 128, 135] to represent the cells, and a
multi-scale continuous framework (from Chapter 2 and 3 or [246, 247, 245, 265, 264])
to represent the microenvironment. To facilitate the description of this multi-scale
hybrid model, let us first introduce some useful notations from both frameworks.
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As in Chapter 2 and 3, the model is defined within a maximal tissue cube Y ∈ RN
with N = 2 and time interval [0, T ]. The state of an arbitrary individual cell is






i (t)}, where Xi(t) denotes
the position of the cell center, Cradi (t) the cell radius, C
age
i (t) the current cell age,
Cmati the cell maturation age (i.e., the age when the cell is ready for division which is
assigned at birth and so it is independent of time) and Cneighi (t) denotes the number
of neighbouring cancer cells at time t. Here, i ∈ {1, . . . ,M(t)} where M(t) is the
number of cancer cells at time t ∈ [0, T ].
To connect the discrete model to the continuous one, we first need to generate
a cancer cell density by using the individual cell properties. For this, let us first
observe that such density can be determined by using the fraction of unit space
that is occupied by the cancer cells. Therefore, at any macro-scale spatio-temporal
position (x, t) ∈ Y × [0, T ] the density of the cancer cell population in a square
neighbourhood B(x, γ
∆x




























:= {z ∈ Y | ∥ Xi − z ∥2≤ Cradi } describes the spatial
region occupied by the body of an individual cell Ci within the neighbourhood
B(x, γ
∆x
) := {z ∈ Y | ∥ x − z ∥∞≤ γ∆x} that is given by a ∥ · ∥∞ −ball of an
appropriately chosen radius γ
∆x
> 0 (which is proportional to the spatial step-size
of the discretised computational domain Y ).
Besides the discrete cancer cell population, here, also we consider the dynamics
of a continuous multi-scale two-phase ECM. Specifically, we use our continuous
multi-scale two-phase ECM, described in Chapter 2, and so we consider a non-fibre
ECM phase denoted by l(x, t) and a fibre ECM phase whose macro-scale density
and spatial bias are denoted by F (x, t) and θf (x, t), respectively.
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Since in this chapter we do not take into consideration the tumour associated
macrophages (i.e., we only account for the cancer cells and the two-phase ECM),
the global tumour vector is given here by
u := (c(x, t), F (x, t), l(x, t))⊺,
and the total space occupied at position x by
ρ(u) := c(x, t) + F (x, t) + l(x, t).
4.2.1 The MultiCell-LF Model
For each single cell in the MultiCell-LF (Multi-Cell Lattice-Free) model, several
individually-regulated life processes are included, such as cell ageing, cell growth,
cell division, cell-cell and cell-ECM interactions, and cell contact inhibition.
The cell cycle
The lifespan of each cell is traced with the current cell age Cagei (t) that progresses at
the same rate as time, and cell maturation age Cmati that is assigned at the cell birth
and varies slightly between the cells to avoid synchronization of cell divisions. The
cell cycle is divided into the usual four phases [4]: the G1 phase (gap 1) during which
the cells are growing in size, the S phase (synthesis) when biological cells replicate
their DNA, the G2 phase (gap 2) in which cells complete the growth and replication
processes in preparation for the M phase (mitosis) in which cells physically divide
into two daughter cells. Following ours and others previous work, the length of the
cell cycle is divided as follows: G1 (45% of the whole cell cycle), S (35%), G2 (15%),
and M (5%), respectively [135, 128, 282]. Within the figures, we indicate the phase
of an individual cell by different colours, i.e., we use white for the G1 phase, yellow
for the S phase, orange for the G2 phase, red for the M phase and black for cells
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that are both in M phase and contact inhibited.
Cell growth and division
The radius Cradi (t) of a growing cell is increasing linearly until it reaches the size
of the mature cell Rmax. The radius increment has been chosen to assure that
the process of cell growth is completed before the M phase. Once the cell current
age reaches its division age (i.e., Cagei (t) = C
mat
i ), it will divide into two daughter
cells that are placed symmetrically around the mother cell’s nucleus Xi(t) within a










where ϕ is a uniform random angle on [0, 2π], Xi(t) is the position of the mother
cell, and Rmax is the maximal cell radius. The initial ages of the two new cells are
set to zero (Cagei1 (t) = C
age
i2
(t) = 0), and their respective maturation ages Cmati1 and
Cmati2 are inherited from the mother cell maturation age with a small noise term ϵmat
to avoid cell cycle synchronisation between the cells [128, 208]:
Cmati1 =C
mat
i (1 + ϵmat),
Cmati2 =C
mat
i (1 + ϵmat),
where ϵmat is a small uniform random variable on [−0.05, 0.05] and Cmati is the
division age of the mother cell. Finally, both initial radii of the daughter cells are
set to 0.65Rmax (i.e., C
rad
i1 (t) = C
rad
i2 (t) = 0.65Rmax) and as a result initially the two
daughter cells are overlapping (4.2). Therefore, right after the cell division, both
daughter cells experience repulsive forces between each other, as well as with other
nearby cells. These forces will push the cells apart until they reach an equilibrium
and are no longer overlapping (see Section 4.2.2).
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Cell contact inhibition
Once the whole cell colony grows in size, individual cells may become overcrowded
and growth-arrested due to the contact inhibition signals from the neighbouring cells.
The overcrowding condition is modelled by counting the number of cells Cneighi (t) in





where I(·)(·) again denotes the indicator function and Si is the set of all cancer cells
that are close to the cell Ci(t), i.e.,
Si =
{
X ∈ {Xk(t)}k=1,...,M(t)| ∥ X−Xi(t) ∥2≤ Rneigh
}
\ {Xi(t)}.
When the number of neighbouring cells reaches a specified threshold Nneigh (i.e.,
Cneighi (t) ≥ Nneigh), the cell Ci(t) is considered overcrowded and growth-arrested.
However, such an arrested cell remains metabolically active [57], and can resume its
active cell cycle when the contact inhibition conditions change. The time spent in
the growth-arrested state does count toward the length of the active cell cycle.
4.2.2 The Hybrid Cell Movement
To model cancer cell passive relocation (due to cell-cell interactions) and active mi-
gration (due to cell-ECM interactions), we combine both discrete and continuous
approaches. While for cell-cell interactions (both repulsive and adhesive forces) we
use the agent-based approach, the cell-ECM (both fibre-based and non-fibre ad-
hesions) are modelled by using a continuous technique, described in Chapter 2.
Ultimately, these forces collectively influence the direction of motion of each indi-
vidual cell, leading to complex tumour dynamics and to the emergence of various
tumour morphologies.
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Discrete cell-cell repulsive interactions
The repulsive forces between nearby cells are introduced to maintain cell volume
and to avoid cell overlapping during its movement or division (see Section 4.2.1).
Following previous works [128, 27], these forces are modelled as linear Hookean
springs. Hence, considering two arbitrary but distinct cells Ci(t) and Cj(t) (with
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where Xdisi,j (t) := Xi(t) − Xj(t), F rep > 0 is the constant spring stiffness and the
spring resting length is set be equal to the sum of the two cells’ radii, i.e., to
C
rad
i (t) + C
rad
j (t). Taking into consideration now the whole cancer cell population,
the overall repulsive force that acts on the cell Ci(t) is given by the sum of all
repulsive forces between the cell Ci(t) and any other overlapping cell Cj(t), with




Frepi,j , j ∈ {1, . . . ,M(t)} \ {i}. (4.3)
Discrete cell-cell adhesive interactions
The adhesive forces are activated between non-overlapping but nearby cells in order
to keep the cell cluster compact. These forces are modelled using Hooke’s law with
a constant spring stiffness F adh > 0 and resting length of 2Rmax [128]. Hence, such
forces are activated between cells separated by the distance larger than 2Rmax, but
not exceeding 2.25Rmax. This prevents from over-activation of the cell-cell adhesion
between cells that are located far off each other. Therefore, considering two arbitrary
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where Xdisi,j (t) := Xi(t) − Xj(t). Similarly to the repulsive forces, each cell can be
subjected to multiple adhesive forces, thus the cumulative adhesive force which acts




Fadhi,j , j ∈ {1, . . . ,M(t)} \ {i}. (4.4)
Continuous cell-ECM adhesive interactions
Besides the cell-cell interactions described above, of particular importance, are the
cell-ECM adhesions [115, 210, 292, 297] that we explore here through a cell-non-
fibre ECM adhesion [84, 90, 91, 119] as well as a cell-fibre ECM adhesion [294, 295].
This type of interaction is usually modelled by a non-local adhesion integral with a
sensing region B(0, R) of radius R, see Chapter 2 or the existing literature [17, 81,
70, 71, 206, 245, 246, 247, 265, 264] for further details. Since in our hybrid model
the two phase ECM is modelled in a continuous manner using densities, we can
adopt this approach to describe the present cell-ECM interactions. To this end, let








n(y)Scll(Xi + y, t)
+ n̂(y, θf (Xi + y, t))ScFF (Xi + y, t)
]
· [1 − ρ(u)]+dy,
(4.5)
142
which has the same form as its continuous counterpart defined for example in (2.23),
the only difference being that we replaced the continuous variable x by the discrete
cell positions Xi, i.e., instead of calculating the integral for each macro-scale point x
we only calculate it for the discrete cell centres Xi. Hence, each component B(0, R)
with R > 0, Scl > 0, ScF > 0, n(·), n̂(·, ·) and K(·) has already been defined in
Section 2.3.1.
Due to the minimal discrepancy between the continuous (2.23) and discrete (4.5)
integrals, we can use the same numerical approach as in Section 2.4.2. Although here
we cannot use convolutions, we can still divide the sensing region B(0, R) into Ns
annulus sectors and use simple bi-linear shape functions, on each annulus sector Sν .
Hence, we can approximate the mean-values of the non-fibres ECM, the fibres ECM,
as well as their associated macro-scale orientations which enables us to appropriately
construct the integral of the step functions associated with each annulus sector Sν
whose value is given by a linear combination of the mean-values. Finally, these mean
values are used to obtain the numerical approximation for FECMi by following the
numerical steps fully described in Section 2.4.2 or in [245, 265, 264].
The overall direction of cell movement
Ultimately, the overall movement direction of a cell Ci(t) depends on each of the
forces discussed above (repulsion, cell-cell adhesion and cell-ECM adhesion). To
this end, the spatial dynamics of a cell Ci(t) is based on Newton’s second law of
motion where we assume that each cell returns to its equilibrium without oscillations.
Further, the overall force acting on a cell Ci(t) is assumed to be proportional to the




= F repi + Fadhi + FECMi , (4.6)
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Figure 4.1: Illustration of the sensing region B(0, R) of radius R around a cancer
cell, highlighted by the white circle. Within the zoomed-in areas (on the left), the red
arrows show the oriented ECM fibre field and the green arrow on the central cancer
cell shows the overall travelling direction of that particular cancer cell which is the
solution of (4.6). On the right, we show the individual cancer cells with the micro-
fibres, the non-fibre ECM densities and the oriented ECM fibre fields (for illustrative
purposes these are coarsened four-fold). a) Cancer cell placed within a random fibre
environment, identical to Figure 4.7c). b) Cancer cell placed within an aligned fibre
environment, identical to Figure 4.7a’)
where η is the damping coefficient and F repi , Fadhi and FECMi are defined in (4.3),
(4.4) and (4.5), respectively. To solve the the spatial dynamics (4.6) of the cell
Ci(t), we use the classical forward Euler method. We illustrate the overall travelling
direction of a cell in Figure 4.1.
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4.2.3 The Continuous Multi-Scale ECM
As mentioned before, tumour development is a complex and multi-scale phenomenon
where the macro-scale events are accompanied by several related micro-scale pro-
cesses. One of the most important of these processes is the re-distribution of the
fibres ECM micro-constituents triggered by various cell-generated forces. Hence,
here we first describe the macro-scale dynamics of the continuous two-phase ECM
and then we briefly detail its micro-scale dynamics.
Similarly to the cancer cell density, to achieve connection between the discrete
and continuous parts of the model, we first need to appropriately approximate the
generated cell forces (F repi , Fadhi and FECMi defined in (4.3), (4.4) and (4.5), re-
spectively) on the macro-scale. For this, let us use the average of the collective
contribution of all cell generated forces within a γ
∆x
neighbourhood of the macro-























where again λ(·) is the Lebesgue measure in RN , B(x, γ
∆x
) is the ∥ · ∥∞ ball used
also in (4.1), I(·)(·) denotes the indicator function.
The two-phase ECM
As opposed to Chapter 2 or 3, here, we only have the cancer cells that degrade the
surrounding two-phase ECM via the secretion of MMPs [99, 153, 191, 257, 287, 293].
Consequently, denoting the constant non-fibre ECM degradation rate by βl > 0
and the fibre ECM degradation rate by βF > 0, the non-dimensional macro-scale
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dynamics of both fibre and non-fibre ECM phases are mathematically formalised as
∂F
∂t





Here, we used the macro-scale density of the cancer cell population c(x, t) (see (4.1)),
which was derived using the properties of the individual cells provided by the agent-
based part of our hybrid model.
Fibre representation and rearrangement
Since we use our multi-scale continuous framework, described in Chapter 2, to model
the two-phase ECM, the representation of the macro-scale fibres remained the same
as well as the rearrangement process. Hence, the micro-fibre distribution f(x, t)
induces both macro-scale quantities, namely the amount F (x, t) and spatial bias
θf (x, t) which we referred to as the fibre bottom-up link, illustrated in Figure 2.5
and fully described in Section 2.2.2.
Similarly, the rearrangement process that we refer to as the top-down link, is
adopted from Section 2.3.2. However, since in this discrete model we do not consider
the presence of macrophages, we consider this complex process to be initiated only
by the spatial flux of the cancer cell population F(x, t) that was defined in (4.7).
Consequently, this flux alone is responsible for the emerging of the micro-fibres
rearrangement vector which here is defined as
r(δY (x), t) := ω(x, t)F(x, t) + (1 − ω(x, t))θf (x, t), (4.9)
where the weight ω(x, t) is the appropriate mass fraction of the cancer cells and
fibres ECM given by
ω(x, t) :=
c(x, t)
c(x, t) + F (x, t)
.
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Ultimately, following the steps described in Section 2.3.2, we are able to calculate
the new positions z∗ of each micro-fibre point z which leads to a rearranged micro-
fibre distribution f(z, t). For more details, we refer the reader to Section 2.3.2 or
[245].
4.3 Parameter Set
In Table 4.1 we summarise the parameter values (and parameter ranges) used
throughout the numerical simulations performed in the next section.
Table 4.1: Parameter set used for the numerical simulations in this chapter. If we
could not find any references for some of our parameters then we “Estimated” them
(i.e., we chose an arbitrary value for the simulations).
Variable Value Description Reference
∆t 1 minute Temporal time-step Estimated
T 28 days Simulation time length Estimated
Rmax 10µm Maximal radius of any cell [242, 193]
F rep 0.45− 0.9 ×10mg/(µm ·min2) Repulsion spring stiffness [22, 232]
F adh 0− 0.12 ×10mg/(µm ·min2) Cell-cell adhesion spring stiffness [22, 232]
η 1 ×10mg/(µm ·min) Medium viscosity [243]
Cmat1 18 hours Baseline maturation age for the first cell [242, 193]
Nneigh 10 Overcrowding threshold Estimated
Scl 0.01× 10mg/min2 Cell-non-fibre adhesion coefficient Estimated
ScF 0− 1.8× 10mg/min2 Cell-fibre adhesion coefficient Estimated
βF 1.5 Non-dimensional degradation coefficient [245, 246, 247]
for fibre ECM due to the tumour
βl 2 Non-dimensional degradation coefficient [245, 246, 247]
Continued on next page
147
Table 4.1 – continued from previous page
Variable Value Description Reference
for non-fibre ECM due to the tumour
R 30− 50µm Sensing radius Estimated
∆x 20µm Macro-scale spatial step-size Estimated
δ 20µm Size of the fibre micro-domain δY (x) Estimated
γ∆x ∆x/2 Radius of the square neighbourhood Estimated
B(x, γ∆x )
fmax 0.636 Maximum of micro-fibre density [245, 246, 247]
at any point
4.4 Results
For completeness of model description, in Figure 4.2 we show a diagrammatic de-
scription of the agent-based modelling of cells, the continuous modelling of the ECM
and the connection of the two models at the specific stages of the numerical simu-
lations. Here, we can also see the main stages of both models and the information
that is required to share with each other.
In the context of the above described multi-scale hybrid framework, here we
present some numerical simulations of the model, which highlight different migra-
tion cell patterns in various tissues with different levels of ECM fibres and differ-
ent alignment levels. To this end, we start each simulation with a single cancer
cell with well defined properties located at a point (x01, x
0
2) (that will be defined
for each simulations) of the computational domain Y = [−1280mm, 1280mm] ×
[−1280mm, 1280mm], and any alteration from this will be stated accordingly. Then,
this single cancer cell is considered to be embedded within the following (scaled)
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Figure 4.2: Diagrammatic description of the agent-based modelling of cells, the
continuous modelling of the ECM and the connection of the two models at the specific
stages of the numerical simulations.
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Figure 4.3: Initial ECM conditions used for the numerical simulations. a) The
macro-scale non-fibres ECM density. b) One aligned micro-fibres domain δY which
is repeated for all macro-node x.






















which can be seen in Figure 4.3a) that is in-silico representation of the heterogeneous
distribution of the non-fibre ECM. Note that this is a scaled version of the non-
fibre ECM initial condition that we used in Chapter 2 and 3 that we chose for
consistency. For illustrative purposes, in Figure 4.3 (as well as throughout the rest
of this Section) we present the non-fibre ECM initial conditions only on the domain
of [−1000mm, 1000mm]× [−1000mm, 1000mm]. Moreover, for both Figures 4.3a)-b)
(as well as for all other figures in this Section), the units of the x and y axes are
in ‘mm’. Finally to highlight the phase of each individual cell, we use five colours.
Specifically, we colour the cells that are in the G1 phase white, those in the S phase
yellow, those in the G2 phase orange, those in M phase red, and the ones that are
both growth-arrested (due to contact inhibition) and in the M phase are coloured
black in all simulations. Each simulation of this chapter is either finishes at the
final time T = 28 days or when a cell reaches the boundary of the computational
domain/tissue cube Y which results in shorter simulations. In these cases, we define
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the final time T for each simulation.
To shed some light on the importance of ECM characteristics on cancer invasion,
throughout this section we investigate numerically the type of cancer migration and
invasion patterns obtained when we consider different cell sensing radii. We note
here that the sensing radius is determined not only by the length of cell membrane
protrusions called pseudopodia (which have lengths greater than 2µm [189, 138]),
but also by the long-range cell sensing due to stress transmission via aligned ECM
fibres (which allows cells to sense other cells up to 100µm away [166]). Throughout
this study we investigate the impact of two sensing radii, R = 30µm or R = 50µm,
on tumour shape and invasion pattern. We also investigate the impact of different
fibres to non-fibres ECM ratios (i.e., 10% : 90%, 20% : 80%, or 30% : 70%), different
ECM fibre distribution (i.e., random, aligned, or mixed), and different cell-cell and
cell-ECM interaction strengths.
4.4.1 Simulations without Cell-ECM Adhesions in a Ran-
dom Fibrous Environment
We start our numerical investigation of this hybrid multi-scale model by showing
some baseline simulations for the case without cell-ECM adhesions, as we vary the
fibre ECM density (i.e., 10− 30% fibres), for two different sensing radii: R = 30µm
in Figure 4.4, and R = 50µm in Figure 4.5. By comparing the numerical results in
Figures 4.4 and 4.5 we can conclude that in the absence of any cell-ECM adhesion,
the tumour colonies have an almost circular shape, and they are stationary (i.e.,
they do not move through the domain). Moreover, the larger cell sensing radius
does not seem to have a significant impact on tumour structure.
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Figure 4.4: Simulation results at final time T = 28 days with random fibres,
sensing radius R = 30µm, repulsion F rep = 0.45×10mg/µm·min2, cell-cell adhesion
F adh = 0.12×10mg/µm ·min2, cell-non-fibre ECM adhesion Scl = 0, cell-fibre ECM
adhesion ScF = 0 and with a) 10% : 90%, b) 20% : 80%, c) 30% : 70% fibres and
non-fibres ECM ratios. For illustrative purposes, all oriented ECM fibre fields are
coarsened four-fold. Initial cell position was: a)-c) (0,0).
Figure 4.5: Simulation results at final time T = 28 days with random fibres,
sensing radius R = 50µm, repulsion F rep = 0.45×10mg/µm·min2, cell-cell adhesion
F adh = 0.12×10mg/µm ·min2, cell-non-fibre ECM adhesion Scl = 0, cell-fibre ECM
adhesion ScF = 0 and with a) 10% : 90%, b) 20% : 80%, c) 30% : 70% fibres and
non-fibres ECM ratios. For illustrative purposes, all oriented ECM fibre fields are
coarsened four-fold. Initial cell position was: a)-c) (0,0).
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Figure 4.6: Simulation results with random and aligned fibres, sensing radius R =
30µm, repulsion F rep = 0.9 × 10mg/µm · min2, cell-cell adhesion F adh = 0.12 ×
10mg/µm ·min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre ECM adhesion
ScF = 1.8 and with a)-a’) 10% : 90%, b)-b’) 20% : 80%, c)-c’) 30% : 70% fibres and
non-fibres ECM ratios. In a),b),c) the fibre orientation field is set to be random and
in a’),b’),c’) it is set to be aligned. Moreover the final simulation times are a),b),c)
T = 28 days, a’) T = 14294 minutes, b’) T = 10761 minutes and c’) T = 4169
minutes. For illustrative purposes, all oriented ECM fibre fields are coarsened four-
fold. Initial cell position was: a),b),c) (0,0), a’),b’),c’) (900,-900).
4.4.2 Simulations with Cell-ECM Adhesions in a Random
Fibrous Environment
Next, we consider cell-ECM adhesion forces (Scl = 0.01, ScF = 1.8), and investigate
again the effect of changes in fibre ECM density (i.e., 10 − 30% fibres), for two
different sensing radii: R = 30µm in Figure 4.6, and R = 50µm in Figure 4.7. Since
now we consider cell-ECM interactions, in these two figures we also show model
dynamics when the ECM environment is described by random fibres (sub-panels
a)-c)) or by aligned fibres (sub-panels a’)-c’)).
First, we see that cell-ECM interactions can lead to irregular-shaped tumour
aggregations as well as elongated tumour aggregations. The random fibres are asso-
ciated with stationary cell aggregations (sub-panels a)-c)), while the aligned fibres
are associated with moving cell aggregations (sub-panels a’)-c’)). The increase in
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Figure 4.7: Simulation results with random and aligned fibres, sensing radius R =
50µm, repulsion F rep = 0.9 × 10mg/µm · min2, cell-cell adhesion F adh = 0.12 ×
10mg/µm ·min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre ECM adhesion
ScF = 1.8 and with a)-a’) 10% : 90%, b)-b’) 20% : 80%, c)-c’) 30% : 70% fibres and
non-fibres ECM ratios. In a),b),c) the fibre orientation field is set to be random and
in a’),b’),c’) it is set to be aligned. Moreover the final simulation times are a),b),c)
T = 28 days, a’) T = 28470 minutes, b’) T = 9260 minutes and c’) T = 6351
minutes. For illustrative purposes, all oriented ECM fibre fields are coarsened four-
fold. Initial cell position was: a),b),c) (0,0), a’),b’),c’) (900,-900).
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sensing region (from R = 30 in Figure 4.6 to R = 50 in Figure 4.7) leads to an
important difference. Even though we have now introduced the cell-ECM adhesion,
in a lower fibre ECM density (10%−20%) the tumour still kept its more round shape
due to the increase of the sensing region. One possible explanation for this is that
by increasing the sensing region in a random ECM environment, the different forces
that emerge from the fibre orientations, cancel each other out and so the cancer cells
are not subject to a strong leading force.
Finally, the increase in cell sensing radius to R = 50 in an aligned fibrous en-
vironment, leads to a more compact tumour aggregation for the case of 10% : 90%
fibres : non-fibres ECM ratios. For higher ratios, the tumour is extremely elongated
and the sensing radius has almost no impact.
4.4.3 Decreasing the Cell-Cell Adhesion Strength
Previous simulations were performed with a relatively high cell-cell adhesion strength
(F adh = 0.12), which impacts the overall shape of tumour aggregations. Let us now
decrease the cell-cell adhesion strength and consider F adh = 0.04 (while keeping all
other parameters as before). In Figure 4.8 and Figure 4.9 we can see that a decrease
in cell-cell adhesion causes more irregularly-shaped tumour aggregations. This is
counterbalanced a bit by an increase in the sensing radius to R = 50 which, as
before, tends to favorise more round-shaped tumour aggregations.
4.4.4 Decreasing the Cell-Fibre ECM Adhesion Strength
Since the previous simulations had low cell-cell adhesion but high cell-fibre ECM
adhesion, next we investigate tumour invasion patterns when we lower the cell-fibre
adhesion strength to ScF = 1.2 (while keeping F
adh = 0.04). In Figure 4.10 and
Figure 4.11 we see that lowering cell-fibre adhesion leads to a highly-irregular tumour
shape, especially for the case of 30% : 70% fibres to non-fibres ECM ratios.
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Figure 4.8: Simulation results with random and aligned fibres, sensing radius R =
30µm, repulsion F rep = 0.9 × 10mg/µm · min2, cell-cell adhesion F adh = 0.04 ×
10mg/µm ·min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre ECM adhesion
ScF = 1.8 and with a)-a’) 10% : 90%, b)-b’) 20% : 80%, c)-c’) 30% : 70% fibres and
non-fibres ECM ratios. In a),b),c) the fibre orientation field is set to be random and
in a’),b’),c’) it is set to be aligned. Moreover the final simulation times are a),b),c)
T = 28 days, a’) T = 11860 minutes, b’) T = 6822 minutes and c’) T = 3378
minutes. For illustrative purposes, all oriented ECM fibre fields are coarsened four-
fold. Initial cell position was: a),b),c) (0,0), a’),b’),c’) (900,-900).
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Figure 4.9: Simulation results with random and aligned fibres, sensing radius R =
50µm, repulsion F rep = 0.9 × 10mg/µm · min2, cell-cell adhesion F dh = 0.04 ×
10mg/µm ·min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre ECM adhesion
ScF = 1.8 and with a)-a’) 10% : 90%, b)-b’) 20% : 80%, c)-c’) 30% : 70% fibres and
non-fibres ECM ratios. In a),b),c) the fibre orientation field is set to be random and
in a’),b’),c’) it is set to be aligned. Moreover the final simulation times are a),b),c)
T = 28 days, a’) T = 21400 minutes, b’) T = 6551 minutes and c’) T = 4305
minutes. For illustrative purposes, all oriented ECM fibre fields are coarsened four-
fold. Initial cell position was: a),b),c) (0,0), a’),b’),c’) (900,-900).
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Figure 4.10: Simulation results with random and aligned fibres, sensing radius
R = 30µm, repulsion F rep = 0.75 × 10mg/µm · min2, cell-cell adhesion F adh =
0.04 × 10mg/µm · min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre ECM
adhesion ScF = 1.2 and with a)-a’) 10% : 90%, b)-b’) 20% : 80%, c)-c’) 30% : 70%
fibres and non-fibres ECM ratios. In a),b),c) the fibre orientation field is set to
be random and in a’),b’),c’) it is set to be aligned. Moreover the final simulation
times are a),b),c) T = 28 days, a’) T = 20183 minutes, b’) T = 12268 minutes and
c’) T = 7589 minutes. For illustrative purposes, all oriented ECM fibre fields are
coarsened four-fold. Initial cell position was: a),b),c) (0,0), a’),b’),c’) (900,-900).
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Figure 4.11: Simulation results with random and aligned fibres, sensing radius
R = 50µm, repulsion F rep = 0.75 × 10mg/µm · min2, cell-cell adhesion F adh =
0.04 × 10mg/µm · min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre ECM
adhesion ScF = 1.2 and with a)-a’) 10% : 90%, b)-b’) 20% : 80%, c)-c’) 30% : 70%
fibres and non-fibres ECM ratios. In a),b),c) the fibre orientation field is set to
be random and in a’),b’),c’) it is set to be aligned. Moreover the final simulation
times are a),b),c) T = 28 days, a’) T = 37517 minutes, b’) T = 14220 minutes and
c’) T = 9982 minutes. For illustrative purposes, all oriented ECM fibre fields are
coarsened four-fold. Initial cell position was: a),b),c) (0,0), a’),b’),c’) (900,-900).
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Figure 4.12: Simulation results with random and aligned fibres, sensing radius
R = 30µm, repulsion F rep = 0.5 × 10mg/µm · min2, cell-cell adhesion F adh =
0.12 × 10mg/µm · min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre ECM
adhesion ScF = 0.3 and with a)-a’) 10% : 90%, b)-b’) 20% : 80%, c)-c’) 30% : 70%
fibres and non-fibres ECM ratios. In a),b),c) the fibre orientation field is set to be
random and in a’),b’),c’) it is set to be aligned. Moreover the final simulation times
are a),a’),b),c) T = 28 days, b’) T = 34707 minutes and c’) T = 25801 minutes.
For illustrative purposes, all oriented ECM fibre fields are coarsened four-fold. Initial
cell position was: a)-c’) (0,0).
Consider now an even lower cell-ECM adhesion strength, ScF = 0.3, and at the
same time a lower cell repulsion F rep = 0.5. In Figures 4.12 and 4.13 we see that
tumour aggregations have recovered their circular shape when the ECM fibres are
distributed randomly, and have either circular or slightly elongated structures when
the ECM fibres are aligned.
We emphasise that the simulations in sub-panels b’)-c’) in the above figures were
ran for shorter times, since for longer times the cells leave the computational domain
Y .
4.4.5 Different Tissues with Different Fibre Orientations
Finally, we investigate numerically what happens with tumour shape and its invasion
pattern when the ECM domain is formed of patches of random and aligned fibres,
corresponding to different types of tissues (see the discussion in the Introduction).
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Figure 4.13: Simulation results with random and aligned fibres, sensing radius
R = 50µm, repulsion F rep = 0.5 × 10mg/µm · min2, cell-cell adhesion F adh =
0.12 × 10mg/µm · min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre ECM
adhesion ScF = 0.3 and with a)-a’) 10% : 90%, b)-b’) 20% : 80%, c)-c’) 30% : 70%
fibres and non-fibres ECM ratios. In a),b),c) the fibre orientation field is set to be
random and in a’),b’),c’) it is set to be aligned. Moreover the final simulation times
are a),a’),b),c) T = 28 days, b’) T = 31873 minutes and c’) T = 31506 minutes.
For illustrative purposes, all oriented ECM fibre fields are coarsened four-fold. Initial
cell position was: a)-c’) (0,0).
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For this we start with a cluster of cells (e.g., 19 cells, for illustration purposes)
instead of just one cell. Moreover, we consider here again the parameter values
used for the results in Figures 4.6c)-c)’, namely: R = 30µm, F rep = 0.9, F adh =
0.12, Scl = 0.01, ScF = 1.8, and 30% : 70% fibres and non-fibres ECM ratios. In
Figure 4.14 we present six scenarios corresponding to different regions of random and
aligned ECM fibres. In sub-panels a)-c) we plot the distribution of cancer cells and
the ECM degradation pattern at a single time snapshot (i.e., a) T = 5283min, b)
T = 4601min, c) T = 9518min). In panels d)-f) we plot the distribution of cancer
cells and the ECM degradation patterns at three different times (T = 9500min,
T = 15000min, T = 20000min), to illustrate the time-evolution of the system.
The simulations in Figure 4.14 show that the initial position of the cluster of tu-
mour cells, together with the ECM alignment in that region, influences the direction
of migration of these cells. In sub-panels a)-b) the cells migrate in the direction of
fibre alignment, while in sub-panel c) the cells migrate along the boundary between
two regions with opposite alignment. A similar migration pattern is observed in
sub-panel d). Finally, in sub-panels e) and f) we observe that when the original
tumour cell cluster is positioned in an area surrounded by different ECM alignment,
the tumour tends to stay in that area and to very slowly invade the neighbouring
tissues (with different ECM orientations). All these different tumour invasive pat-
terns are consistent with the experimental results in [56, 219], which showed that
aligned collagen fibres perpendicular to tumour boundary are associated with tu-
mour invasion along those fibres, and the experiments in [219] which showed that
aligned collagen fibres parallel to tumour boundary impede invasion.
4.5 Discussion
The composition and structural characteristics of the extracellular matrix (ECM) are
known to vary widely among different tissues [175], and this has a significant impact
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Figure 4.14: Simulation results with different aligned fibre structures, sensing
radius R = 30µm, repulsion F rep = 0.9 × 10mg/µm · min2, cell-cell adhesion
F adh = 0.12 × 10mg/µm ·min2, cell-non-fibre ECM adhesion Scl = 0.01, cell-fibre
ECM adhesion ScF = 1.8 and with 30% : 70% fibres and non-fibres ECM ratios. In
the first row of each panel a)-f), we present the four-fold coarsened initial oriented
ECM fibre field and the purple lines represent the dividing lines between the regions
with different tissue alignments. In panel a) we plot a single result at time T = 5283
minutes, in b) at time T = 4601 minutes and in c) at time T = 9518. In panels d)-f)
we plot the results at three different times to illustrate the evolution of the tumour,
specifically, we use T = 9500, T = 15000, T = 20000 minutes, respectively. The
oriented ECM fibres fields are coarsened four-fold for illustration purposes. Initial
center of cell cluster position was: a)-e) (0,0), f) (-400,-200).
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on the evolution of cancer. Since there is an increasing need for understanding
the spatio-temporal changes in ECM and their roles in cancer progression, in this
study we introduced a new multi-scale hybrid mathematical model for cell-cell and
cell-ECM interactions, and used it to investigate numerically the impact of ECM
fibre orientation and fibre density on cancer cell invasion patterns. To this end,
we varied a number of parameters associated with the cell-cell interactions (e.g.,
cell sensing radius R, cell-cell adhesion stiffness F adh, cell-cell repulsion stiffness
F rep), and parameters associated with cell-ECM interactions (i.e., cell-fibre adhesion
coefficient ScF , and cell-non-fibre adhesion coefficient Scl), as well as we varied the
random or aligned distribution of fibres. This enables us to explore their impact on
the formation of cell aggregations and their collective dynamics.
Through numerical simulations, we tested a variety of scenarios: from the im-
pact of smaller/larger cell sensing radius on tumour aggregations, to the impact of
random vs. aligned fibres on the migration and invasion of cancer cells into nearby
tissues, the role of different fibre orientation in the neighbourhood of initial tumour,
and the roles of cell-cell and cell-ECM strengths on the shape of solid tumours. We
summarise all these numerical results in Table 4.2 (for the case R = 30µm) and Ta-
ble 4.3 (for the case R = 50µm). By comparing the 3rd column (Description) with
the 10th column (Fibre orientation) it is clear that a random ECM fibre distribution
leads to stationary tumour aggregations, while an oriented fibre distribution leads
to moving tumour aggregations. These numerical results are consistent with exper-
imental results showing that oriented collagen fibres direct tumour invasion, with
the alignment of collagen fibres coinciding with the cell invasive direction [97, 56].
Moreover, our numerical results in Figure 4.14 showed that collagen fibres that are
relatively parallel to tumour boundary (and create a capsule-like orientation) can
limit tumour invasion. These results are consistent with a recent note by Friedl [79],
as well as the experiments in [219], about to the importance of ECM orientation
relative to the tumour (see also Figure 1 in [79]).
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The results in Figure 4.14 suggest that if we could know the orientation of col-
lagen fibres surrounding the tumour (which may be spanning different tissues with
different ECM structures) we could predict the fast or slow evolution of the solid
tumour, as well as potential cell migration directions. Since collagen can be eas-
ily visualised in standard histopathology slides through second harmonic generation
microscopy [56] or via multiphoton tomography [283], such predictions on the evo-
lution of tumours might help treatment decisions, e.g., by deciding to resect more
surrounding tissue if the imaging shows collagen fibres aligned perpendicular to tu-
mour boundary in a certain area, or by deciding to preserve more surrounding tissue
if the imaging shows collagen fibres parallel to tumour boundary. Intraoperative vi-
sualisation of tumour microenvironment, including collagen alignment in resected
tissues [262], could be further combined with mathematical simulations in 2D (and
even in 3D, although this is expected to carry a considerably higher computational
cost) to improve such treatment decisions.
Finally, our numerical simulations suggest that the sensing radius R (determined
by the length of membrane protrusions called pseudopodia [189, 138], as well as by
the long-range sensing due to stress transmission via aligned ECM fibres [166])
impacts the shape of tumour colonies in an aligned fibrous ECM environment with
relatively low ratios of fibres to non-fibres. More precisely, when the ECM ratio
of fibres to non-fibres is 10% : 90%, larger R leads to more compact tumor cell
colonies (compare with the cluster invasion pattern in [80]). For higher fibres : non-
fibres ratios this sensing radius has almost no impact, the tumour being extremely
elongated as the cells move quickly along the collagen fibres (compare with the
strands and files patterns in [80]).
Overall, this study not only confirmed some of the previous experimental results
on the importance of alignement of ECM collagen fibres on tumour invasion [56, 219],
but also proposed new hypotheses on the biological mechanisms involved in the
shape of the tumour colonies (e.g., the roles of sensing radius vs. fibres to non-fibres
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ratios; the roles of sensing radius vs. cell-cell and cell-ECM mechanical forces).
Moreover, this multi-scale hybrid modelling, which incorporates ECM remodelling
and fibre rearrangement in the direction of cell travelling (via cell flux F(x, t)), can
be further applied to understand various other fibrotic diseases characterised by
ECM remodelling [58].
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Table 4.2: Summary of numerical results obtained for a cell sensing radius of
R = 30µm.
Figure Tumour Description R F adh Scl ScF F
rep Fibre ratio Fibre
Type orientation
Figure 4.4a) circular stationary 30 0.12 0 0 0.45 10% random
Figure 4.4b) circular stationary 30 0.12 0 0 0.45 20% random
Figure 4.4c) circular stationary 30 0.12 0 0 0.45 30% random
Figure 4.6a) irregular stationary 30 0.12 0.01 1.8 0.9 10% random
Figure 4.6a’) elongated moving 30 0.12 0.01 1.8 0.9 10% oriented
Figure 4.6b) irregular stationary 30 0.12 0.01 1.8 0.9 20% random
Figure 4.6b’) elongated moving 30 0.12 0.01 1.8 0.9 20% oriented
Figure 4.6c) irregular stationary 30 0.12 0.01 1.8 0.9 30% random
Figure 4.6c’) elongated moving 30 0.12 0.01 1.8 0.9 30% oriented
Figure 4.8a) circular stationary 30 0.04 0.01 1.8 0.9 10% random
Figure 4.8a’) elongated moving 30 0.04 0.01 1.8 0.9 10% oriented
Figure 4.8b) irregular stationary 30 0.04 0.01 1.8 0.9 20% random
Figure 4.8b’) elongated moving 30 0.04 0.01 1.8 0.9 20% oriented
Figure 4.8c) irregular stationary 30 0.04 0.01 1.8 0.9 30% random
Figure 4.8c’) elongated moving 30 0.04 0.01 1.8 0.9 30% oriented
Figure 4.10a) circular stationary 30 0.04 0.01 1.2 0.75 10% random
Figure 4.10a’) elongated moving 30 0.04 0.01 1.2 0.75 10% oriented
Figure 4.10b) circular stationary 30 0.04 0.01 1.2 0.75 20% random
Figure 4.10b’) elongated moving 30 0.04 0.01 1.2 0.75 20% oriented
Figure 4.10c) irregular stationary 30 0.04 0.01 1.2 0.75 30% random
Figure 4.10c’) elongated moving 30 0.04 0.01 1.2 0.75 30% oriented
Figure 4.12a) circular stationary 30 0.12 0.01 0.3 0.5 10% random
Figure 4.12a’) circular moving 30 0.12 0.01 0.3 0.5 10% oriented
Figure 4.12b) circular stationary 30 0.12 0.01 0.3 0.5 20% random
Figure 4.12b’) elongated moving 30 0.12 0.01 0.3 0.5 20% oriented
Figure 4.12c circular stationary 30 0.12 0.01 0.3 0.5 30% random
Figure 4.12c’) elongated moving 30 0.12 0.01 0.3 0.5 30% oriented
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Table 4.3: Summary of numerical results obtained for a cell sensing radius of
R = 50µm.
Figure Tumour Description R F adh Scl ScF F
rep Fibre ratio Fibre
Type orientation
Figure 4.5a) circular stationary 50 0.12 0 0 0.45 10% random
Figure 4.5b) circular stationary 50 0.12 0 0 0.45 20% random
Figure 4.5c) circular stationary 50 0.12 0 0 0.45 30% random
Figure 4.7a) circular stationary 50 0.12 0.01 1.8 0.9 10% random
Figure 4.7a’) elongated moving 50 0.12 0.01 1.8 0.9 10% oriented
Figure 4.7b) circular stationary 50 0.12 0.01 1.8 0.9 20% random
Figure 4.7b’) elongated moving 50 0.12 0.01 1.8 0.9 20% oriented
Figure 4.7c) irregular stationary 50 0.12 0.01 1.8 0.9 30% random
Figure 4.7c’) elongated moving 50 0.12 0.01 1.8 0.9 30% oriented
Figure 4.9a) circular stationary 50 0.04 0.01 1.8 0.9 10% random
Figure 4.9a’) elongated moving 50 0.04 0.01 1.8 0.9 10% oriented
Figure 4.9b) irregular stationary 50 0.04 0.01 1.8 0.9 20% random
Figure 4.9b’) elongated moving 50 0.04 0.01 1.8 0.9 20% oriented
Figure 4.9c) irregular stationary 50 0.04 0.01 1.8 0.9 30% random
Figure 4.9c’) elongated moving 50 0.04 0.01 1.8 0.9 30% oriented
Figure 4.11a) circular stationary 50 0.04 0.01 1.2 0.75 10% random
Figure 4.11a’) elongated moving 50 0.04 0.01 1.2 0.75 10% oriented
Figure 4.11b) irregular stationary 50 0.04 0.01 1.2 0.75 20% random
Figure 4.11b’) elongated moving 50 0.04 0.01 1.2 0.75 20% oriented
Figure 4.11c) irregular stationary 50 0.04 0.01 1.2 0.75 30% random
Figure 4.11c’) elongated moving 50 0.04 0.01 1.2 0.75 30% oriented
Figure 4.13a) circular stationary 50 0.12 0.01 0.3 0.5 10% random
Figure 4.13a’) circular moving 50 0.12 0.01 0.3 0.5 10% oriented
Figure 4.13b) circular stationary 50 0.12 0.01 0.3 0.5 20% random
Figure 4.13b’) elongated moving 50 0.12 0.01 0.3 0.5 20% oriented
Figure 4.13c) circular stationary 50 0.12 0.01 0.3 0.5 30% random




Glioblastomas Invasion within the
Brain: a 3D Multi-Scale
Moving-Boundary Approach
Aims and Novelty: In this chapter, we extend our multi-scale moving boundary
framework from 2D (described in Chapters 2 and 3) to 3D and use it to numerically
simulate brain tumours. To do this, we also use T1 weighted and DTI images that
ultimately allows us to investigate explicitly the role of brain micro-fibres in 3D
invading brain tumours.
5.1 Introduction
Although so far, the presented models focused on generic tumours within a 2-
dimensional environment, it is also important to consider specific type of tumours
and their evolution within a 3D environment. These models can help connect math-
ematical models to real-world examples of tumour progression, for instance via pa-
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rameter fitting or determining how different components/aspects of the modelling
approach affect the overall tumour dynamics.
One of the most invasive and aggressive type of brain tumour is the glioblastoma
multiforme, a type of tumour that we have restricted knowledge of since experimental
approaches on the brain are limited. However, one important aspect of the brain
that can be obtained experimentally, via MRI and DTI scans, is its structure which
also plays a vital role in tumour progression.
Hence, in this chapter, we model glioblastoma invasion within a 3D fibrous
brain environment to investigate the effects of brain micro-fibres as well as both
T1 weighted and DTI scans on the overall tumour progression. To that end, we ex-
tend the general 2D multi-scale moving-boundary modelling framework introduced
in Chapters 2 and 3 to a 3D one and apply it to model the glioblastoma invasion.
The content of this chapter has been thoroughly discussed and presented in our
recent publication [266].
5.2 Multi-Scale Modelling of the Tumour Dynam-
ics
To model the evolution of glioblastomas within a 3-dimensional brain, we employ the
multi-scale moving boundary framework that we introduced in the previous chapters,
but here, we model the tumours in the absence of macrophages. To account for
the brain’s structure, we aim to use 3D T1 weighted and DTI scans that ultimately
influence the migration of the cancer cells as well as affect both micro-scale dynamics.
Hence, here we aim to explore the impact of the brain structure on the interlinked
macro-scale and micro-scale tumour dynamics.
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5.2.1 Macro-Scale Dynamics
Since in this work we extend the 2-dimensional (2D) modelling framework introduced
in Chapter 2 and 3, we begin by revisiting briefly some of the key features of this
framework and by giving a few useful notations. First, we denote by Ω(t) the
expanding 3-dimensional (3D) tumour region that progresses over the time interval
[0, T ] within a maximal tissue cube Y ⊂ RN with N = 3, i.e., Ω(t) ⊂ Y, ∀t ∈
[0, T ]; see also Figure 5.1 for a 3D illustration. Then at any macro-scale spatio-
temporal point (x, t) ∈ Y × [0, T ] we consider a cancer cell population c(x, t) that
is placed within and interacts with a two-phase ECM: the non-fibre l(x, t) and
fibre F (x, t) ECM phases [245, 247, 246, 265, 264]. On the one hand, the fibre
ECM phase accounts for all major fibrous proteins such as collagen and fibronectin,
whose micro-scale distribution induces the spatial orientation of the ECM fibres.
Hence, the macro-scale spatio-temporal distribution of the ECM fibres is represented
by an oriented vector field θf (x, t) that describes their spatial bias, as well as by
F (x, t) :=∥θf (x, t)∥ which denote the amount of fibres at a macro-scale point (x, t)
[245, 247, 246, 265, 264] (for further details on these two quantities, we refer the
reader to Section 2.2.2). On the other hand, in the non-fibre ECM phase we bundle
together every other ECM constituent such as non-fibrous proteins (for example
amyloid fibrils), enzymes, polysaccharides and extracellular Ca2+ ions [245, 247, 246,
265, 264]. Furthermore, we incorporate the structure of the brain by extracting data
from DTI and T1 weighted brain scans, and then using this data to parametrise the
model. Specifically, we denote by DWater(x) the water diffusion tensor that is induced
by the DTI scan. Also, we denote by w(x) the white matter density and by g(x)
the grey matter density, both of which are extracted from the T1 weighted image.
Finally, to facilitate the description of the model and to make the mathematical
notations more compact, we denote by u the global tumour vector which at each
(x, t) is given by

















Figure 5.1: Schematics of the multi-scale model. a) Illustration of the sensing
region B(x,R), the two vectors y and y + θf (y + x, t) and the overall travelling
direction Ac. b) An example of a fibre micro-domain δY (x) containing fibres (blue
lines) that induces an overall orientation θf (x, t) for δY (x). c) An example of a
boundary micro-domain ϵY (x) where the blue volume represents the tumour volume
at the current time-step with boundary point x and the red volume represents the
evolved tumour at next time-step with shifted boundary point x∗ϵY .
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With this notation, the total space occupied by the macroscopic tissue is denoted
by ρ(u) and is defined as
ρ(u) := c(x, t) + l(x, t) + F (x, t).
Cancer cell population dynamics
To describe the spatio-temporal evolution of the cancer cell population c(x, t), we
first assume a logistic-type growth with rate µ as in Chapters 2 and 3 [145, 146,
275, 245, 247, 246, 265, 264]. For the movement of this cell population, we use
the structure of the brain by taking into account both the T1 weighted and DTI
scans (from the IXI Dataset [1]), as well as the various adhesion mediated processes
[49, 55, 115, 210, 292, 297]. Hence, the spatio-temporal dynamics of the cancer cell





































, N = 3,
with Di,j denoting the components of the tumour diffusion tensor DT . Since classical
diffusion models with constant coefficient cannot capture any directional cues, as
those provided by the DTI data, in Eq. (5.1) we use a tensor model (involving a
fully anisotropic diffusion term) that is able to incorporate the anisotropic nature
of the cancer cell movement. These tensor models were proposed in [20, 21, 18, 19]
and have been used to mathematically model the gliomas within the brain; see for
instance [75, 116, 202]. The main idea of this approach is to use the measured water
diffusivity in the structured, fibrous brain environment characterised by a symmetric
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and appropriately construct a macroscopic diffusion tensor for the cancer cell popu-
lation. Since this water tensor (5.2) is naturally symmetric (due to the DTI scans)
[196], it can be diagonalised. Denoting its eigenvalues by λ1(x) ≥ · · · ≥ λN(x) and
the associated eigenvectors by ϕ1(x), · · ·ϕN(x), with N = 3, we follow [108, 178, 202]
and construct the 3D tumour diffusion tensor as
DT (x) := Dc DWG(x)
[(








+ (1 − r)
(












Here, Dc > 0 is the diffusion coefficient, r ∈ [0, 1] specifies the degree of isotropic
diffusion, I3 denotes the 3 × 3 identity matrix, k(x) is given by
k(x) := KFAFA(x),
with KFA ≥ 0 being a proportionality constant measuring the sensitivity of the cells











Finally, it is well known that the malignant glioma cells positioned in the white
matter exercise quicker motility than those situated in the grey matter [51, 133,
251, 267]. To account for this effect, in (5.3), we use a regulator term DWG(·) that
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is given by
DWG(x) = a+ (1 − a)
((





where 0 ≤ DG ≤ 1 is the grey matter regulator coefficient, ∗ is the convolution
operator [64], ψρ := ψ(x)/ρ
N denotes the standard mollifier defined in Appendix A.2
and g(x) and w(x) are the grey and white matter densities provided by the T1
weighted image (following an image segmentation process). Finally, 0 ≤ a ≤ 1 is a
parameter that distinguishes between different cases (see Section 5.5).
In addition, as in the previous chapters, the movement of the cancer cells is
further biased by various adhesion mediated process [49, 55, 115, 210, 292, 297].
Due to the increasing evidence that gliomas induce a fibrous environment within
the brain [88, 93, 125, 186, 209, 212, 221, 226, 285, 284, 305], in (5.1) we model the
overall adhesion process using a non-local flux term that was introduced in [245]
(see also Sections 2.3.1 and 3.2.1 as well as [17, 70, 81, 206, 247, 246, 265, 264]
for similar terms). Specifically, we explore the adhesive interactions of the cancer
cells at x ∈ Ω(t) with other neighbouring cancer cells, with the distribution of the
non-fibre ECM phase [84, 90, 91, 119] as well as with the oriented fibre ECM phase
[294, 295], all located within a sensing region B(x,R) of radius R > 0. For this, we
define the non-local flux term as









Sccc(x+ y, t) + Scll(x+ y, t)
)
+ n̂(y, θf (x+ y, t))ScFF (x+ y, t)
][




Although each term and notation has already been introduced in previous chapters,
here, for completeness, we redefine them as well. Hence, in (5.5) Scc, Scl, ScF > 0
are the strengths of the cell-cell, cell-non-fibre ECM and cell-fibre ECM adhesions,
respectively and while we take both Scl and ScF as positive constants, we consider the
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emergence of strong and stable cell-cell adhesion bonds to be positively correlated
with the level of extracellular Ca+2 ions (one of the non-fibre ECM component)
[94, 109]. Hence, following the approach in Chapters 2 and 3 as well as [245, 246,
247, 265, 264], we describe the cell-cell adhesion strength by
Scc(x, t) := Smin + (Smax − Smin) exp
[
1 − 1
1 − (1 − l(x, t))2
]
,
where Smin > 0 and Smax > 0 are the minimum and maximum levels of Ca
+2 ions.
Furthermore, in (5.5) we denote by n(·) and n̂(·, ·) the unit radial vector and the






if y ∈ B(0, R) \ {0},
0 if y = 0,
n̂(y, θf (x+ y)) :=

y + θf (x+ y, t)
∥ y + θf (x+ y, t) ∥2
if y ∈ B(0, R) \ {0},
0 if y = 0 or y = θf (x+ y, t),
respectively (for details on the fibre orientation θf see Section 2.2.2). Also, to
account for the gradual weakening of all adhesion bonds as we move away from the
centre point x within the sensing region B(x, t) in (5.5), we use a radially symmetric





, ∀y ∈ B(0, R),
where ψ(·) is the standard mollifier. Finally, in (5.5) a limiting term [1 − ρ(u)]+ :=
max(0, 1 − ρ(u)) is used to prevent the contribution of overcrowded regions to cell
migration [81]. For a schematic of this adhesion process, we refer the reader to
Figure 5.1a).
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Two phase ECM macro-scale dynamics
In addition to the cancer cell population, the rest of the macro-scale tumour dy-
namics are described by the two-phase ECM. Here, both fibres and non-fibres ECM
phases are assumed to be simply described by a degradation term due to the cancer
cell population. Hence, per unit time, their dynamics is governed by
∂F
∂t





where βF > 0 and βl > 0 are the degradation rates of the fibre and non-fibre ECM
phases, respectively.
The complete macro-dynamics
In summary, equations (5.1) for cancer cells dynamics and (5.6) for the two-phase
ECM dynamics lead to the following non-dimensional PDE system describing the























To complete the macro-scale model description, we consider zero-flux boundary con-
ditions and appropriate initial conditions (for instance the ones given in Section 5.5).
5.2.2 Micro-Scale Processes and the Double Feedback Loop
As we have mentioned it before, the cancer invasion process is genuinely a multi-
scale phenomenon, and so several micro-scale processes are closely linked to the
macro-scale dynamics [293]. Identically to Chapters 2 and 3, here, we consider
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two of these micro-processes, namely the rearrangement of the ECM fibres micro-
constituents [245] and the cell-scale proteolytic processes that occur at the leading
edge of the tumour [279]. Although the description of both micro-scale dynamics
follows identical steps as before, for completeness, in the following, we give a brief
outline of them.
Two-scale representation and dynamics of fibres
Since the underlying mathematics that describes the emerging fibres bottom-up link
remains the same as in previous chapters, i.e., we utilise the micro-scale fibre dis-
tribution f(z, t) within a fibre micro-domain δY (x) analogously to Section 2.2.2 to
calculate the amount of ECM fibres F (x, t) and their bias θf (x, t), we refer the
reader to Section 2.2.2 for details on these calculations. Also, a 3D illustration of a
micro-domain δY (x) and its corresponding macro-scale orientation θf (x, t) can be
seen in Figure 5.1b).
As opposed to Chapters 2 and 3, here we do not consider the presence of
macrophages that naturally influence the fibre rearrangement process (i.e., the fibres
top-down link), and so we need to adjust the equations accordingly. Since here we
consider one cell population, only the spatial movement of the cancer cells trigger a
rearrangement of ECM fibres micro-constituents on each micro-domain δY (x) (en-
abled by the secretion of matrix-degrading enzymes that can break down various
ECM proteins). Hence, using the fact that the fully anisotropic diffusion term can




= ∇·[DT (x)∇c+c∇·DT (x)], the fibre rearrangement
process is kicked off by the cancer cell spatial flux
Fc(x, t) := DT (x)∇c+ c∇ · DT (x) − cAc(x, t,u, θf ), (5.8)
which is generated by the tumour macro-dynamics (5.7). Then, at any spatio-
temporal point (x, t) ∈ Ω(t) × [0, T ] this flux (5.8) gets naturally balanced in a
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weighted fashion by the macro-scale ECM fibre orientation θf (·, ·), resulting in a
rearrangement flux
r(δY (x), t) := ω(x, t)Fc(x, t) + (1 − ω(x, t))θf (x, t), (5.9)
with ω(x, t) := c(x, t)/(c(x, t)+F (x, t)), that acts uniformly upon the micro-fibre dis-
tribution on each micro-domain δY (x). Ultimately, this macro-scale rearrangement
vector (5.9) induces a micro-scale reallocation vector νδY (x)(z, t) (see Section 2.3.2
for details), enabling us to appropriately calculate the new position z∗ of any micro-
node z ∈ δY (x) as
z∗ := z + νδY (x)(z, t). (5.10)
For further details on the micro-fibre rearrangement process, we refer the reader to
Section 2.2.2 and for illustration of the two links see Figure 2.5.
MDE micro-dynamics and its links
To explore the second micro-scale process that occurs along the invasive edge of
the tumour, we use the same approach as in Sections 2.2.2 and 3.2.2. Hence, we
consider a bundle of overlapping cubic of micro-domains {ϵY }ϵY ∈P(t), with ϵ > 0
being the size of each micro-domain ϵY , which allows us to decompose the overall
MDE micro-process, transpiring on
⋃
ϵY ∈P(t) ϵY , into a union of proteolytic micro-
dynamics occurring on each ϵY ; see also Figure 5.1c). Then, as before, denot-
ing the spatio-temporal distribution of the MDEs by m(y, τ) at any micro-point
(y, τ) ∈ ϵY × [0,∆t], we observe that the cancer cell population, located within an
appropriately chosen distance γh > 0 from y ∈ ϵY , induce a source h(y, τ) of MDEs
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c(x, t0 + τ) dy
λ(B(y, γh) ∩ Ω(t0))
y ∈ ϵY ∩ Ω(t0),
0 y /∈ ϵY \ (Ω(t0) + {z ∈ Y | ∥z∥2 < ρ}),
(5.11)
where 0 < ρ < γh is a small mollification range and B(y, γh) denotes the ∥ · ∥∞ ball of
radius γh centred at a micro-node y. Since again, the calculation of this micro-scale
MDE source (5.11) directly involves the macro-scale cancer cell population c(·, ·),
we observe a naturally arising MDE top-down link that connects the macro-scale to
the MDE micro-scale. Then, we can use the same MDE micro-dynamics on each
ϵY defined in (2.15) as well as use the same procedure, detailed in Section 2.2.2,
to acquire the movement direction and magnitude of a tumour boundary point
x∗ϵY within the peritumoral area covered by the associated boundary micro-domain
ϵY . Ultimately as before, this causes a boundary movement, and as a consequence
we obtain a new evolved tumour macro-domain Ω(t0 + ∆t), the link of which we
refer to as the MDE bottom-up link. For illustration of the boundary movement we
refer the reader to Figure 5.1c), for further details of the MDE micro dynamics see
Section 2.2.2 and for illustration of the two links see Figure 2.5.
5.3 Numerical Approach
In this section, we aim to give a description of the numerical approach that we use to
solve the macro-scale dynamics (5.7), and for details on the numerical approach used
for the MDE micro-scale dynamics we refer the reader to Chapter 2. Here, we use the
method of lines approach to discretise the macro-scale tumour dynamics (5.7) first in
space, and then, for the resulting system of ODEs, we employ a non-local predictor-
corrector scheme [245]. In this context, we carry out the spatial discretisation on a
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uniform grid, where both spatial operators (fully anisotropic diffusion and adhesion)
are accurately approximated in a convolution-driven fashion. First, we note that the
















which enables us to use a combination of two appropriate distinct schemes for an
accurate approximation. While for the diffusive part in (5.12), we use the symmet-
ric finite difference scheme [76, 85], for the combination of the advective (5.12) and




Ac(x, t,u, θf ) + ∇ · DT (x)
)]
) we use the stan-
dard first-order upwind finite difference scheme which ensures positivity and helps
avoiding spurious oscillations in the solution. Finally, to approximate the adhesion
integral Ac(x, t,u, θf ), we consider an analogous approach to Chapter 2, but instead
of Ns well-placed barycentric points bSν , here, we use Ns random points located
within the sensing region B(0, R) and sums of discrete-convolutions.
To facilitate the narrative, we first introduce some basic notations. For our
purposes, it is adequate to discretise the computational domain Y ∈ R3 uniformly in
each direction of step-size ∆x, allowing us to represent the discretisation of Y by the
macro-spatial nodes {xi, xj, xk}i,j,k=1,...,N , with N = length(Y )/∆x + 1. Besides, at
any time-step n we denote the three-dimensional tumour vector by un = [cn, F n, ln]⊺































5.3.1 Diffusion operator: ∇ · [D(x)∇u]
To approximate the anisotropic diffusion operator (∇ · [D(x)∇u]) in (5.13), we fol-
low [76, 85] and use the symmetric finite difference scheme as well as present its
convolutional form. As before, we aim to split the tumour domain and diffusion
operator into two parts (interior and boundary) so that we can use two different
computational technique that ultimately reduces the computational time. For this,
we use the indicator functions IB(·, ·) and IIn(·, ·) introduced in (2.34) and (2.35),
respectively. Hence, at any spatial node (i, j, k) at time-step n, the spatial diffusion















if InB(i, j, k) = 1,
0 otherwise.
(5.14)
In this context, the symmetric finite difference scheme [76, 85] goes as follows. First,
we need to approximate the tumour gradients at the centre points (see Figure 5.2a)
for visual representation) that we do by
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 a)  b)
Figure 5.2: Illustration of a) the approximation of the gradient at one of the center
point (i+ 1/2, j + 1/2, k + 1/2), b) the approximation of the divergence using the 8











































































Then since our aim is to use convolution for interior nodes, we note that these
gradients (5.15) can be equivalently represented by discrete convolutions, i.e.,
(ux)
n =































±1/2,±1/2,±1/2 and Kz±1/2,±1/2,±1/2 is
appropriately constructed, using the usual representation (5.15) of the scheme. The
next step is to also approximate each component (d, p) ∈ Q×Q, with Q := {x, y, z},
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at the centre points which we do via the midpoint rule. Therefore, considering an




























and similarly for the remainder (Dmid)d,pi±1/2,j±1/2,k±1/2. On the other hand, such
approximation can also be written by using discrete convolutions, hence we can
approximate each entry of Dmid at the centre points by
(Dmid)d,p =








where again we can appropriately construct the 3 × 3 × 3 matrices KD±1/2,±1/2,±1/2,
by using the usual formula for the midpoint rule. The final step in the scheme is to











































where we note that each (Dmid)i±1/2,j±1/2,k±1/2 is a 3 × 3 matrix, which ultimately
allows us to approximate the divergence of the flux with the usual central difference
formula. Consequently, the approximation of the diffusion term at any boundary
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where the set of numbers is defined as W := {+1/2,−1/2} and FxD, F
y
D and F zD
denotes the x, y and z component of the flux (5.19), respectively. The involved
center points in (5.20) are illustrated in Figure 5.2b. However, since (5.20) is the
approximation of the anisotropic diffusion at the boundary nodes, it is inevitable
to use ghost/outside nodes during the calculations. Since these are outside of the
tumour domain Ω(tn) we need to approximate their values, that we do by symmet-
rically reflect the values of the interior nodes to these ghost node in a node by node
fashion. In some cases, due to the possibly irregular tumour domain, such values
may not be uniquely defined since two different boundary nodes can use the value
of the same ghost point, however because of the reflection this value may be dif-
ferent for the two boundary nodes. Hence, for the boundary points we cannot use
universal operators (convolution) and we need to approximate the diffusion with the
usual form (5.20) in a node by node fashion. On the other hand, for interior nodes
we do not have such restriction since the approximation of the diffusion at these
nodes involves only known values and so here it is appropriate to use convolution
(universal operator). Therefore, for all interior nodes, the convolutional form of the
185





































where ◦ is the Hadamard product [87] and q is defined as
q :=

















5.3.2 Adhesion-advective operator: ∇ · F(u)
To approximate the second spatial operator that describes cell movement ∇ ·F(u),
we simply use the first order upwind scheme which helps avoiding spurious oscilla-
tions and guarantees positivity. Once more, we split the domain and spatial opera-
tor into two parts (interior and boundary) using the indicator functions IB(·, ·) and
IIn(·, ·) defined in (2.34) and (2.35), respectively. Hence, we note that the spatial















if InB(i, j, k) = 1,
0 otherwise,
(5.22)
and as before, we aim to use a convolutional form for the interior nodes and the
standard (non-convolutional) form for the boundary nodes. In this context, for any
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where a+ and a− are defined as
a+ := max(F(u), 0), a− := min(F(u), 0), (5.24)




y are the x, y and z components as well as Fx, Fy and F z are
the x, y and z components of the vector field F , respectively. Within the formula
defined in (5.23), we may need to use the value of outside/ghost nodes, that as
before, we approximate by symmetrically reflecting the value of the interior nodes
to these outside nodes in a node by node fashion.
On the other hand, we can observe that (5.23) can be written as sums of convo-
lutions for any interior node (i, j, k) (since we only use nodes that are located within



















where Q := {x, y, z} and each K is defined as
















where we note that K±z are (1x1x3) matrices. This completes the description of the
convolution driven upwind scheme that is used for the approximation of the spatial
operator ∇ · F(u).
5.3.3 Adhesion integral: Ac(x, t,u, θf)
To model the various adhesion processes (cell-cell, cell-non-fibre ECM and cell-fibre
ECM), that take place within the sensing region x+B(0, R), we employed an integral
form (5.5) in the macro-scale dynamics (5.13). To numerically approximate this
integral, we use a quasi-random sequence of Ns = P
3 points pν , with ν = 1, . . . , Ns
and P = ⌈2R/∆x⌉+1. Here, these off-grid quasi-random points are similar and play
the same role as the off-grid barycentres bS(·) used in previous chapters, however,
their position within the sensing region B(0, R) are different. Hence, considering
the minimal cubic region of macro-nodes {yxl,m,n}l,m,n=1,...,P that covers the entire
sensing region B(0, R), we note that these quasi-random points pν are positioned





l+1,m,n] × [yxl,m,n, yxl,m+1,n] × [yxl,m,n, yxl,m,n+1]
contains exactly one of these quasi-random points, i.e., pν ∈ Sν whose position is
generated uniformly. Then, this enables us to approximate the adhesion integral
(5.5) as the sum of the integrals of the step functions associated with each cube Sν .
Furthermore, we observe that these cubes Sν are on-grid cubes, and so we know the
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values of the cancer cell density, both ECM components and the fibre orientations
at the corner points, which we can utilise to approximate the values at the quasi-
random points pν by using bi-linear shape functions. Thus, each value, at point pν ,
is approximated by a convex combination of the on-grid neighbouring points, i.e.,
by the corners of Sν , with uniquely determined weights β
r
ν , r = 1, . . . , 8. Hence,
here we approximate the value of each step function by the value at its associated
random point pν .
Since we seek to use convolutions, we need to construct Ns different matrices
(one for each cube Sν), using the uniquely determined weights β
r
ν . Considering an
arbitrary cube Sν , its associated matrix K̃νA entries are defined as
(K̃νA)w1,w2,w3 :=

β1ν if (w1, w2, w3) = (P − l, P −m,P − n),
β2ν if (w1, w2, w3) = (P − l − 1, P −m,P − n),
β3ν if (w1, w2, w3) = (P − l, P −m− 1, P − n),
β4ν if (w1, w2, w3) = (P − l, P −m,P − n− 1),
β5ν if (w1, w2, w3) = (P − l − 1, P −m− 1, P − n),
β6ν if (w1, w2, w3) = (P − l − 1, P −m,P − n− 1),
β7ν if (w1, w2, w3) = (P − l, P −m− 1, P − n− 1),
β8ν if (w1, w2, w3) = (P − l − 1, P −m− 1, P − n− 1),
0 otherwise.






where the set Pin contains the indices whose associated quasi-random point is located
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In Table 5.1, we summarise the parameter values that will be used in the presented
numerical simulations in the upcoming section.
Table 5.1: Parameter set used for the numerical simulations in this chapter. If we
could not find any references for some of our parameters then we “Estimated” them
(i.e., we chose an arbitrary value for the simulations).
Variable Value Description Reference
Dc 1.25× 10−4 Diffusion coeff. for the cancer cell population [202]
DG 0.25 Grey matter regulator coefficient Estimated
r 0.1 Degree of randomised turning [202]
a 0 Model switching parameter Estimated
KFA 100 Cell’s sensitivity to the directional information [202]
Smax 0.5 Cell-cell adhesion coeff. [245]
Smin 0.01 Minimum level of cell-cell adhesion [265]
Scl 0.01 Cell-non-fibre adhesion coeff. [245]
ScF 0.3 Cell-fibre adhesion coeff. [70]
µ 0.25 Proliferation coeff. for cancer cell population [70]
βF 1.5 Degradation coeff. of the fibre ECM [264]
βl 3.0 Degradation coeff. of the non-fibre ECM [264]
β 0.8 Optimal tissue environment controller [279]
Continued on next page
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Table 5.1 – continued from previous page
Variable Value Description Reference
R 0.15 Sensing radius [245]
fmax 0.636 Maximum of micro-fibre density at any point [245]
∆x 0.03125 Macro-scale spatial step-size [279]
ϵ 0.0625 Size of a boundary micro-domain ϵY (x) [279]
δ 0.03125 Size of a fibre micro-domain δY (x) [245]
Ns 450 Number of random points used for the Estimated
approximation of the adhesion integral Ac
∆t 10−3 Macro-scale temporal step size Estimated
∆τ 10−4 MDE micro-scale temporal step size Estimated
5.5 Computational Results: Numerical Simula-
tions in 3D
For the numerical simulations presented in this paper, we consider the tissue cube












and for the non-fibre ECM phase, the initial condition l(x, 0) is acquired by appro-
priately scaling the T1 weighted image via a normalising constant. Current DTI
scans do not provide suitable resolution to determine the underlying micro-fibre
distributions, and so here, we describe the initial micro-fibre distribution within a
micro-domain δY (x) as follows. When the macro-scale point x that corresponds
to the micro-domain δY (x) is located in the grey matter, then within δY (x) we







Figure 5.3: Schematics of the initial condition of the micro-fibres (blue lines) within
a micro-domain δY (x) of orientation θf (x, t) located in the a) white matter and in
the b) grey matter.
the points that do not belong to the collection of lines is about 35% : 65%. On
the other hand, when the point x is located within the white matter, we use a set
of predefined lines with the same point ratio (35% : 65%), ultimately achieving a
random orientation within the grey matter and an aligned orientation within the
white matter [225]. Finally, the grey matter’s fibre density is assumed to be 1/DG
times smaller than the density in the white matter [225]. A schematics of this initial
condition for the micro-fibres can be seen in Figure 5.3. Hence, we also incorporate
the information about the white and grey matter tracks provided by the T1 weighted
image into our micro-scale fibre distribution.
5.5.1 Numerical Simulations in 3D
Here, we present the 3D numerical solutions of the multi-scale model described
above, for the parameter values listed in Table 5.1 in Appendix 5.4 (any alteration
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from these values will be stated accordingly). To display the advanced tumours at
time 50∆t, we show four panels for each simulation results. In the first three panels
we show the three classical cross-section planes i.e., the coronal plane (the head
of the subject is viewed from behind), the axial plane (the head of the subject is
viewed from above) and the sagittal plane (the head of the subject is viewed from
the left). In the last panel of each simulation we show the 3D image of the brain
with the embedded tumour alongside the 3D tumour in isolation.
The three Figures shown below investigate tumour evolution when the initial
tumour starts in different regions of the brain. To present the simulations, we
divide each result into four panels: coronal, axial, sagittal and 3D view. Within
each coronal, axial and sagittal views, we show the tumour embedded within the
brain on the left, the cancer cell density on the top-right and the ECM density on
the bottom-right. In the 3D view (the most right panel in each results) we show the
cross-section of the whole brain with the tumour on the bottom-left corner and on
the top-right corner we show the isolated tumour.
In Figure 5.4 we present three distinct cases obtained by varying different param-
eters that appear in the tumour diffusion tensor DT (x) defined in (5.3). In Figure 5.4
a) we assume that the tensor DT (x) depends on the white-grey matter and for that
purpose we set r = 1 in (5.3) and a = 0 in (5.4); this results in isotropic tumour
diffusion. In Figure 5.4 b) we use the DTI data (i.e., there is no a-priory assumption
about the preferential direction for cell movement in white matter) and thus we set
a = 1 in (5.4) (with r = 0.1, as in Table 5.1); this results in an anisotropic diffusion
that does not depend explicitly on the white-grey matter. In Figure 5.4 c) we use
both DTI data and the white-grey matter dependency (i.e., r = 0.1 and a = 0),
with the baseline parameters from Table 5.1. Here, it is worth mentioning that even
though we do not use the T1 weighted image to obtain functions w(x) and g(x)
that appear in DWG (as DWG = 1 in Figure 5.4 b), since a = 1) we still use the T1
weighted image to initialise the micro-scale non-fibre initial density as well as the
193
initial micro-scale fibre distributions as described above.
In all these simulations shown in Figure 5.4, we place the small initial tumour in the
middle-right part of the brain, and we show the results of the three cases at time
50∆t where we observe significant tumour morphology changes across the three
cases. By comparing Figure 5.4 a) to b) and Figure 5.4 b) to c), we see that when
we include the white-grey matter dependency function DWG within the tumour dif-
fusion tensor it leads to a more advanced tumour. On the other hand, comparing
Figure 5.4 a) to c) shows that including the DTI data, which creates an anisotropic
tumour diffusion term, leads to a slight reduction in tumour spread. Furthermore,
in all three cases, we can notice that the advancing tumour tends to mostly follow
the white matter tracks and usually avoids the invasion of tissues located in the grey
matter. This invasion resulted in the degradation (and rearrangement) of the ECM
that we can see in the bottom-right of each panel (coronal, axial and sagittal) which
enabled the tumour to further expand into the surrounding tissues.
In Figure 5.5 we keep the same three cases as in Figure 5.4, i.e., Figure 5.5 a)
only white-grey matter dependency, Figure 5.5 b) only DTI data and Figure 5.5
c) both. However, here we place the initial tumour in the front-right part of the
brain and show the results of tumour invasion at the final time 50∆t. Due to the
initial position of the tumour, we can see a tumour that is growing away from
the skull towards the centre of the brain as well as it is mainly following the white
matter. This creates a highly heterogeneous elongated tumour with many branching
outgrowths. On the other hand, in Figure 5.5 we only see slight differences between
the three cases. This contradicts the results from Figure 5.4 and suggests that both
the DTI data and white-grey matter dependency may not always be decisive factor
in tumour morphology.
Similarly to Figure 5.4 and Figure 5.5, in Figure 5.6 we keep the same three
cases (Figure 5.6 a) only white-grey matter dependency, Figure 5.6 b) only DTI
data and Figure 5.6 c) both) while we place the initial tumour mass in the middle
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Figure 5.4: 3D computer simulation results a) with only white-grey matter depen-
dency (r = 1), b) with only DTI data used (DG = 1) c) with both white-grey matter
dependency and DTI data incorporated. To present the simulations, we divide each
result into four panels: coronal, axial, sagittal and 3D view. Within each coronal,
axial and sagittal views, we show the tumour embedded within the brain on the left,
the cancer cell density on the top-right and the ECM density on the bottom-right. In
the 3D view (the most right panel in each results) we show the cross-section of the
whole brain with the tumour on the bottom-left corner and on the top-right corner
we show the isolated tumour.
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Figure 5.5: 3D computer simulation results a) with only white-grey matter depen-
dency (r = 1), b) with only DTI data used (DG = 1) c) with both white-grey matter
dependency and DTI data incorporated. To represent the simulation results, we use
the same format as in Figure 5.4.
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Figure 5.6: 3D computer simulation results a) with only white-grey matter depen-
dency (r = 1), b) with only DTI data used (DG = 1) c) with both white-grey matter
dependency and DTI data incorporated. To represent the simulation results, we use
the same format as in Figure 5.4.
of the brain and present the results at time 50∆t. As a consequence of the initial
location, we see a ”butterfly” shaped tumour that branched to both the left and
right side of the brain with some asymmetry. Also, as in Figure 5.5 we can see
that all three cases are quite similar, and so the additional information provided by
both the DTI data and white-grey matter dependency seems to be unnecessary for
this initial condition. However, we must note that the initial conditions (fibre and
non-fibre ECM) still uses the information provided by the T1 weighted image, and
so here, we only investigate the effect of changing the diffusion tensor.
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As we mentioned, we see significant differences between the three cases only in
Figure 5.4. This either indicates that the anisotropic diffusion tensor provides valu-
able information only in certain cases or that the initial micro-fibre density differs
from the one that produced the DTI scan (i.e., the actual distribution). Since we use
an artificial micro-fibre structure that does not depend on the DTI scan which also
aid the movement of the cancer cell population via the adhesion integral Ac(·, ·, ·, ·)
defined in (5.5), it is possible that in this specific case the micro-scale fibre distri-
bution introduced a significantly different travelling direction than the DTI data,
resulting in discrepancies between the simulations. However, due to the resolution of
current DTI scans, it is not possible to construct a unique fibre distribution within
a micro-domain δY (x). Hence, to genuinely capture the underlying brain structures
that we can use within a mathematical model, our results suggest that DTI scans
with their present resolution may not be sufficient, and one might need to look into
either obtaining better resolution DTI scans or combine this with the strength of
different technologies such as magnetic resonance elastography. Nonetheless, this
exceeds the current scope of this work and requires further investigation.
5.6 Discussion
In this chapter, we have further extended the 2D multi-scale moving-boundary
framework previously introduced in Chapters 2 and 3 as well as in [279, 245], by
developing it to 3D and applying it to the study of glioma invasion within the brain.
Since experiments are limited within the brain, we focused on incorporating DTI
and T1 weighted scans into our framework to provide insights into the structure of
the brain, the tumour, and the surrounding tissue.
The original framework developed in [279, 245] modelled a generic tumour in a
2D setting, and so to model gliomas within a 3D brain, we extended this modelling
approach by considering the structural information provided by both DTI and T1
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weighted scans. We used both DTI and T1 weighted scans to construct the tumour
diffusion tensor DT (x) defined in (5.3), which resulted in a fully anisotropic diffusion
term. While the T1 weighted image can give different diffusion rates based on
whether the cancer cells are located in the white or grey matter, the DTI data
is used to incorporate the underlying brain structure and to give higher diffusion
rates along specific directions based on how the measured water molecules behaved
within the brain. The T1 weighted image, which provided the white-grey matter
densities, were also used in our initial conditions for both ECM phases. Hence, the
initial density of the non-fibre ECM phase was taken as a normalised version of
the T1 weighted image, and the initial condition of the micro-fibre distribution and
magnitude were also considered to be dependent on the white-grey matter structure.
Furthermore, as the available DTI scans lack the adequate resolution required to
construct more appropriate micro-fibre distributions, in this chapter we considered
a simple case where we set the fibre distributions to be either random or oriented
based on whether they are positioned in the grey or white matter, respectively.
Therefore, compared to other previous 3D models such as those in [75, 116, 202],
here we can explicitly capture the underlying tissue structure changes via the micro-
fibre rearrangement process and trace how the boundary of the tumour changes
over time. Moreover, the cancer cells’ movement is not only influenced by the T1
weighted and DTI scans (through an anisotropic diffusion term) but also biased by
crucial non-local adhesions such as cell-cell and cell-fibre ECM adhesion the latter of
which is naturally interconnected to the tissue structural changes. Hence, our model
presents a novel approach that can incorporate several vital processes for tumour
development and have not been available in other previous models. This allowed
us to produce exciting and valuable results/outcomes which provide further insights
into the overall tumour development process.
To that end, we used this new 3D model to explore the effects of the anisotropic
diffusion term for the cancer cell population. Our numerical simulations in Figure 5.4
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showed that including an anisotropic diffusion term may lead to significant changes
in the overall tumour morphology. However, it seems that these changes depend on
the position of the tumour inside the brain, as Figures 5.5 and 5.6 do not exhibit
changes consistent to the ones observed between the three sub-panels of Figure 5.4.
This may be the result of the underlying brain structure and its microscopic fibre
representation, which seems to take a leading role in influencing cancer-invasion
patterns through the underlying cell-adhesion process (see Eq. (5.5)), overshadowing
this way the diffusion process. More precisely, the simplified fibre representation
might not be sufficient for Figure 5.4, where the initial tumour was positioned in
the right-middle part of the brain. However, this fibre representation might be
enough for Figure 5.5 (with tumour positioned in the front-right of the brain) and
for Figure 5.6 (with tumour positioned in the middle of the brain), where we did not
see significant morphological differences between the three sub-panels considered in
each of these figures.
To conclude this chapter, we mention that further investigation is needed to de-
termine whether these changes in tumour invasion patterns are caused by the lack of
directional information on the fibre micro-scale level or an anisotropic diffusive cell
motility is necessary to better represent the invasion process. A feasible approach
would also be to use a new imaging technology called magnetic resonance elastog-
raphy, but this is beyond the scope of this thesis. Nonetheless, these results are not
only interesting and important from a mathematical modelling point of view but
from a medical one as well. For instance, we showed how different model param-
eters change the evolution of the tumour boundary, this being a vital and desired
information in any clinical/medical decision-making process. Such a model with
tuned parameters (to specific patients) could help, for example, decide the optimal
amount of tissue to resect so that the chance of survival is maximised.
Finally, as our simulations are able to reproduce known tumour patterns of
growth seen clinically, future experiments will be refined by MRI data collected
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prospectively from glioma patients and also incorporate the effects of their radio-




The main purpose of this thesis is to further develop and propose new extensions of a
multi-scale moving boundary modelling framework initially introduced in [245, 279]
with the aim to investigate tumour invasion patterns and how tumour aggregations
respond to different TME compositions, tissue scenarios and cell properties. For
this, we used both fully continuous and hybrid mathematical modelling frameworks
that enabled a comprehensive insight into the underlying relationships and how
these affect the overall tumour development process. On the one hand, the fully
continuous multi-scale moving boundary framework was based on the one initially
introduced in [279] to account for the proteolytic processes occurring at the leading
edge of the tumour and later expanded in [245] to account for the fibrous struc-
ture of the ECM. Hence, here, both the tumour macro-scale (tissue-scale) and the
two micro-scale (cell-scale) dynamics were modelled using continuous approaches
(for example, coupled system of partial differential equations) which are ultimately
interlinked though a double feedback loop. On the other hand, in the hybrid multi-
scale framework, we used an agent-based lattice free method to model the cancer
cells population that was based on the model derived in [27, 128, 135] as well as
used the continuous multi-scale two-phase ECM which was developed in [245] (that
we also used for our continuous framework). Thus, here, we have a feedback loop
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between the micro-fibre structure and the cancer cell population as well as several
communication channels between the discrete and continuous frameworks.
In Chapter 2, we built upon the multi-scale moving boundary framework [245,
279] to investigate how the directional movement of the M2-like macrophages af-
fect the overall tumour progression and morphology. To that end, we considered a
tumour macro-scale dynamics that consist of two cell populations (cancer cell and
M2 TAMs) and two ECM phases (fibre and non-fibre) and which is interlinked to
both fibre and MDE micro-scales. To model the macro-scale dynamics of the M2
TAMs population, we considered their motility to be given by a mixture of random
and directed movements, where the latter was described by the combination of self,
ECM fibre and cancer cell (non-local) adhesions. The rest of the M2 TAMs dy-
namics consisted of a fibre and cancer dependent proliferation term, a linear death
term and an influx term which aimed to model a constant M2 TAMs supply on the
outer tumour boundary. Furthermore, we considered a few effects of these M2-like
macrophages exerted on the rest of the dynamics such as cancer-macrophage adhe-
sion and the regularisation of cancer cell proliferation. Due to their ability to secrete
MDEs, both cell populations naturally contribute to the proteolytic processes taking
place at the leading edge of the tumour, and so this MDE top-down link is modelled
via an emerging source of the MDEs on the micro-scale. Consequently, this results
in a degradation of the peritumoral ECM within a cell-scale neighbourhood of the
tumour that ultimately leads to an expanded tumour macro-scale domain which we
refer to as the MDE bottom-up link. On the other hand, the second feedback loop
arise from the redistribution of the ECM fibres micro-constituents initiated by the
movement of both cell populations. Hence, here, the spatial fluxes (generated by the
cancer cell and M2 TAMs populations) trigger a rearrangement of the ECM fibres
micro-constituents which is called the fibre top-down link. As a consequence, the
rearranged micro-fibre distribution changes the macro-scale density and orientation
of the fibres ECM which is referred to as the fibre bottom-up link.
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Therefore, in this chapter, we addressed the lack of knowledge about the effects
of the directional movement of the M2 TAMs on the overall tumour development,
and so we used this extended model to investigate some hypotheses on tumour
spread connected to the M2 TAMs population. First, we explored whether the
various M2 TAMs adhesions can significantly enhance tumour spread individually,
and concluded that although none of them are capable of increasing it alone, they do
introduce a few changes in tumour morphology. However, we showed that utilising
all these different adhesion terms within the M2 TAMs equation at once, leads to
an increase in tumour spread. Then, we shifted our attention to the fibre ECM
phase and studied how its density and the M2 TAMs-fibre ECM adhesion strength
affect the tumour development. Here, the numerical simulations suggested that
reduced fibre density decreased tumour spread and that the M2-fibre adhesion played
only a minor role and did not influence tumour progression notably. Finally, we
also investigated the effects of the underlying ECM fibre structure by considering
unstructured, random oriented fibres which revealed a dramatically reduced tumour
spread but it did not propose any new properties.
Building on Chapter 2, in Chapter 3, we extended our multi-scale modelling
framework and also incorporated the pro-inflammatory M1-like macrophages as well
as the nutrients, to study multiple properties of a possible re-polarisation based
treatment strategy. Hence, the macro-scale dynamics included three cell populations
(cancer, M1 and M2 TAMs), two ECM phases (fibres and non-fibres ECM) and the
nutrients, most of which influence both micro-scale dynamics (fibre and MDE micro-
scales). On the one hand, to model both macrophage phenotypes, we considered
their movement to be described by a combination of random motility given by a
diffusion term with non-constant coefficient, and directed movement described by
a non-local adhesion term. The rest of the TAMs dynamics consisted of a cancer,
fibre and nutrient dependent proliferation term, a nutrient dependent death term,
a nutrient dependent polarisation and a re-polarisation terms. Moreover, we also
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considered the nutrients to influence the cancer cell population via the proliferation
as well as death terms, latter of which is affected by the M1-like macrophages as
well. Since M1-like macrophages also secrete various MDEs, they also contribute to
the degradation of the two ECM phases on both macro- and micro-scales, which we
incorporated into this model accordingly.
Using this extended model allowed us to study whether a re-polarisation (M1↔M2)
based treatment strategy is temporal, spatial and/or nutrient dependent. First, we
studied the spatial dependency of the re-polarisation for which we considered the
re-polarisation domain Ωp(t, Rp) with various radii Rp. Here, our numerical results
suggested that although tumour spread does not seem to be highly affected by the
re-polarisation, tumour spread can be dramatically reduced especially in the case of
Rp = 0, i.e., when we re-polarise M2 TAMs within the whole tumour domain. Then,
we also explored the temporal aspect of the re-polarisation by varying the start time
parameter tp, where our numerical simulations suggested that although the most op-
timal time to start the re-polarisation is as early as possible, even for later times the
tumour mass can be significantly reduced. Finally, we also explored whether these
results were impacted by the nutrients, and so we presented the same numerical
results in the absence of nutrients. Here, we noticed changes within the distribution
of the three cell population, suggesting that the varying level of nutrients within the
different tumour regions induce more heterogeneous cell populations, that might be
of great importance for other models that use the information of how cell popula-
tions are distributed within a region (for example tumour region). However, the
fundamental results of the spatial and temporal dependencies achieved previously
(in the presence of nutrients) remained unchanged. All these results were consistent
for three tumour types (that differ in MDE secretion rate) and within three ECM
environment (controlled by the parameter β).
Furthermore, in Chapter 4, we developed a hybrid multi-scale model that enabled
us to investigate the emerging shape of tumour aggregations and their migration
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types. On the one hand, we described the cancer cell population with a discrete
Multi-Cell Lattice-Free model that allowed us to assign different properties for each
individual cells such as position, radius and age as well as track the forces that
act on each cell, for instance, repulsion, cell-cell adhesion and cell-ECM adhesion
forces. Hence, the migration of these cells is biased by both the neighbouring cells
and ECM fibre structure that ultimately drives the overall movement of tumour
aggregations and in some cases leads to non-stationary tumours. On the other
hand, we used the same continuous multi-scale two-phase ECM that we used in
Chapters 2 and 3 which enabled us to model various ECM structures and how these
affect tumour aggregations. As before, since cancer cells are capable of degrading
and rearranging the ECM, we modelled the interaction with the same feedback
loop that we described and used in Chapters 2 and 3. Hence, the movement of
cancer cells naturally trigger a rearrangement of micro-fibres (fibres top-down link)
which in turn, changes the macro-scale ECM structure (fibres bottom-up link) and
consequently influence cell migration. To provide sufficient communication between
the two frameworks, we ensured that connections between the two are established
at stages where one require any information from the other.
Using numerical simulations of this hybrid model, we tested a number of scenar-
ios which provided further insights into the different processes and cell properties
that can significantly impact the overall tumour shape. Specifically, we have demon-
strated that our hybrid model is capable of creating both stationary tumours in the
case of random ECM micro-fibre distribution and moving tumour aggregations when
we consider an aligned fibre distributions which are consistent with experimental re-
sults. Another interesting property of our model is the ability to produce fibre
aggregations at the tumour boundary with a capsule-like orientation that can ulti-
mately limit tumour invasion which are also consistent with biological experiments.
We suggested that using some existing technology for visualising collagen could po-
tentially aid treatment decisions since this could be used to predict the speed of
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tumour in a patient specific environment. Hence, for example, such visualisations
can aid in deciding how much of the surrounding tissue should be removed which
could be further combined with mathematical simulations to improve predictions.
Finally, we identified some key parameters and their combinations that can impact
tumour shape such as sensing radius and ratio of fibres and non-fibre ECM as well
as we carried out an extensive set of simulations with different parameter values to
show different tumour behaviours.
Finally in Chapter 5, we extended our 2D continuous multi-scale moving bound-
ary framework to a 3D one and applied to a specific type of brain tumour, i.e.,
glioblastomas to study the role of brain micro-fibres. Hence, the model consisted of
a macro-scale dynamics, including a cancer cell population and a two-phase ECM as
well as the two micro-scale dynamics (fibres and MDE). While we kept the underly-
ing principles of the two-micro scale dynamics, on the macro-scale, we incorporated
3D T1 weighted and DTI scans to describe the movement of the cancer cells (via an
anisotropic diffusion term) in addition to the adhesion-mediated one.
Using numerical simulations of this extended 3D model, we explored how the
anisotropic diffusion term affects the cancer cell motility and the way brain micro-
fibres influence the 3D invading tumour. Our numerical results showed that includ-
ing an anisotropic diffusion term for specific micro-fibre distributions may lead to
significant changes in the overall tumour morphology, while in other cases this ef-
fect may be smaller or neglectable and may be dependent on the initial position of
the tumour. We argued that this may be caused by the underlying brain structure
and its microscopic fibre representation, which seems to take the primary role in
affecting cancer-invasion patterns through the underlying cell-adhesion process that
ultimately overshadows the diffusion process. Hence, our simplified initial condition
for the ECM fibres might not be adequate in some cases.
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6.1 Possible Extensions and Future Works
Looking forward, there are several ways to extend this multi-scale modelling frame-
work. First, as it was already mentioned, macrophages are also present in the tu-
mour stroma because they arrive to the sites through the vasculature as an immune
response. Since in Chapters 2 and 3 we only studied the effects of macrophages lo-
cated within the tumour, this could be extended by also incorporating peritumoral
macrophages. This aspect may be of great importance, for example, because of the
accumulated non-aligned ECM at the tumour boundary which is known to limit
tumour progression (that we also demonstrated in Chapter 4). Since macrophages
are capable of secreting MDEs, and so breaking down ECM components, they may
degrade these accumulated ”collagen fibre walls” and as a consequence they free the
cancer cells, leading to faster tumour spread. However, a higher M1 TAMs density
in the peritumoral regions could also result in a reduced tumour spread and even
fully stop tumour progression since the M1 phenotype has the ability to kill cancer
cells, and so they could potentially kill them before they invade further into the
surrounding tissues.
Another type of cell that can change the micro-scale structure of the ECM is
called the fibroblasts. While these cells can highly remodel their surrounding ECM,
they can also secrete significant amounts of collagen along their long axis, thereby
creating a more aligned ECM [38, 211, 235] which are vital in many biological
processes such as wound healing. However, these properties can also be critical in
tumour development since they can penetrate those collagen fibre walls (mentioned
in the previous point) and set the cancer cells free, resulting in faster tumour spread.
Besides, by producing aligned collagen fibre bundles, fibroblasts could also create an
aligned pathway of fibres toward vasculatures which would increase the probability
of metastasis as well [187]. Hence, incorporating these type of cells could also be of
great significance and could lead to further insights and knowledge about tumour
development.
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In addition to these two previous points, one could further extend this modelling
framework by introducing a network of blood vessels along with vascular endothelial
growth factors to model the evolution of the tumour vasculature and its effect on
the tumour development. This network could also be used as the supply for the
macrophage population (since at the moment the supply of macrophages is modelled
via a constant influx on the boundary), which would create further heterogeneity
within the various cell populations.
Finally, different therapy options could be incorporated into this multi-scale
framework. On the one hand, drug and chemotherapy deliveries could be added
that naturally follow the non-fibre ECM phase and investigate the effects of these
treatments on the proteolytic processes and how they affect the spread and mass of
the tumour. On the other hand, one can add a macrophage-mediated drug delivery
treatment option since macrophages are abundant in the TME and are known to
penetrate the tumour effectively. Hence, macrophages could be used to deliver vari-
ous drugs into each layer of the tumour, potentially leading to further advancements




A.1 Definition of the Outer Boundary
Let x ∈ ∂Ω(t). Then, x ∈ ∂Ωo(t) if and only if there exists ϕx : [0,∞) → Rd such
that the following four properties hold true simultaneously:
1) ϕx(0) = x,
2) ϕx(s) ̸= x, ∀s ∈ (0,∞),
3) Imϕx \ {x} ⊂ ∁Ω(t),
4) lim
s→∞
dist(ϕ(s), ∂Ω(t)) = ∞,
where ∀ s ∈ (0,∞), we have dist(ϕ(s), ∂Ω(t)) := inf
z∈∂Ω(t)
∥ ϕ(s) − z ∥2 and represents
the Euclidean distance from ϕ(s) to ∂Ω(t).
210
A.2 Standard Mollifier (The Compact Support
Function)
The smooth compact support function ψ : Rd → R+ used for the construction of













∥ z ∥22 −1
)
dz
if x ∈ B(0, 1),
0 if x /∈ B(0, 1).
(A.1)
A.3 Hadamard Product and Frobenius Inner Prod-
ucts
The Hadamard product of two square matrices A and B of the same dimensions, is
the matrix entry-wise product that is defined by
(A ◦B)i,j = Ai,j ·Bi,j,
which we use to derive our numerical scheme.
The Frobenius norm of an n by m matrix A, is the square root of the sum of all






where AH is the conjugate transpose.
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A.4 Definition of the Re-Polarisation Domain: Ωp(t, Rp)
Here, we define the re-polarisation domain used in (3.12), which allows us to inves-
tigate the spatial dependency of a re-polarisation strategy. Hence, let us define this
new domain by
Ωp(t, Rp) := {x ∈ Ω(t), xB ∈ ∂Ωo(t)| ∥ x− xB ∥2≥ Rp} ⊂ Ω(t),
where Rp > 0 is a constant and ∂Ωo(t) is the outer tumour boundary, defined in
Appendix A.1. Again, this new domain is illustrated in Fig. 3.2.
A.5 Vectors Induced by the ZSWENO Scheme
Here, for completeness we define the vectors used for the discrete convolutions in
(3.45) and (3.49). Let us start with the vectors that were induced by the ENO fluxes

































































































































































Then, the other vectors induced by the smoothness indicators (3.47) and (3.48)
are K±k,+ and K
±
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[207] Pérez-Velázquez, J., Gevertz, J.L., Karolak, A., Rejniak, K.A.: Microenviron-
mental niches and sanctuaries: A route to acquired resistance. In: Advances
in Experimental Medicine and Biology, pp. 149–164. Springer International
Publishing. DOI 10.1007/978-3-319-42023-3 8
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S., Müller-Holzner, E., Fiegl, H., Böck, G., van Rooijen, N., Theurl, I.,
Doppler, W.: In situ proliferation contributes to accumulation of tumour-
associated macrophages in spontaneous mammary tumors 44(8), 2247–2262
[282] Tyson, J.J., Novak, B.: Temporal organization of the cell cycle. Current
Biology 18(17), R759–R768 (2008). DOI 10.1016/j.cub.2008.07.001
251
[283] Uchugonova, A., Zhao, M., Weinigel, M., Zhang, Y., Bouvet, M., Hoffman, R.,
König, K.: Multiphoton tomography visualises collagen fibres in the tumour
microenvironment that maintain cancer-cell anchorage and shape 114(1), 99–
102
[284] Veeravalli, K.K., Ponnala, S., Chetty, C., Tsung, A.J., Gujrati, M., Rao, J.S.:
Integrin α9β1-mediated cell migration in glioblastoma via SSAT and kir4.2
potassium channel pathway 24(1), 272–281. DOI 10.1016/j.cellsig.2011.09.011
[285] Veeravalli, K.K., Rao, J.S.: MMP-9 and uPAR regulated glioma cell migration
6(6), 509–512. DOI 10.4161/cam.21673
[286] Vinogradov, S., Warren, G., Wei, X.: Macrophages associated with tumours as
potential targets and therapeutic intermediates. Nanomedicine 9(5), 695–707
(2014)
[287] Visse, R., Nagase, H.: Matrix metalloproteinases and tissue inhibitors of met-
alloproteinases: structure function and biochemistry. Circ Res 92, 827–839
(2003). DOI 10.1161/01.RES.0000070112.80711.3D
[288] Wang, X., Jiang, J., Wu, C.: Prognostic significance of tumor-associated
macrophage infiltration in gastric cancer: a meta-analysis. Genetics and
Molecular Research 15(4) (2016). DOI 10.4238/gmr15049040
[289] Wang, Y., Yang, T., Ma, Y., Halade, G.V., Zhang, J., Lindsey, M.L., Jin,
Y.F.: Mathematical modeling and stability analysis of macrophage activation
in left ventricular remodeling post-myocardial infarction 13(Suppl 6), S21.
DOI 10.1186/1471-2164-13-s6-s21
[290] Webb, S.D., Owen, M.R., Byrne, H.M., Murdoch, C., Lewis, C.E.:
Macrophage-based anti-cancer therapy: Modelling different modes of tumour
252
targeting. Bulletin of Mathematical Biology 69(5), 1747–1776 (2007). DOI
10.1007/s11538-006-9189-2
[291] Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., Liu, Q.,
Dou, R., Xiong, B.: Crosstalk between cancer cells and tumor associated
macrophages is required for mesenchymal circulating tumor cell-mediated
colorectal cancer metastasis. Molecular Cancer 18(1), 64 (2019). DOI
10.1186/s12943-019-0976-4
[292] Weiger, M.C., Vedham, V., Stuelten, C.H., Shou, K., Herrera, M., Sato, M.,
Losert, W., Parent, C.A.: Real-time motion analysis reveals cell directionality
as an indicator of breast cancer progression. PLOS ONE 8(3), 1–12 (2013).
DOI 10.1371/journal.pone.0058859
[293] Weinberg, R.A.: The Biology of Cancer. Garland Science, New York (2006)
[294] Wolf, K., Alexander, S., Schacht, V., Coussens, L., Andrian, U., Rheenen, J.,
Deryugina, E., Friedl, P.: Collagen-based cell migration models in vitro and
in vivo. Semin Cell Dev Biol 20, 931–41 (2009). DOI 10.1016/j.semcdb.2009.
08.005
[295] Wolf, K., Friedl, P.: Extracellular matrix determinants of proteolytic and non-
proteolytic cell migration. Tren. Cel. Biol. 21(12), 736–744 (2011)
[296] Wu, P., Wu, D., Zhao, L., Huang, L., Chen, G., Shen, G., Huang, J., Chai,
Y.: Inverse role of distinct subsets and distribution of macrophage in lung
cancer prognosis: a meta-analysis. Oncotarget 7(26), 40451–40460 (2016).
DOI 10.18632/oncotarget.9625
[297] Wu, P.H., Giri, A., Sun, S.X., Wirtz, D.: Three-dimensional cell migration
does not follow a random walk. Proceedings of the National Academy of
Sciences 111(11), 3949–3954 (2014). DOI 10.1073/pnas.1318967111
253
[298] Wullkopf, L., West, A.K.V., Leijnse, N., Cox, T.R., Madsen, C.D., Odder-
shede, L.B., Erler, J.T.: Cancer cells’ ability to mechanically adjust to ex-
tracellular matrix stiffness correlates with their invasive potential. Molecular
biology of the cell 29(20), 2378–2385 (2018). DOI 10.1091/mbc.E18-05-0319
[299] Xuan, W., Qu, Q., Zheng, B., Xiong, S., Fan, G.H.: The chemotaxis of m1 and
m2 macrophages is regulated by different chemokines. Journal of Leukocyte
Biology 97(1), 61–69 (2014). DOI 10.1189/jlb.1a0314-170r
[300] Yamaguchi, H., Pixley, F., Condeelis, J.: Invadopodia and podosomes in tumor
invasion. European Journal of Cell Biology 85(3-4), 213–218 (2006). DOI
10.1016/j.ejcb.2005.10.004
[301] Yamaguchi, H., Wyckoff, J., Condeelis, J.: Cell migration in tumors. Current
Opinion in Cell Biology 17(5), 559–564 (2005). DOI 10.1016/j.ceb.2005.08.002
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